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ABSTRACT 
 
 Muscle injury particularly the hamstring group is the most common type of 
sports related injury among athletes. Despite its frequent occurrence, the best treatment 
for hamstring injury is not known. Athletes affected by muscle injury often need 
considerable amount of time to recover. Recently autologous biological products are 
being used for treatment of soft tissue injury including that of muscles. Off recent, an 
autologous platelet-rich plasma (PRP) therapy is one of the ‘hot topics’ discussed in 
literatures. A systematic review of the available literatures on PRP therapy showed 
evidences to support PRP use for rotator cuff injury, lateral epicondylitis (tennis elbow), 
patellar tendinopathies and Achilles' tendinopathies. As clinical evidence to support its 
usefulness is limited, a randomised controlled trial is needed to examine the effect of 
PRP on muscle injury. Besides, current evidences were based on few laboratory animal 
studies and case reports. 
 
 Since information on injury prevalence and management of muscle injury in the 
local settings is limited, a cross-sectional study was conducted to investigate the pattern 
of muscle injury among Malaysian athletes. Medical records of athletes diagnosed with 
muscle injury were examined and injury mechanisms, types, treatment and duration to 
return-to-play (DRP) recorded. The pattern of muscle injury among Malaysian athletes 
was comparable to those reported by earlier researchers. Surprisingly, the DRP of local 
athletes were considerably longer compared with other studies (7.4 versus 3.8 weeks). 
Further, duration before first consultation, recurrent hamstring injury and female 
athletes were significant predictors of DRP.  
 
  iv 
 The decision to allow return-to-play was based on athlete’s symptoms of pain 
and objective clinical assessments including muscle flexibility test. An active knee 
extension (AKE) test was designed for assessment of hamstring flexibility in the RCT. 
A preliminary study on 14 healthy individuals showed excellent interater and test-retest 
reliabilities with intraclass correlation coefficient ranges from 0.78 to 0.92. This 
findings support the inclusion of the AKE test in the RCT.  
 
 Twenty-eight athletes diagnosed with grade-2 acute hamstring injury were 
recruited in an RCT to explore effect of PRP on DRP. Both intervention and control 
groups were prescribed with a standard rehabilitation program. Additionally patients in 
the PRP group received a single 3 ml injection of autologous PRP (approximately 5-
fold increase in platelets and white blood cells) into the injured muscle. Significantly 
earlier DRP (p = 0.013) was noted among participants in the PRP (median 21.0 ± IQR 
13.0 days) compared with control (median 34.0 ± IQR 37.3 days). In addition the PRP 
group has significantly (p ≤ 0.001) lower pain severity score (1.14 ± SE 0.19) than 
control at all time points (2.31 ± SE 0.23). Furthermore participants reported no severe 
adverse effect of PRP therapy. In conclusion the findings of this research suggest PRP 
therapy is a safe and effective treatment for muscle injury.  
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ABSTRAK 
 
 Kecederaan otot terutamanya kumpulan otot hamstring merupakan kecederaan 
sukan yang kerap dialami oleh atlet. Meskipun kecederaan ini kerap berlaku, rawatan 
terbaik bagi kecederaan otot masih belum dikenalpasti. Kebanyakan atlet mengambil 
masa yang panjang untuk pulih dari kecederaan otot. Kebelakangan ini produk 
autologous biologikal mula digunakan bagi merawat kecederaan tisu lembut termasuk 
kecederaan otot. Kebelakangan, penggunaan autologous platelet-rich plasma (PRP) 
bagi rawatan kecederaan tisu lembut merupakan topik hangat dibincangkan dalam 
literatur. Memandangkan bukti menyokong penggunaan PRP masih tidak mencukupi 
kajian berbentuk ujian kawalan rawak diperlukan bagi menentukan kesan PRP untuk 
kecederaan otot.  
 
 Penganalisaan ulasan sistematik literatur menunjukkan bukti menyokong 
pengunaann PRP bagi kecederaan rotator cuff, lateral epicondylitis, patellar 
tendinopathies dan Achilles’ tendinopathies. Namun begitu pengetahuan berkenaan 
penggunaan PRP bagi kecederaan otot masih terbatas. Di samping itu bukti sedia adalah 
berdasarkan kajian makmal haiwan dan beberapa laporan kes. Sehubungan itu suatu 
kajian ujian kawalan rawak (RCT) dirancang bagi mengkaji kesan PRP terhadap 
kecederaan otot. Memandangkan maklumat berkenaan prevalen kecederaan dan kaedah 
rawatan di kalangan atlet tempatan masih terhad. Suatu kajian cross-sectional bagi 
mengenal pasti corak kecederaan otot di kalangan atlet Malaysia dijalankan. Rekod 
perubatan atlet yang mengalami kecederaan otot diteliti. Maklumat berkaitan dengan 
kecederaan otot yang dialami termasuk mekanisma kecederaan, jenis kecederaan, jenis 
rawatan dan masa yang diambil untuk pulih (DRP) direkod. Corak kecederaan otot di 
kalangan atlet Malaysia adalah setara dengan kajian yang dilaporkan oleh pengkaji lain. 
  vi 
Menariknya DRP atlet tempatan lebih panjang berbanding kajian lain (7.4 berbanding 
3.8 minggu). Masa sebelum konsultasi pertama, kecederaan hamstring berulang dan 
atlet wanita adalah faktor signifikan bagi meramalkan DRP.  
 
 Keputusan bagi membenarkan atlet untuk kembali bersukan adalah berdasarkan 
gejala kesakitan dan ujian objektif klinikal termasuk ujian fleksibiliti otot. Ujian active 
knee extension (AKE) dipilih bagi menentukan fleksibiliti hamstring dalam kajian RCT. 
Kajian awalan melibatkan 14 individu yang sihat menunjukkan kesahan intra-penguji 
dan uji-ujisemula yang sangat baik dengan koefisi korelasi intra-klas antara 0.78 hingga 
0.92. Kajian ini menyokong penggunaan ujian AKE dalam kajian RCT. 
 
 Dua puluh lapan atlet yang mengalami kecederaan gred-2 hamstring mengambil 
bahagian dalam RCT ini. Kedua-dua kumpulan menerima program rehabilitasi yang 
piawai. Tambahan itu peserta dari kumpulan PRP juga menerima satu suntikan 3 ml 
autologous PRP (mengandungi 5 kali ganda jumlah platelet) pada otot yang cedera. 
Masa penyembuhan (DRP) bagi peserta kumpulan PRP secara signifikan lebih singkat 
(p = 0.013) (median 21.0 ± IQR 13.0 hari) berbanding kawalan (median 34.0 ± IQR 
37.3 hari). Tambahan, peserta kumpulan PRP juga menunjukkan skor tahap kesakitan 
signifikan (p ≤ 0.001) lebih rendah berbanding kawalan (1.14 ± SE 0.19) pada setiap 
poin masa (2.31 ± SE 0.23). Di samping itu tiada seorang peserta pun melaporkan kesan 
sampingan serius terhadap rawatan PRP. Kesimpulannya kajian ini mendapati rawatan 
PRP adalah selamat dan berkesan bagi kecederaan akut gred-2 hamstring.  
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Chapter 1  Introduction 
 
1.1 Background 
 
Muscle injury is one of the commonest injury seen in athletes. This injury 
commonly affects athletes engaging in sports that involved in high-speed sprinting and 
kicking. Muscle injuries were reported in Australian rule football, rugby union, soccer 
and American football (Brooks et al., 2005; Fuller et al., 2005; Brooks, 2006; Elliott et 
al., 2011; Ekstrand, 2012; Murphy et al., 2012). Despite of its frequency the best 
management of muscle injury is still unclear (Reurink et al., 2012). Sports medicine 
practitioners used various treatment methods in attempt to hasten recovery and allow 
early return-to-play (RTP). In the early phase following an injury the treatment 
objective is to limit the extent of injury. This can be achieved by applying the RICE 
principles which involve rest, intermittent application of ice, compression and elevation 
of the affected region (Järvinen et al., 2000). 
 
In the later stage, treatment focusses on control of symptoms and enhancing 
recovery. Several approaches are often combine including use of rehabilitation 
programmes, electrotherapeutic modalities, hyperbaric oxygen therapy and injection of 
substances to the injured area (Worrell, 1994; Drezner, 2003; Bennett et al., 2005; 
Järvinen et al., 2007; Heiderscheit et al., 2010; Stevens et al., 2010; Franklyn-Miller et 
al., 2011). Clinical evidence to support these modalities for muscle injury is limited 
(Orchard et al., 2008; Reurink et al., 2012). Despite various treatment modalities, the 
duration of RTP following muscle injury is lengthy (Wright-Carpenter et al., 2004; 
Askling, 2006). Currently, there is no consensus on the optimal treatment for muscle 
injury. More recently, injection of autologous platelet-rich plasma (PRP) have gain 
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much attention for muscle injury. Theoretically, PRP contains many growth factors and 
cytokines that is essential for regenerating muscle fibres. These substances are stored 
within the α- and dense granules of platelets (Mejia et al., 2011). Preliminary animal 
study showed significant acceleration of muscle healing in injured mice (Wright-
Carpenter et al., 2004). Human study to demonstrate the potential capacity of PRP for 
muscle injury is limited. Controversies exist as two case control studies found 
contrasting effects of PRP for muscle injury (Wright-Carpenter et al., 2004; Rettig et 
al., 2013). More well design study to examine the effect of autologous PRP on muscle 
injury are needed (Engebretsen et al., 2010). 
 
 A short review of the skeletal muscle structure and function is presented in this 
chapter. This is followed by a discussion on the pathobiology of muscle injury and 
muscle healing. The epidemiology of muscle injury specifically the hamstring muscle 
(most frequent muscle injured) including its incidence, mechanisms of injuries and 
injury severity are explored. Finally, the current management of muscle injury is 
discussed. 
 
 
1.2 Skeletal muscle 
 
Skeletal muscle cells are unique as they have the capacities of contracting in 
response to activation by an action potential (Marieb, 2009; Tate, 2011). Each muscle in 
the human body comprised of multiple bundles of muscle fascicles. These muscle 
fascicles itself are collection of muscle fibres grouped. Each muscle fibre is an 
elongated cells extending throughout the length of the muscle (Figure 1.1). 
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Muscle bundles usually comprised of various muscle fibre subtypes. Depending 
on the muscle main role, the proportion of fibre subtypes distribution differs. Fast 
contracting muscles have a higher percentage of Type II fibres, whereas slower 
contracting muscle comprised mainly of Type I fibres. Therefore, sprinters, have a 
higher percentage of muscle Type II fibres while long-distance runners have a lower 
percentage of Type II fibres in the vastus lateralis muscle (Komi et al., 1977).  
 
 
Figure 1.1. Skeletal muscle structure (Source: Seeley's Principle of Anatomy & 
Physiology, 2nd Edition 2012, p. 201). 
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 Type II muscle fibres are more susceptible to eccentric contraction-induced 
injury than Type I fibres. This was demonstrated in both human and animal studies 
(Friden et al., 1983; Jones et al., 1986). It is hypothesized that depletion of high-energy 
phosphates and resulting formation of actin-myosin cross-bridges in the rigor state is 
responsible for the increased injury susceptibility of type II fibres. Breaking the rigor 
cross-bridges through mechanical loading induced by eccentric contractions could lead 
to muscle injury (Patel & Cuizon, 1998).  
 
 Differences in the cytoskeletal proteins between Type I and II muscle fibres 
might also play a role in injury susceptibility. Type I fibres have higher levels of certain 
cytoskeletal proteins that provide structural support to sarcomeres and the cell 
membranes. These structures provide protection from eccentric contraction-induced 
injury (Koh, 2002). Other protective substances, including a family of “stress proteins” 
may also affect the risk of injury. These stress proteins, also known as “heat shock 
proteins” protects cells from mechanical stress during eccentric contraction. The levels 
of “heat shock proteins” are higher in Type I than II fibres (Koh, 2002).  
 
 
1.3 Skeletal muscle injury 
 
Muscle injury is one of the commonest sports related injuries affecting elite or 
recreational athletes (Järvinen et al., 2000; Brooks et al., 2005; Ekstrand, 2008). These 
injuries occur through various mechanisms, including direct trauma (e.g., lacerations, 
contusions and strains) and indirect causes (e.g. ischemia and neurological dysfunction) 
(Schiaffino et al., 2008; Tiidus, 2008; Tate, 2011). More than 90 % of sports related 
muscle injuries are either contusions or strains (Järvinen et al., 1993; William, 1999), 
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while muscle laceration occurs less frequent. A muscle contusion occurs when a muscle 
is subjected to sudden heavy compressive force, such as a direct hit to the muscle often 
seen in contact sports (Junge et al., 2004; Järvinen et al., 2005; Junge et al., 2010). 
Muscle strains on the other hand are often reported during explosive activities such as 
jumping and sprinting, when the muscle develops tension while lengthening (eccentric 
contraction) (Crisco et al., 1994; Gabbe et al., 2004; Järvinen, 2005). Muscle strain 
occurs especially when the contractions are performed by muscle not previously 
conditioned with eccentric contractions (Jones et al., 1986; Garrett, 1996; Schultz, 
1989; Lieber & Friden, 2007; Tiidus, 2008; Flann et al., 2011). Patel et al. (1998) 
hypothesised the low oxidative capacity of fast glycolytic fibres predisposes to injury 
during repetitive eccentric contractions through depletion of high-energy phosphates. 
Depletion of high-energy phosphates subsequently leads to formation of actin-myosin 
cross-linkages in the rigor state. Added mechanical loading induced by eccentric 
contractions will cause breaking of this rigor cross bridges causing muscle injury (Patel 
& Cuizon, 1998; Scott et al., 2001).  
 
 Garret (1996), reported that certain muscle are more susceptible to strain injury. 
Muscle that crosses multiple joints or has complex architecture such as the hamstring; 
quadriceps and gastrocnemius muscles have higher risk of injury (Komi et al., 1977; 
Garrett, 1996; Ekstrand, 2012; Ropiak & Bosco, 2012). Hamstring muscle injuries are 
the most common muscle injury reported in athletes (Garrett, 1996; Patel & Cuizon, 
1998; Junge et al., 2004; Ekstrand, 2006; Eirale et al., 2013).  
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1.3.1 Pathobiology of muscle injuries and healing 
 
Injury to muscle, whether through direct trauma or indirect strain, follows a 
fairly constant healing pattern. Unlike bone, muscle has limited ability to regenerate 
new fibres; following injury muscle heals through repair process. Three phases of 
muscle healing have been identified; (1) destruction phase, (2) repair phase and (3) 
remodelling phase (Figure 1.2) (Kalimo et al., 1997; Hurme et al., 2006; Koh, 2008). 
The latter 2 phases are usually closely associated and chronologically overlapped each 
other. In each phases, complex interaction between various cells including 
inflammatory cells, platelets, fibroblasts, satellite cells, and substances such as 
cytokines and growth factors are involved (Järvinen et al., 2000; Koh, 2002; Järvinen, 
2005; Tiidus, 2008).  
 
1.3.1 (a) Destruction phase 
 
Excessive mechanical force can lead to tearing of the sarcoplasm in muscle 
injury. As myofibres are long and string-like cells there is a possibility that necrosis can 
extend along the entire muscle length. This is prevented by a condensation of 
cytoskeletal material known as contraction band (Järvinen, 2005). 
 
Cellular contents released from injured cells serve as chemo attractants (wound 
hormones) further heightening the inflammatory reaction (Järvinen, 2005). 
Inflammatory cells (mainly macrophages) infiltrate injured muscle to remove necrotic 
cells via phagocytosis while leaving the basal lamina intact. The intact basal lamina 
serves as scaffolds for satellite cells to form new myofibres (Hurme et al., 1992; Hurme 
et al., 1993).  
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Figure 1.2. Different stages of muscle healing after injury (Source: Huard et al., 2002, 
p. 826). 
 
 
1.3.1 (b) Repair and remodelling phase 
 
The repair phase starts once the destruction phase has subsided.  This phase 
begins with two concomitant processes that are supportive but at the same time 
competitive; the regeneration of disrupted myofibres (including nerves) and the 
formation of a connective tissue scar (Kalimo et al., 1997; Hurme et al., 2006). Optimal 
recovery of muscle contractile function depends on a balance progression of both 
processes.  
 
Immediately after injury, the gap that develops between ruptured muscle fibres 
is filled with blood clot (haematoma) (Figure 1.3). Within the next few hours, 
inflammatory cells including phagocytes arrived to the injured site to remove necrotic 
cells and haematoma. This is followed by invasion of fibroblasts, forming early 
granulation tissue. Later, fibroblasts start to synthesise proteins and proteoglycans to 
restore the integrity of the connective tissue framework (Lehto et al., 1986; Hurme et 
  8 
al., 1991; Hurme et al., 2006). In the early stage fibroblasts synthesise fibronectin, 
tenascin-C and type III collagen. After few days Type I collagen is replaced with the 
considerably stronger scar tissue (mainly Type II collagen) (Hurme et al., 1991).  
 
Muscle tissue limited regeneration capacity occurs by means of a pool of 
undifferentiated reserve cells called the satellite cells. These cells are located 
underneath the basal lamina of individual myofibre (Kalimo et al.,1997; Tiidus, 2008). 
Satellite cells proliferate and later differentiate into multinucleated myoblast in response 
to injury. In a laboratory studies on single muscle fibres culture, Bischoff et al., (2006) 
showed satellite cells activation and proliferation occurred only when exposed to 
crushed muscle extract. These cells remain quiescent when exposed to normal muscle 
extract or crushed extract from non-muscle tissues. They concluded that myogenic 
satellite cells, and muscle regeneration are regulated by multiple growth factors released 
by injured muscle (Figure 1.4). Their conclusion was supported by in vitro and in vivo 
studies by other researches (Table 1.1). 
 
 The newly formed multinucleated myotubes will then fused with the injured 
myofibres that have survived the initial injury (Järvinen et al., 2007). On both ends of 
connective tissue scar, survived muscle fibres form multiple branches in attempt to 
pierce through the scar separating them. But, after extending for a short distance, most 
regenerated myofibres only managed to adhere to connective tissue forming 
minimyotendinous junction with scar (Vaittinen et al., 2002). As scar tissue contracts 
with time, the stumps adhere closer to one another (Hurme et al., 1993). Also, the 
regenerative capacity of skeletal muscle is significantly reduced with age. This 
diminished capacity is attributed to the deterioration and slowing down of each phases 
of the repair (Järvinen et al., 1983). 
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Figure 1.3. A schematic illustration of the healing skeletal muscle. 
Day 2: necrotized parts are being removed by macrophages while, concomitantly, the 
formation of connective tissue scar by fibroblasts has begun. Day 3: satellite cells have 
become activated within the basal lamina cylinders. Day 5: myoblasts have fused into 
myotubes with the connective tissues become denser. Day 7: the regenerating muscle 
fibres extend out of the old basal lamina cylinders and begin to pierce through the scar. 
Day 14: the scar further condensed and reduced in size, and the regenerating myofibers 
closing the gap. Day 21: the interlacing myofibres are virtually fused with little 
intervening connective tissue (scar) in between (Source: Järvinen et al., 2007, p. 319). 
 
 
 
Figure 1.4. Regulators of myogenic satellite cells activation, proliferation and 
differentiation. FGF = fibroblasts growth factor, IGF = insulin-like growth factor, LIF = 
leukaemia inhibitory factor, TGF - β = transforming growth factor beta (Source: Tiidus 
2008, p. 83). 
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Table 1.1 : Growth factors affecting myogenic satellite cells activity. 
In vitro studies Myogenic satellite cells activity 
Growth factor Activation Proliferation Differentiation References 
HGF Increased Increased Decreased 
(Allen et al., 1995; 
Miller et al., 2000) 
FGF  Increased Decreased (Thompson et al., 1989) 
IGF-1  Increased Increased (Thompson et al., 1989) 
IGF-2  Increased Increased 
(Florini, 1987; Haugk et 
al., 1995) 
MGF Increased   (McKoy et al., 1999) 
LIF  Increased  
(Austin & Burgess, 
1991) 
TGF-β  Decreased Decreased 
(Allen & Boxhorn, 
1989) 
In vivo studies Myogenic satellite cells activity 
HGF Increased   (Tatsumi et al., 1998) 
FGF  Increased Decreased (Armand et al., 2005) 
IGF-1  Increased Increased 
(Chakravarthy et al., 
2000) 
IGF-2  Decreased Decreased (Kirk et al., 2003) 
MGF Increased   (Hill et al., 2003) 
LIF  Increased  (Kurek et al., 1997) 
TGF-β  Decreased  (Thomas et al., 2000) 
 
 
 
1.4 Epidemiology of muscle injury 
 
 
1.4.1 Incidence of muscle injury 
 
One of the frequently injured muscles is the hamstring’s muscle group (biceps 
femoris, semitendinosus and semimembranosus). Hamstring muscle injury accounts for 
12 – 52 % of all injuries suffered in sports events (Askling et al., 2004; Feeley et al., 
2008; Shariff et al., 2009; Ekstrand et al., 2011; Orchard & Seward, 2011; Murphy et 
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al., 2012). A two-year prospective study among professional rugby union players 
reported higher incidence of hamstring injury during rugby match (5.6 per 1000 match 
hours) than at training (0.27 per 1000 training hours). They also noted majority of 
hamstring injury often occurred during running. Injuries resulting from kicking however 
were associated with longer recovery period (36 days) (Brooks et al., 2005; Brooks, 
2006; Elliott et al., 2011; Ekstrand, 2012; Murphy et al., 2012). An injury rate of 0.87 
per 1000 hours of exposure was reported in competitive sprinters. The incidence of 
hamstring injuries was higher at the beginning of the season, with 58.3 % injuries 
occurring in the first 100 hours of exposure. Further analysis showed athletes with 
hamstring: quadriceps peak torque ratio less than 0.60 at angular speed of 180 °/sec 
have a 17-fold increase risk of hamstring injury (Yeung et al., 2009; Reurink et al., 
2012).  
 
Data from one of the longest injury survey study (from 1992 – 2012) found 
hamstring injury as the most frequent and prevalent injury among Australian Football 
League players. They estimated six new hamstring injury occurs per club per seasons, 
resulting in 20 missed matches each season. Surprisingly, the incidence of hamstring 
injury has not declined in recent decades (Orchard et al., 2008; Orchard et al., 2013).  
 
Posterior thigh strains were reported as the most common injury among 
professional football players (Ekstrand et al., 2012; Reurink et al., 2012). Seven players 
are expected to suffer new hamstring muscle injury in a team of 25 per season. Further, 
approximately 12 % of athletes who suffered hamstring injuries require more than 28 
days to achieve full recovery (Wright-Carpenter et al., 2004; Askling, 2006; Ekstrand et 
al., 2011). In a self-reported hamstring injury study among ballet dancers, Askling et al. 
(2002) found 34 % of dancers reported history of acute and 17 % had history of chronic 
  12 
hamstring injuries over the past 10 years. They noted majority of hamstring injuries 
occurred during flexibility training activities such as splits while only a few (12 %) 
during powerful movements (Askling et al., 2002). Researchers also reported hamstring 
injuries mainly occurred during sprinting, kicking or jumping as muscle develops 
tension while lengthening (Zarins et al., 1983; Kujala et al., 1997; Wright-Carpenter et 
al., 2004a).  
 
 
1.4.2 Anatomy of hamstring muscles 
 
The hamstring muscle group is located in the posterior compartment of the thigh 
(Figure 1.5). This muscle primarily involved in hip extension and knee flexion. In 
addition, hamstring muscle also medially (semimembranosus) or externally rotates 
(biceps femoris) the knee while in flexion. The hamstring’s muscle group consists of 
semimembranosus (SM), semitendinosus (ST) and biceps femoris muscles. These 
muscles are long, and predominantly biarticular, hence higher susceptibility to strain 
injury (Heiser et al., 1984; Bennell et al., 1998; Orchard & Seward, 2002; Slavotinek et 
al., 2002 Engebretsen et al., 2010). In addition, hamstring muscles contain significantly 
high proportion of Type II fibres compared with quadriceps or adductors (Garrett et al., 
1984; Brooks, 2006; Marieb, 2009; Elliott et al., 2011; Orchard & Seward, 2011; Tate, 
2011; Ekstrand, 2012).   
 
1.4.2 (a) Semimembranosus (SM)  
 
The SM has the longest proximal tendon (72.7 % of total SM length) of all the 
hamstring muscles. The proximal tendon attaches to the lateral part of the upper half of 
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the ischial tuberosity. From here the tendon widened becoming broad, expansive and 
aponeurotic, being thick and rounded at its lateral border and flattening into a thin 
membrane medially (Komi et al., 1977; Woodley & Mercer, 2005; Reurink et al., 
2012). The distal tendon of semimembranosus is thicker and shorter and attaches into 
the posterior part of the medial condyle of the tibia. The tibial division of the sciatic 
nerve usually innervates the SM muscle. 
 
Figure 1.5. Right posterior thigh (hamstring) muscle (Source: Seeley's Principles of 
Anatomy & Physiology 2nd Edition 2012, p. 259). 
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1.4.2 (b) Semitendinosus (ST) 
 
The proximal ST muscle arose from distinct locations: the posteromedial parts 
of the medial portion upper half of the ischial tuberosity and the medial border of BF 
long head tendon. The distal tendon is long and thin and passes along the medial aspect 
of the knee joint (Friden et al., 1983; Jones et al., 1986; Woodley & Mercer, 2005; 
Orchard et al., 2008; Reurink et al., 2012). The distal ST tendon on the other hand 
attaches to the medial surface of proximal tibia. The ST muscle receives nerve supply 
form the tibial division of the sciatic nerve. 
 
1.4.2 (c) Biceps femoris (BF) 
 
The BF has two distinct portions; the BF long head (BFlh) and short head 
(BPsh). The BFlh has a fusiform muscle belly, and attaches to the medial portion of the 
upper half of the ischial tuberosity by means of a thick, round tendon (Patel & Cuizon, 
1998; Woodley & Mercer, 2005; Askling, 2006). BFlh distal tendon is flattened on the 
sides, with muscle fibres of the short head inserted into its deep surface. The tendon 
passes downwards and forwards directly inserted into the head of the fibula, the lateral 
ligament of the knee and lateral condyle of the tibia. In addition, the tendon blends 
anteriorly with the ilio-tibial tract and gives off expansions to the crural fascia covering 
the anterior, lateral and posterior compartment of the leg. The BFlh is supplied by one 
muscle nerve that branches off the sciatic nerve (Woodley & Mercer, 2005; Koh, 2008; 
Tate, 2011). 
 
The short head of BF (BFsh) arose from three locations: (i) the linea aspera of 
the femur, (ii) the upper two thirds of the lateral supracondylar line and (iii) the lateral 
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intermuscular septum (separating BFsh from the vastus lateralis muscle). The muscle 
belly of BFsh is relatively thin, but broad and long. The distal tendon of BFsh inserted 
into the tendon of BFlh and innervated by two nerve branches: (i) the nerve branch from 
the sciatic nerve and (ii) the nerve branch from the common peroneal nerve.   
 
The dual innervation of the BF muscle might lead to asynchronous stimulation 
of the two heads (Sutton, 1984; Koh, 2002; Woods et al., 2004; Wright-Carpenter et al., 
2004). It had been suggested that mistimed contraction of the different parts of 
hamstring muscles  (BFlh and BFsh) leads to reduced capacity to produce effective 
tension to control imposed loads of the muscle (Zuluaga, 1995; Järvinen et al., 2000; 
Brooks et al., 2005; Ekstrand, 2008; Engebretsen et al., 2010). 
 
 
1.4.3 Mechanism of hamstring injury 
 
Previous researches noted hamstring injury often occurred during eccentric 
muscle contraction (Zarins & Ciullo, 1983; Garrett et al., 1989; Brockett et al., 2004; 
Schiaffino & Partridge, 2008; Tiidus, 2008; Marieb, 2009; Tate, 2011). Eccentric 
contraction occurs during many sport activities including running, sprinting, jumping, 
kicking and during passive hamstring stretching (Komi et al., 1977; Järvinen & Lehto, 
1993; William, 1999; Seward, 2003; Woods et al., 2004; Askling, 2006). A total of 587 
hamstring injuries were diagnosed over seven-year follow-up period among European 
male professional footballers. Majority of these injuries occurred while running or 
sprinting (Friden et al., 1983; Jones et al., 1986; Junge et al., 2004; Järvinen, 2005; 
Junge & Dvorak, 2010; Ekstrand, 2012). Hamstring injury was also the most prevalent 
injury in Gaelic football; the author described noncontact nature, including sprinting, 
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turning and landing from a jump as the principal mechanism of injuries (Murphy et al., 
2012). Most (76.9 %) hamstring injury observed by Gabbe et al. (2004) occurred in 
competition, with the rest occurred at training sessions. The majority (80.8 %) of 
hamstring injury occurred while performing rapid acceleration movement during 
running or sprinting (Gabbe et al., 2004). Kicking was responsible for hamstring injury 
less often (19.2 %) (Jones et al., 1986; Schultz, 1989; Garrett, 1996; Gabbe et al., 2004; 
Lieber & Friden, 2007; Koh, 2008; Tiidus, 2008; Flann et al., 2011). Others, however, 
observed acute hamstring injury occurred more often (88 %) during slow, controlled, 
voluntary stretching activities with remaining 12 % occurred during a powerful and 
energetic movement such as a ‘grandejeté’ (split jumping) (Patel & Cuizon, 1998; Scott 
et al., 2001; Askling et al., 2002; Koh, 2002).  
 
Askling et al. (2000) reported two cases of acute hamstring injury with different 
aetiologies. The magnetic resonance imaging (MRI) performed in both cases 
demonstrated injury occurred at two different locations, suggesting different tissues 
involvement. In artistic dancer, hamstring injury occurred during slow stretching 
activities and involved proximal semimembranosus tendon. In sprinter however, MRI 
changes mainly observed in the lateral and anterior part of the semitendinosus muscle 
belly. Further, the recovery period was significantly longer for the dancer (18 months 
vs. 6 months) than the sprinter. They demonstrated the importance of defining the exact 
anatomical localisation of injured tissue and the duration of recovery is also affected by 
type of tissue involved (Asking et al., 2000). 
 
A laboratory study conducted by McCully & Faulkner (1985) concluded 
lengthening (eccentric) contraction causes significant skeletal muscle injury compared 
with isometric or shortening contraction (McCully & Faulkner, 1985). During eccentric 
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exercises, the contracting muscles are forcibly stretched which might disrupt cellular 
structure and function (Jones et al., 1986; Garrett, 1996; Järvinen et al., 2000; 
Schiaffino & Partridge, 2008; Tiidus, 2008; Tate, 2011; Liu et al., 2012). Such 
contraction occurs during downhill running when the contracting quadriceps muscle 
forcibly lengthened against the force of gravity with each step (Järvinen & Lehto, 1993; 
William, 1999; Proske & Morgan, 2001). Chumanov et al. (2012) observed that peak 
hamstring musculotendinous stretch occurred during late swing of the gait cycle. They 
also shown that peak hamstring force and negative musculotendinous work increased 
significantly with speed (Junge et al., 2004; Järvinen, 2005; Thelen et al., 2005; Junge 
& Dvorak, 2010; Chumanov et al., 2012). 
 
 
1.4.4 Location of hamstring injury 
 
Radiological imaging modalities including ultrasonography (US), MRI and 
computed tomography (CT) allow accurate assessment of injury location, extent and 
severity (Crisco et al., 1994; Garrett, 1996; Järvinen, 2005; Wong, 2005). Studies have 
consistently showed that forceful stretching injury usually occurs near the muscle-
tendon and bone-tendon junction (Schultz, 1989; Garrett et al., 1984; Jones et al., 1986; 
Garrett, 1990; El-Khoury, 1995; Garrett, 1996; Lieber & Friden, 2007; Tiidus, 2008; 
Flann et al., 2011; Silder et al., 2013). A study on posterior thigh muscle injury in elite 
track and field athletes, found majority of hamstring (85 out of 90 cases) injuries 
affected the musculotendinous junction (Patel & Cuizon, 1998; Scott et al., 2001; 
Malliaropoulos et al., 2010).  Similarly, Connell et al. (2004) found 62.2 % of 
hamstring injuries occurred at the musculotendinous junction on ultrasound (US) 
assessment (Connell et al., 2004).  
  18 
Researchers also showed most hamstring injuries affected the musculotendionus 
of the biceps femoris tendon (Friden et al., 1983; Jones et al., 1986; Garrett, 1996; 
Järvinen et al., 2000; Connell et al., 2004; Brooks, 2006; Cohen et al., 2011; Liu et al., 
2012; Silder et al., 2013). Up to 84 % of hamstring injuries among professional 
footballers affected the biceps femoris muscle (Garrett, 1996; Patel & Cuizon, 1998; 
Junge et al., 2004; Ekstrand, 2006; Ekstrand et al., 2012; Eirale et al., 2013). Similarly, 
in a retrospective study of Australian Football League and Rugby league athletes, 
Comin et al. (2012) found majority of hamstring injury involved the bicep femoris 
muscle (45 of 62 hamstring injury cases). Hamstring injury involving the central tendon 
have significantly worse prognosis than those that only involve muscle fibres, epimysial 
fascia or the musculotendinous junction (Kalimo et al., 1997; Hurme et al., 2006; Koh, 
2008; Comin et al., 2012). In contrast, Askling et al. (2008) found semimembranosus 
muscle was most commonly injured in 83 % of athletes from various sports (Askling et 
al., 2008). 
 
 
1.4.5 Diagnosis of a hamstring injury 
 
In most instances diagnosing a hamstring injury is easy and straightforward. 
Diagnosis begins with careful history of the injury as most athletes presented with 
sudden onset posterior thigh pain and tenderness sustained during activities (Huard et 
al., 2002; Malliaropoulos et al., 2010; Ekstrand et al., 2011). Brooks et al. (2005) found 
most hamstring injuries resulted from noncontact injury during running and cutting 
movements (Brooks et al., 2005; Järvinen, 2005). A thorough clinical examination 
(inspection and palpation) combined with functional hamstring muscle testing 
(flexibility and strength testing) is usually performed to diagnose hamstring injury 
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(DeLee, 2003; Järvinen, 2005; Gielen et al., 2007; Järvinen et al., 2007; Brukner & 
Khan, 2010). The diagnosis of hamstring injury is easy when a typical history of strain 
is accompanied by objective evidence of swelling and ecchymosis (bruising) just distal 
to the injured site (Hurme et al., 1993; Järvinen et al., 2007). In some cases, however, 
swelling and ecchymosis are less prominent especially when haematoma developed 
intramuscularly, where the extravasation of blood (from torn muscle fibres and blood 
vessels) are contained within the intact muscle fascia, limiting the size of swelling 
(Kalimo et al., 1997; Järvinen et al., 2000; Hurme et al., 2006). In such cases, palpation 
of the affected site while athlete is in supine will usually elicit pain. In addition, athletes 
often have reduced flexibility (including the active knee extension test) and reduced 
strength of the injured hamstring (including 15 ° resisted knee flexion in supine test) 
(Lehto et al., 1986; Hurme et al., 1991; DeLee, 2003; Tornese et al., 2006; Brukner & 
Khan, 2010; Malliaropoulos et al., 2010). Based on hamstring clinical assessment 
several injury classifications were proposed (Table 1.2).  
 
Unfortunately, clinical based classification does not accurately reflect the 
anatomy of the injury and has not been shown to reliably predict prognosis and time to 
return to sport (Best, 1995; Kalimo et al., 1997; Tiidus, 2008). Therefore, radiological 
assessment including US and MRI has been recommended in assessing hamstring 
injuries (Table 1.3). The availability, low cost and ease of examination suggested that 
US might be superior to MRI (Peetrons, 2002; Järvinen et al., 2007). Both US and MRI 
allow better understanding of the injury location, extent and severity of injury, which 
are relevant prognostic factors for predicting recovery time, return to pre-injury sport 
activity and risk of recurrence (Vaittinen et al., 2002; Askling et al., 2006; Guillodo et 
al., 2011; Ekstrand et al., 2012). Hence a classification system that combines both 
clinical and radiological imaging (MRI or US) of acute muscle injuries was proposed 
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(Hurme et al., 2006; Cohen et al., 2011; Chan et al., 2012; Mueller-Wohlfahrt et al., 
2013).  
 
Table 1.2 : Overview of clinically based muscle injury classification systems. 
Author/s Brukner & Khan 
(2010)  
Järvinen et al. 
(2007) 
DeLee & Drez 
(2003) 
Malliaropoulos et 
al. (2010) 
Injury 
severity 
    
Grade I 
 
Strain involves a small 
numbers of muscle 
fibres with localized 
pain but no loss of 
strength. 
Tear of only few 
muscle fibres with 
minor swelling 
and discomfort 
accompanied with 
no or minimal 
loss of strength 
and restriction of 
movement (ability 
to mobilise) 
Tearing of few 
muscle fibres with 
mild and minimal 
loss of strength 
AROM deficit < 
10° 
Grade II 
 
Tear of significant 
number of muscle 
fibres with associated 
pain and swelling. 
Greater damage to 
the muscle with 
clear loss of 
function (ability 
to contract) 
Increased tearing 
of muscle fibres 
with some 
strength loss 
AROM deficit 10° - 
19° 
Grade III Complete tear of the 
muscle. Pain is 
reproduced on muscle 
contraction. Strength is 
reduced and movement 
is limited by pain 
Tear extending 
across the entire 
cross-section of 
the muscle with 
virtually complete 
loss of muscle 
function 
IIIA: Tearing of 
the entire muscle 
with complete 
loss of strength.  
IIIB: Avulsion 
fracture of at the 
tendon’s origin or 
insertion site 
(more commonly 
in adolescent and 
small subset of 
adults) 
AROM deficit 20° - 
29° 
Grade IV NA NA NA AROM deficit   
> 30 ° 
AROM = active range of motion; NA = not applicable. 
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Table 1.3 : Overview of radiological muscle injury classification systems. 
 Ultrasonography based MRI based 
Author Peetrons (2002) Lee & Healy 
(2004) 
Pathria & Boutin 
(2005) 
Stoller (2007) 
Injury 
severity 
    
Grade I Minimal elongation 
with < 5 % of 
muscle involved 
Normal appearance 
or focal or general 
areas od increased 
echogenicity.  
 
Normal muscle 
morphology with 
mild abnormalities 
of muscle signal, 
particularly in the 
region of the 
myotendinous 
junction 
MRI negative, no 
structural damage. 
Hyperintense 
oedema with or 
without 
hemorrhage 
Grade II Lesion involving 
from 5 to 50 % of 
the muscle volume 
or cross-sectional 
diameter 
Hypervascularity 
around disrupted 
muscle fibres with 
intramuscular fluid 
collection with 
surrounding 
hypoechoeic halo 
Signal changes and 
mild alterations in 
muscle 
morphology. T2 
weighted images 
may show 
irregularity, 
thinning, and mild 
waviness of the 
tendon fibres.  
MRO-positive with 
tearing up to 50 % 
of the muscle 
fibres. Possible 
hyperintense focal 
defect and partial 
retraction of 
muscle fibres. 
Grade III Complete muscle 
tear with complete 
retraction 
Complete 
myotendinous or 
tendoosseous 
avulsion 
More significant 
alterations in the 
muscle morphology 
representing 
complete rupture of 
the myotendionus 
junction. Large 
amounts of 
haemorrhage with 
obvious tendons 
retraction 
Muscle rupture or 
100 % structural 
damage. Complete 
tearing with or 
without muscle 
retraction 
 
 
 
1.4.6 Severity and recurrence  
 
Currently there is no standard classification for muscle injury severity. 
Researchers use several approaches in describing the severity of muscle injury. Injury 
severity often described by the number of days absent from games or training sessions 
in epidemiological studies. An injury is given an A grade if athlete missed less than 7 
days; B if missed 7 to 14 days; C if missed more than 14 days and D if missed more 
than 8 weeks (Järvinen et al., 1997; Feeley et al., 2008). Other researchers classify 
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hamstring injury into minor (≤ 1 week), moderate (>1 to 3 weeks), and major (> 3 
weeks) injuries based on time absence from training or competition (Askling et al., 
2004; Brooks et al., 2005; Feeley et al., 2008b; Shariff et al., 2009; Ekstrand et al., 
2011a; Orchard & Seward, 2011; Murphy et al., 2012).  
 
Only few studies used specific clinical evaluation to decide on athlete’s 
readiness to return-to-play (Askling et al., 2002; Brooks et al., 2005; Ekstrand, 2008; 
Feeley et al., 2008b; Shariff et al., 2009; Malliaropoulos et al., 2010; Warren, et al., 
2010). Further, the criteria used for determination of athlete’s readiness to return to 
sports vary across studies, as there is no consensus for safe return to sport following 
muscle injury (Askling et al., 2004; Woods et al., 2004; Brooks, 2006; Ekstrand, 2008; 
Feeley et al., 2008b; Yeung et al., 2009b; Warren et al., 2010; Murphy et al., 2012). In 
an attempt to standardise injury definitions and data collection, the FIFA Medical 
Assessment and Research Centre defines injury severity slight (0 - day); minimal (1 - 3 
days); mild (4 - 7 days); moderate (8 - 28 days); severe (> 28 days) based on time loss 
from participation (Fuller et al., 2006; Orchard et al., 2013).  
 
By combining anatomical diagnosis, physical examination and radiology 
imaging (including ultrasonography or MR imaging), the severity of hamstring injury 
can be categorised as Grade I: mild strain injury with minimum tear and minor loss of 
strength, Grade II: moderate strain injury with partial tear and significant loss of muscle 
strength that results in significant functional limitations, and Grade III: severe injury 
with complete rupture and associated with severe functional disability. Such grading is 
useful for standardising muscle injury severity and to forecast time-lost from 
participation (Tornese & Melegati, 2006; Järvinen et al., 2007; Ekstrand et al., 2011; 
Eirale et al., 2013). The average time losses for different grades of hamstring injury 
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among professional soccer players was 17 days for grade I, 22 days for grade II and 73 
days for grade III (Askling et al., 2002; Ekstrand et al., 2011). 
 
Despite of various injury grading systems, it is comforting to know that majority 
of hamstring injuries were minor or moderate injuries. Brooks et al. (2006) found 74 % 
of hamstring muscle injuries occurred among professional rugby players were recorded 
as either minor or moderately severe injury (Brooks, 2006). Similarly, Malliaropoulos et 
al. (2011) also noted most hamstring injury falls under grades I to II injury severities 
(Malliaropoulos et al., 2011; Tate, 2011). During the 1998/99 football seasons, 158 
hamstring injuries recorded with 151 injuries were classified as grades I and II (Heiser 
et al., 1984; Bennell et al., 1998; Orchard & Seward, 2002; Slavotinek et al., 2002; 
Dadebo et al., 2004). In a prospective study of professional football players, only 31 
(18.3 %) cases of major injuries were diagnosed between 1989 and 1996 (Elliott et al., 
2011). Further, Ekstrand et al. (2011) found severe hamstring injuries (causing absence 
of > 28 days) among professional soccer players represent only 16 % of total hamstring 
injuries (Ekstrand et al., 2011). 
 
Apart from causing considerable time lost from training and competition, 
another significant sequelae of hamstring injury are recurrent injuries (reinjuries). A 
recurrent injury is defined as an injury of the same type (diagnosis), which occurred 
after a player’s full return to participation. A recurrent injury occurring within 2 months 
of a player’s return to full participation is referred to as an “early recurrence” while 
those occurred between 2 to 12 months as “late recurrence”. A recurrent injury 
occurring after 12 months is referred as “delayed recurrence” (Fuller et al., 2006). 
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Analysis of recurrence data from the Australian Football League injury 
surveillance showed higher proportion of hamstring injury recurred during the first 
week after return to sport. Further, the risk of recurrence remains elevated for many 
weeks after return to play (Table 1.4) (Orchard & Best, 2002). Reduced tensile strength 
of the scar tissue, reduced muscle strength because of disuse atrophy, reduced flexibility 
of the muscle-tendon unit and adaptive changes in biomechanics following injury were 
suggested to be responsible of increased risk of recurrences (Orchard & Best, 2002). 
 
The incidence of hamstring recurrent injury is estimated between 12 to 48 % of 
athletes (Hawkins et al., 2001; Woods et al., 2004; Brooks, 2006; Warren et al., 2010; 
Malliaropoulos et al., 2011; Ekstrand et al., 2011; Murphy et al., 2012; Eirale et al., 
2013). An audit of injuries in professional soccer in from 1997 to 1999 reported 202 (48 
%) cases of recurrent hamstring injuries. Athletes who reinjured his hamstring within 
the same season were found to have a more severe injury than the previous injury and 
needed significantly longer recovery period (31.8 vs. 27.3 days) (Hawkins et al., 2001). 
A prospective study of 51 football teams (2299 players) saw 16 % cases of recurrent 
hamstring muscle injury with reinjuries causes 30 % longer absences than did non-
reinjuries (Ekstrand et al., 2011). 
 
Volpi et al. (2004) reported the lowest incidence of recurrent injury from a five-
year injury survey of an Italian major league soccer team. Only one (3 %) case of 
recurrent hamstring injury was reported during the period of 1995 - 2000. The author 
suggested that constant and well coordinated monitoring of injured athletes by team 
doctor and other consultants form various areas including physiotherapists and trainers 
are responsible for such lower recurrent injury rate (Volpi et al., 2004).  
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A steady decline in hamstring recurrence rate was observed over the past 10 
years in Australian Football League. The decline in injury recurrences was attributed to 
more conservative approaches in managing hamstring injury and more conservative 
decision on return-to-play (Orchard & Seward, 2011; Orchard et al., 2013). 
 
Table 1.4 : Chance of hamstring injury recurrence after return from injury (1992 - 
1998 Australian Football League) (Source: Orchard & Best 2002, pg:4) 
 Weekly percentage risk of injury recurrence (%) 
Weeks after return from 
initial injury 
Hamstring injury 
(n = 858) 
Quadriceps injury 
(n = 251) 
Calf injury 
(n = 217) 
1 12.6 9.0 7.8 
2 8.1 4.7 5.7 
3 6.8 3.3 3.3 
4 - 5 4.7 3.7 0.0 
6 - 8 3.1 3.3 2.8 
9 - 14 2.7 0.5 1.1 
15 - 22 1.4 2.2 2.1 
Cumulative risk of recurrence  30.6 22.9 12.2 
 
 
Hamstring injuries affect both the team performance as well as the club financial 
state. A football league average club loss due to injury during the season of 1999-2000 
was estimated to be £74.7 million (Woods et al., 2004). At elite level, a quick and 
accurate determination of hamstring injury severity is important, as this would allow 
coaches to instil appropriate plan for the team while the injured player is recovering 
(Woods et al., 2004; Järvinen, 2007). Medical imaging is a useful tool when combined 
with thorough clinical assessment (clinical history and medical examination) for 
accurate assessment of injury severity (Peetrons, 2002; Wong, 2005; Woodhouse & 
McNally, 2011). Radiological examination including US and MRI however would be a 
costly exercise. The cost of plain single part MRI and musculoskeletal US in the 
University Malaya Medical Centre is estimated around USD170.00 and USD 19.00 
respectively. Further, the management for athletes with confirmed hamstring often 
involved physiotherapy sessions, which results in added expenses for the club. 
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Hamstring injury may result in loss of playing time for up to eight weeks (Warren et al., 
2010) and affect an average of six out of a team of 38 players each season (Orchard & 
Seward, 2002). Therefore hamstring injuries represent a substantial percentage of the 
season that may be lost. The effect can be more devastating for the team, should 
hamstring injury occurred on key player (primary goal scorer of playmaker), as this 
might disrupt team dynamic and indirectly affect success. In addition the loss of up to 
five players at one time could potentially affect team earnings through reduce gate 
receipt income as supporters might lose interest in attending matches (Seward, 2003). 
Hamstring injury may also impact on the player’s individual income. In professional 
sports individual player wage structure often related to performance and the number of 
games played. Further, athlete with history of hamstring injury has higher risk of future 
hamstring injury and this may influence on on-going contract offered to the athlete.  
 
 
1.4.7 Management of hamstring injury 
 
Despite its frequency, the best treatment for hamstring injury is not clearly 
defined. The effectiveness of current interventions is still inconclusive (Copland et al., 
2009; Heiderscheit et al., 2010; Mendiguchia & Brughelli, 2010; Petersen et al., 2010; 
Reurink et al., 2012). Guided by the pathophysiology understanding of muscle injury, 
current approaches in injury management are targeted according to phases of muscle 
repair. The main goal of treatment in the acute phase of muscle injury is to limit extent 
of injury by controlling haemorrhage, oedema and pain (Järvinen et al., 2007). The 
conservative approach of rest, ice, compression and elevation (RICE) with short period 
of immobilisation is frequently used. Scientific evidence to support RICE approach is 
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largely based on experimental and animal studies (Drezner, 2003; Jarvinen, 2005; 
Järvinen et al., 2007; De Carli et al., 2009; Prior et al., 2009; Ropiak & Bosco, 2012).  
 
The use of non-steroidal anti-inflammatory drugs (NSAIDs) in the acute phase 
of muscle injury is controversial, as researchers found conflicting results. Laboratory 
studies showed short term gains in contractile and histologic properties of healing 
muscle but negative effects were reported with prolonged NSAIDs used (flubiprofen 
and piroxicam) (Obremsky et al., 1994; Mishra et al., 1995). In contrast, a double-blind 
placebo controlled study showed no additive effect of meclofenamate or diclofenac 
when combined with standard physiotherapeutic modalities (Reynolds et al., 2008). In 
addition, higher frequency of adverse events was reported in both treatment groups 
(meclofenamente: 38 %, diclofenac: 35 %) than control (14 %).  
 
While short-term (first few days after injury) immobilisation reduces 
haemorrhage and limits the extent of injury, longer period (beyond the acute phase) is 
associated with significant muscle atrophy of healthy muscle fibres, excessive 
deposition of scar tissues and substantially retard recovery of muscle strength (Järvinen, 
2005). Therefore more active treatment is recommended once the acute phase of injury 
has passed, gradual active exercises including isometric training, isotonic training and 
isokinetic dynamic training (Järvinen, 2005). Generally these active exercises are 
combined with flexibility (stretching) exercises in the various active rehabilitation 
exercise programs (Malliaropoulos et al., 2004; Gabbe et al., 2006; Malliaropoulos et 
al., 2010). 
 
Recent study demonstrated nearly 50 % of the British team physiotherapist’s 
time was spent administering therapeutic massage on muscles of team athletes 
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(Robertson et al., 2004). Despite its wide use, there is relatively little research available 
on the effect of massage therapy on damaged muscle (Tiidus, 2008). Electrotherapeutic 
modality is another form of treatment that is used commonly for muscle injury. 
Therapeutic ultrasound (US) is an example of an electrotherapeutic modality widely 
used despite lacking scientific evidence (Markert et al., 2005).   
 
It should be reminded that most physiotherapeutic techniques for rehabilitation 
of hamstring injuries have not been assessed in randomised clinical trials (Mason et al., 
2007). A recent systematic review concluded that at this moment there is limited 
evidence to suggest that the rate of recovery is influenced by the frequency of hamstring 
stretching exercises. In addition there is limited evidence to suggest that exercises to 
correct movement dysfunction could reduce time to return to play and risk of reinjury. 
Based on these until further evidence is available, current published rehabilitation 
regimens cannot be supported or refuted (Mason et al., 2007).  
 
While majority of hamstring injury responded well to conservative approach, it 
often requires significant recovery time and period of increased susceptibility for 
recurrent injury (Gabbe et al., 2006; Orchard & Seward, 2011). A cohort study of 
hamstring injured athletes treated with rehabilitation protocol, found the number of days 
lost from training and competition ranged from 4 to 74 days. More severe injury 
required significantly longer rehabilitation and recovery time (Malliaropoulos et al., 
2010).  
 
In attempt to hasten recovery various treatment alternatives are being explored 
by researches. These include hyperbaric oxygen therapy, sclerosing therapy, injection of 
various substances into the injured area including mixed traumeel (a homeopathic anti-
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inflammatory) and actovegin (protein-free extract from filtered calf blood), 
corticosteroids and local anaesthetic injection. It should be reminded that most of these 
treatment alternatives lack clinical scientific evidence and their uses are still 
controversial (Bennett et al., 2005; Järvinen et al., 2007; Stevens et al., 2010; Franklyn-
Miller et al., 2011).  
 
More recently, administration of biological substances has gained a lot of 
attention. Substances like autologous blood and blood products including autologous 
condition serum (ACS) and platelet-rich plasma (PRP) are used for soft tissues 
(muscles, tendons and ligaments) injuries despite limited clinical evidence (Engebretsen 
et al., 2010). 
 
Following muscle strain, injured muscle usually goes through the initial phase of 
destruction, where all injured myofibres including the intramuscular nerve branches 
undergoes necrosis. This phase is followed by repair and remodelling phase, in which 
undifferentiated reserve cells known as the satellite cells, in response to various growth 
factors and cytokines proliferates and differentiates into mature myoblasts (Järvinen et 
al., 2000). These growth factors and cytokines play a significant role in myoblast 
proliferation and differentiation (Creaney & Hamilton, 2008). Inflammatory response 
that occurred following muscle injury leads to accumulation and activation of platelets 
at the injured site. Activated platelets degranulates releasing various growth factors 
including, platelet derived growth factors (PDGF), vascular endothelial growth factors 
(VEGF), epidermal growth factor (EGF), fibroblasts growth factors (FGF), insulin like 
growth factor-1 (IGF-1) and tumor growth factor beta-1 (TGF-B1) (Menetrey et al., 
2000). Researchers have showed that IGF-1 and FGF have the ability to speed up 
healing following muscle and tendon injury (Sanchez et al., 2005; Hammond et al., 
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2009). Hammond et al. (2009) in an animal model study demonstrated autologus PRP 
injection of an injured tibialis anterior muscle significantly accelerate duration to fully 
functional recovery from 21 to 14 days (Hammond et al., 2009a). Sanchez et al. (2005) 
noted athletes with small hamstring tear obtained full recovery within half of the 
expected time when treated with PRP (Sanchez et al., 2005). Even though there is 
increasing popularity to use PRP for muscle injury. The scientific evidence to support 
such used is based on limited human clinical study. Currently, there are two case 
reports, single case series and a case control study to support the use of PRP for muscle 
injury (Wright-Carpenter et al., 2004; Sanchez et al., 2005; Loo et al., 2009; Hamilton 
& Best, 2011; Rettig et al., 2013). A study with robust study design and method is 
needed to evaluate the effect of PRP for hamstring injuries. 
 
 
1.5 Problem statement 
 
Limited information is available on the epidemiology of acute muscle injuries 
among Malaysian athletes (Shariff et al., 2009). In addition information on how these 
injuries are managed in Malaysian is not available. Consequently, time taken to fully 
recover and the duration return-to-play (DRP) among Malaysian athletes is 
inconclusive. It is possible that wide spectrums of treatments are being employed to 
treat muscle injuries in the local setting. Therefore, a cross-sectional study was 
conducted to study the patterns of muscle injury, current treatment regimens and the 
effectiveness of treatment among Malaysian athletes. Further, potential predictors of 
DRP after muscle injury were examined.  
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An accurate assessment in diagnosing and grading of muscle injury severity is 
important especially during on-field setting where immediate decision needed whether 
to allow athlete to continue with the games or otherwise. Ideally this can be achieved 
with a thorough clinical assessment and early radiological investigation using MRI or 
US. In practice though, physician would base their decision on clinical judgement, as 
radiological tools are rarely available on field. The severity of muscle injury was based 
on subjective feedback from athletes on pain intensity during clinical examination. The 
other objective assessment to determine injury severity is the active range of movement 
of the affected knee. As there are several methods of assessing AROM available, 
questions on the reliability of the different assessment methods arose (Bohannon, 1982; 
Booher & Thibodeau, 1985; Baltaci et al., 2003). Active knee extension (AKE) test is 
one of the more popular methods for assessment of knee AROM. The AKE test aided 
by metal rig showed a high intrarater correlation coefficient when conducted within 30 
minutes (Gajdosik & Lusin, 1983; Kuilart et al., 2005). Others questioned the 
practicality of this method, as the apparatus used were complicated and rarely available 
in clinic setting. Also more than one assessor is needed to conduct the test (Worrell et 
al., 1990; Rakos et al., 2001). Hence a simple, reliable and practical method of knee 
ROM assessment is proposed.  
 
The best treatment for sports related muscle injuries is still inconclusive (Prior et 
al., 2009). More recently, autologous biological substances including PRP injection 
have received much attention as treatment alternatives for acute muscle injury. 
Interestingly, despite limited clinical evidence PRP are currently used by health care 
providers for soft tissue injuries including muscle injuries (Engebretsen et al., 2010b; 
Filardo & Kon, 2012; Engebretsen & Schamasch, 2012; “Athletes Using PRP,” 2012; 
“What is blood spinning,” 2013). More robust clinical trials to evaluate the effect of 
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PRP for sports related muscle injury is needed (Engebretsen et al., 2010b; Taylor et al., 
2011).   
 
 
1.6 Conceptual framework 
 
Figure 1.6 illustrates the conceptual framework of this study. The primary 
objective of this study was to examine the safety and effectiveness of intralesion 
autologous PRP injection in hastening muscle recovery.  
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Figure 1.6. Study’s conceptual framework for recovery of muscle injury.
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1.7 Research objectives 
 
 to explore the patterns of muscle injury and explore predictors of 
duration to return-to-play among Malaysian athletes. 
 
 to design and construct a simple, easy to use and reliable method of 
assessing knee active range of movement (AROM).   
 
 to investigate the effect of single intralesional PRP injection combined 
with hamstring rehabilitation program on the DRP of patients with 
grade-2 hamstring muscle injury. 
 
 
1.8 Research questions 
 
 Question 1.1 What is the pattern of muscle injury among Malaysian athletes? 
 
 Question 1.2 What factors predicts the duration to return-to-play (DRP) among 
  Malaysian athletes? 
 
 Question 2.1 What is the interater reliability of the active knee extension  
   (AKE) test among healthy adults? 
 
 Question 2.2  What is the intrarater reliability of the active knee extension  
   (AKE) test among healthy adults? 
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Question 3.1 Is there a difference in the DRP on patient with grade-2 
hamstring muscle injury receiving single PRP injection combined 
with hamstring rehabilitation compared to patient receiving 
hamstring rehabilitation program alone?  
 
Question 3.2 Is there a difference in injury symptoms (pain intensity and 
interference) and sign (active knee extension angle) over time 
between patients receiving single PRP injection combined with 
hamstring rehabilitation compared to patient receiving hamstring 
rehabilitation program alone? 
 
 
1.9 Research hypothesis 
 
To answer research question 3, the study set out the following research 
hypotheses respectively; 
 
Hypothesis 1 Patient group receiving PRP combine with hamstring 
rehabilitation program will demonstrate significantly 
shorter DRP (faster recovery) compared to group 
receiving hamstring rehabilitation program alone. 
 
Hypothesis 2 Patient group receiving PRP combine with hamstring 
rehabilitation program will demonstrate significantly 
faster improvement in pain severity score (BPI-SF) 
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compared to group receiving hamstring rehabilitation 
program alone. 
 
Hypothesis 3 Patient group receiving PRP combine with hamstring 
rehabilitation program will demonstrate significantly 
faster improvement in pain interference (BPI-SF) 
compared to group receiving hamstring rehabilitation 
program alone. 
 
Hypothesis 4 Patient group receiving PRP combine with hamstring 
rehabilitation program will demonstrate significantly 
faster improvement in active knee extension (AKE) test 
compared to group receiving hamstring rehabilitation 
program alone. 
 
 
1.10 Overview of methodology 
 
 A quantitative design was used for this research, and conducted in three phases: 
 
 Phase 1 is a cross-sectional study aimed to examine the pattern of muscle injury 
among Malaysian athletes. The types of muscle injury including injury severity, muscle 
commonly injured and treatment employed were explored. Factors that predict DRP 
were also studied. This study is presented in Chapter 3. 
Information gathered from this study is used as a guide for subsequent study design of 
phase 3 – the randomised controlled trial (RCT).   
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 Phase 2 is a cross-sectional study to determine the interater and intrarater 
reliability of an active knee range of movement (AROM) test that was designed and 
constructed. This study is presented in Chapter 4.  
 
 Phase 3 study is the randomised controlled trial that was conducted to 
investigate the effect of a single intralesional injection of platelet-rich plasma (PRP) 
combined with standard rehabilitation program for treatment of muscle injury. This 
study is presented in Chapter 4.    
 
 
1.11 Significance of study 
 
To our knowledge this is the first RCT conducted to examine the effect of a 
single intralesion administration of PRP combined with hamstring rehabilitation 
program on the DRP for a grade-2 hamstring muscle injury. Findings from this study 
could establish the effect of PRP and guide practitioners on deciding whether to include 
this treatment as one alternative for grade-2 hamstring muscle injury. Further, 
researchers could also use results from the current study as a reference point on further 
exploring the best methods of PRP use (dosages, frequency of administration, method 
of administration, etc.).  
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Chapter 2  Systematic Review on Platelet-Rich Plasma (PRP) Therapy for 
Muscle Injury 
 
2.1 Introduction 
 
To explore the role of platelet-rich plasma (PRP) for acute muscle injury a 
systematic review of literature was conducted. Acute muscle injury specifically the 
hamstring muscle is one of the commonest types of injury seen in athletes. Hamstring 
muscle injury often results in loss of training and competition time (Askling & 
Karlsson, 2004; Feeley et al., 2008; Shariff et al., 2009; Ekstrand et al., 2011; Orchard 
& Seward, 2011; Murphy et al., 2012). Despite its frequent occurrence, the best 
treatment for hamstring injury is not fully understood. Common treatments usually 
involve rest, ice, compression and elevation (RICE) especially in the early stage 
following injury (Kujala et al., 1997; Huard et al., 2002; Jarvinen, 2005; Gielen et al., 
2007; Järvinen et al., 2007; Yeung et al., 2009). Additional treatment modalities include 
painkillers, rehabilitative exercises, electrotherapeutic modalities, hyperbaric oxygen 
therapy and prolotherapy (Almekinders, 1999; Harrison et al., 2000; Mason et al., 2007; 
Banffy & ElAttrache, 2012; Orchard et al., 2013). Clinical evidence to support the use 
of these modalities however is limited.  
 
More recently, injection of autologous platelet-rich plasma (PRP) have gain a lot 
of attention for the treatment of sports injury. Despite limited clinical evidence to 
suggest effectiveness, PRP injection are used for various sports related injuries 
including acute muscle injury (Kaspriske, 2010; Ekstrand et al., 2011; Engebretsen et 
al., 2011; “Athletes Using PRP,” 2012). The objective of this review is to explore the 
current evidence on PRP use for acute muscle injury.  
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2.2 Methods 
 
A systematic review using qualitative synthesis method was conducted to 
retrieve and review the findings of previous literatures on PRP use for acute muscle 
injury. The process started with a search question: Is the use of platelet-rich plasma 
effective for treating acute muscle injury? The question was developed using the PICOS 
(Participant, Intervention, Control, Outcomes, Study design) approach as in Table 2.1. 
The objective, characteristics of the study, contents of the intervention, targeted 
outcome and major findings for each of the selected study were assessed in this review. 
 
Table 2.1 : Formulating the search questions. 
Question Element 
Who are the group of patients? Participants Adults aged ≥ 18 years with muscle injury 
What intervention to evaluate? Intervention PRP/PRFM/ACS/platelet concentrate/ platelet 
gel injection/PRGF/platelet releasate/ platelet 
lysate/ L-PRP/P-LRP 
What is the main or usual 
alternative? 
Comparison Rehabilitation exercise program/ 
physiotherapy treatment 
What could the intervention offer? Outcomes The length of DRP 
What is(are) the study design(s)? Study design Randomised controlled trial 
PRP = platelet rich plasma; PRFM = platelet rich fibrin matrix; ACS = autologous conditioned serum; 
PRGF = preparation rich in growth factors; L-PRP = leucocyte platelet rich plasma;  
P-LRP = platelet leucocyte rich plasma. 
 
 
This qualitative systematic review includes the description of the criteria for 
study selection and the search methods for identification of studies, detailed qualitative 
synthesis of the selected studies and to discuss the findings from this review.  
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2.2.1 Criteria for study selection  
 
The criteria for considering studies in this review include types of study, types 
of participants, types of interventions and types of outcome measures.  
 
Types of study participants  
Studies that include adults (≥ 18 years) diagnosed with acute hamstring muscle 
injury are considered for this review.  
 
Types of interventions 
 This review includes studies with interventions to promote early recovery; 
shorter duration to return-to-play (DRP) among adults with acute muscle injury. The 
interventions may include one or combination of: 
 Rehabilitation exercise program  
 PRP injection therapy 
 
 No restrictions are defined regarding the type and contents of the control group. 
The interventions can be compared with no intervention control, group assigned to a 
waiting list, or minimal intervention control group.   
 
Types of outcome measures 
The primary outcome measures in the selected studies to include the DRP from 
acute muscle injury.  
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2.2.2 Search methods for identification of studies  
 
The search is conducted according to the Preferred Reporting Items for 
Systematic reviews and Meta-Analyses (PRISMA) guideline (Liberati et al., 2009). The 
process of this search method included describing the data sources, search strategy, data 
extraction and quality assessment. 
 
 
2.2.3 Data sources and search strategy 
 
The studies were searched electronically using the following databases: 
OvidMEDLINE, PubMed, EMBASE, SPORTDiscus and CINAHL. The reference lists 
of review articles and included studies were hand searched for other potentially eligible 
studies using the same selection criteria as described earlier. Published systematic 
reviews on PRP were used as a source of randomised controlled trials. Peer-reviewed 
published articles until December 2012 were searched. In view of limited resources for 
translation, only articles published in English were considered. No attempts were made 
to contact authors for additional information, however, cross-referencing on related 
previously published study is performed to obtain additional information. The search 
strategy used for OvidMEDLINE (Appendix A) is described in Table 2.2. Comparable 
searches were made for the other databases (Appendices B, C, D and E). In addition, 
search through a local library for archived articles from the South-East Asian region 
using the earlier described selection criteria were also performed.  
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2.2.4 Data extraction and quality assessment 
 
 The titles and abstracts of all studies retrieved from the search were reviewed 
following study selection criteria to decide whether the full-text manuscripts were 
needed for further evaluation. Each full-text manuscript retrieved were evaluated 
systematically according to the study’s: 1) objective(s), 2) characteristics of the study 
(study design, participants, age and sample size), 3) contents of intervention 
(intervention strategies, intervention provider, duration of intervention and follow-up 
contacts), 4) targeted outcome(s) and 5) major findings. The outcomes extracted from 
the selected study were neither combined nor reanalysed due to the nature of this 
qualitative systematic review. 
 
Table 2.2 : Search strategy for OvidMEDLINE. 
Dates: Jan 1946 – Dec 2012 Result 
1 Exp Platelet-Rich Plasma/ 1338 
2 platelet rich fibrin matrix.mp 16 
3 autologous conditioned serum.mp 22 
4 platelet concentrate.mp 602 
5 platelet gel.mp 173 
6 autologous growth factors.mp 52 
7 preparation rich in growth factors.mp 14 
8 platelet releasate.mp 101 
9 platelet lysate.mp 281 
10 leucocyte platelet rich plasma.mp 1 
11 platelet leucocyte rich plasma.mp 0 
12 muscle injury.mp 1738 
13 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 
10 or 11 
2417 
14 12 and 13  5 
Data was retrieved on 29th June 2013. 
 
 
Each selected article was evaluated for their methodological quality. Two 
investigators independently graded the methodological quality of each eligible article. 
The initial intention was to use the Physiotherapy Evidence Database Scale (PEDro) 
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(Zarins & Ciullo, 1983; Kujala et al., 1997; Sherrington et al., 2000) for evaluating 
randomised controlled trials (RCT) and the Newcastle-Ottawa Scale (NOS) (Heiser et 
al., 1984; Bennell et al., 1998; Wells et al., 2000; Slavotinek et al., 2002) for 
prospective studies. Since the literature search was unable to identify any RCT, only 
NOS were used in the final study evaluation. 
 
The Newcastle-Ottawa Scale is a 9-point scale used to grade case control or 
cohort studies on their methodological quality of selection, comparability, exposure, and 
outcome of the study participants (Table 2.3). A quality score of ≥ 7 was chosen to 
represent high quality study. Studies with score of 5 or 6 were considered to be of 
moderate quality, and those with score of ≤ 4 were considered to be of low quality 
(Woodley & Mercer, 2005; Orchard et al., 2008; Simunovic et al., 2010; Reurink et al., 
2012; Sheth et al., 2012). 
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Table 2.3 : Newcastle - Ottawa quality assessment scale case control studies. 
No. Criteria 
Selection 
1)  Is the case definition adequate? 
 a) yes, with independent validation 
 b) yes, eg record linkage or based on self reports 
 c) no description 
2)  Representativeness of the cases 
 a) consecutive or obviously representative series of cases   
 b) potential for selection biases or not stated 
3)  Selection of controls 
 a) community controls 
 b) hospital controls 
 c) no description  
4)  Definition of controls 
 a) no history of disease (endpoint) 
 b) no description of source 
Comparability 
1)  Comparability of cases and controls on the basis of the design or analysis 
 a) study controls for _______________  (Select the most important factor.)   
 b) study controls for any additional factor   (This criteria could be modified to indicate 
specific control for a second important factor). 
Exposure 
1)  Ascertainment of exposure 
 a) secure record (eg surgical records) 
 b) structured interview where blind to case/control status 
 c) interview not blinded to case/control status 
 d) written self report or medical record only 
 e) no description 
2)  Same method of ascertainment for cases and controls 
 a) yes 
 b) no 
3)  Non-response rate 
 a) same rate for both groups 
 b) non respondents described 
 c) rate different and no designation 
Note: A study can be awarded a maximum of one star for each numbered item within the Selection and 
Exposure categories. A maximum of two stars can be given for Comparability. 
 
 
 
 
2.3 Results 
 
 
2.3.1 Study selection and characteristics 
 
The initial search identified 1016 potential articles from the databases search and 
another 3 were found through cross-referencing. After removing duplicates, 883 articles 
were assessed based on titles and abstracts against the selection criteria.  A total of 842 
  45 
articles were excluded because the studies were not on platelet-rich plasma and muscle 
injuries. Of the 41 full-text articles retrieved for further evaluation, only four articles 
were included in the final qualitative synthesis. The remaining 37 articles were excluded 
because 35 of them were review articles (including systematic reviews) and the 
remaining two were case reports. Figure 2.1 describes the PRISMA flow diagram for 
the study selection. 
 
 
2.3.2 Data extraction and synthesis 
 
All articles were in English language published between year 2000 and 2012. 
 
2.3.2 (a) Selected studies  
 
Table 2.4 describes the characteristics of selected studies. Out of the four studies 
selected for the review, one was a case control study (CC) (Wright-Carpenter et al., 
2004a) while the remaining three were in vivo laboratory studies (Wright-Carpenter et 
al., 2004b; Hammond et al., 2009; Gigante et al., 2012). Therefore the discussion on the 
pilot human clinical trial and laboratory studies were conducted separately.    
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Figure 2.1. PRISMA flow diagram for the study selection. 
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2.3.2 (b) Description of studies 
 
 Clinical study 
 
This pilot case control study was conducted in a clinic setting (Clinic for Sports 
Medicine & Orthopaedic). The participants in this study were professional sportsmen 
diagnosed with acute “moderate strains” (second degree) muscle injury. The diagnoses 
of injury were based on clinical assessment and magnetic resonance imaging (MRI) 
examinations (detection of bleeding of the involved muscle). The mean age of 
participants in the control and intervention groups and other demographics were not 
available for comparisons (Wright-Carpenter et al., 2004a). 
 
The intervention used in this study was intra-lesional injection of 2.5 ml 
autologous conditioned serum (ACS) combined with 2.5 ml of saline. The method of 
ACS preparation was adequately described. The ACS was injected to the affected area, 
guided only by palpation. Prior to administration of ACS, 5 ml local anaesthetic 
(Meaverin 0.5 %) was injected in portion of 1 ml to minimise the tonus of muscle. The 
ACS injection started two days after diagnosis and was repeated every second day until 
full recovery was achieved. The mean number of ACS injection per patient was 5.4.  
 
Interestingly the control group in this study was a retrospective analysis of 11 
patients who had been treated with local injection of Actovegin®/Traumeel® (3:2) 
combination therapy. Actovegin® is a deproteinised dialysate of bovine blood, while 
Traumeel® is a homeopathic formulation containing both botanical and mineral 
ingredients. This treatment combination is purported to suppress the release of 
inflammatory mediators and stimulate the release of anti-inflammatory cytokines 
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(Franklyn-Millet et al., 2011). Local injection of Actovegin®/Traumeel® is considered a 
standard treatment of muscle strain in the centre. The method of Actovegin®/Traumeel® 
administration was similar to the ACS injection technique. The mean number of 
treatments in the control group was 8.3 Actovegin®/Traumeel® injections per patient. 
Participants in both groups underwent a standard rehabilitation program. In addition 
participants in both groups were given oral antipholgistics. The frequency and dosages 
of the rehabilitation sessions were not specified. 
 
The severity of muscle tears between intervention and control groups was 
comparable. Most tears were located in the hamstring and adductor muscles (12 in the 
ACS and 9 in the control group). The main outcome measured was the time required to 
resume full sporting activities. Return to full sporting activities was determined based 
on participant’s subjective impression of readiness to resume activities and 
physiotherapist’s standard examination. Athletes were allowed to resume full activities 
only when they were pain free and hamstring strength restored to at least 90 % of that of 
the unaffected limb muscle. The method of strength assessment was unclear, as 
isokinetic strength was not performed for fear of reinjury during testing. 
 
The mean recovery time for participants in the ACS group (16.6 days) was 
significantly shorter compared to participants in the control group (22.3 days). In 
addition, MRI scans on day 16 demonstrated faster regression of the oedema/bleeding in 
the ACS group. Both treatments were considered safe, as there were no local or 
systemic side effects reported.  
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 In vivo laboratory studies 
 
All studies were controlled animal studies conducted on different species of 
syngeneic rodents (Garrett et al., 1989; Wright-Carpenter et al., 2004b; Hammond et 
al., 2009; Marieb, 2009; Gigante et al., 2012). Studies differ in their methods of 
inducing muscle injuries. In one study muscle contusion was induced by dropping a 
stainless steel ball on the animal’s hind limb from the height of 100 cm (Wright-
Carpenter et al., 2004b). In contrast, Hammond et al., (2009) induced eccentric muscle 
injury over the tibialis anterior muscle by superimposing a lengthening contraction onto 
a maximally isometric contraction, using either a single repetition (large strain) or 
multiple repetitions (small strain) (Friden et al., 1983; Jones et al., 1986; Hammond et 
al., 2009; Ekstrand, 2012). Gigante et al. (2012) on the other hand cause a bilateral 
muscle tear in on the longissimus dorsi muscle using a standard pincer technique.  
 
As myogenesis relies upon satellite cells activation, proliferation, differentiation, 
and fusion between damaged muscle and maturation (increased myofibre diameter) 
(Patel & Cuizon, 1998; Jarvinen, 2005; Murphy et al., 2012), majority of studies used 
objective assessment of muscle regeneration via immunohistochemical staining as one 
of their outcome measures. Wright-Carpenter et al., (2004), used Ki-67 labelled 
antibody as marker of satellite cells proliferation (Wright-Carpenter et al., 2004b). 
While, Hammond et al., 2009 and Gigante et al., 2012 both assayed the level of MyoD 
and Myogenin as markers of muscle regeneration (Hammond et al., 2009; Gigante et 
al., 2012). In addition, both studies also assessed the percentages of centrally nucleated 
fibres (CNFs) presence in the injured area as an additional measure of myogenesis.  
  50 
 Surprisingly, only one study assessed the functional recovery of the injured 
muscle. The assessment was done using maximal isometric torque test on the tibialis 
anterior muscle (Hammond et al., 2009)   
   
 
 Characteristics of interventions 
 
The interventions used in each study vary markedly. Wright-Carpenter et al. 
(2004), utilised blood from 20 syngenic mice to produce autologous conditioned serum 
(ACS) using a method originally developed for human blood (Meijer et al., 2003). 
Animals in the intervention group received 10 μl of PRP at days 0, 3, 5 and 7. While the 
controls was injected with same volume of saline at the same intervals  (Wright-
Carpenter et al., 2004) 
 
Hammond et al., (2009) used 20 ml of blood collected from five adult male 
Sprague-Dawley rats to produced autologous platelet-rich plasma (PRP) using a 
commercial kit. The autologous PRP was conditioned using high-frequency ultrasound 
to lyse platelets and release growth factors thus enriching the PRP prior to injection. 
Animals in the intervention group were injected with 100 μl of PRP into the injured 
tibialis anterior and the controls received same amount of platelet-poor plasma or no 
treatment. All injections were administered on days 0, 3, 5 and 7 (Hammond et al., 
2009). 
 
In the study by Gigante et al., (2012), platelet rich fibrin matrix (PRFM) was 
prepared using a commercial kit. The lesion in one side of the body was filled with 
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PRFM while the contralateral injured muscle (control) left untreated. The PRFM was 
given once throughout the study (Gigante et al., 2012)  
  
 
 Effectiveness of interventions 
 
The outcome measures and results of interventions promoting earlier muscle 
recovery are presented in Table 2.4. The primary outcome in all studies was 
quantification of muscle regeneration (myogenesis). In two studies this was achieved by 
immunohistochemical detection of Myogenin and MyoD (markers of muscle 
regeneration) (Hammond et al., 2009; Gigante et al., 2012). Whereas Wright-Carpenter 
et al. (2004) used Ki-67 markers as indicator of satellite cells proliferation (Wright-
Carpenter et al., 2004b). Only one study assessed muscle functional recovery in 
addition to the tests mentioned above. Hammond et al. (2009), measured maximal 
isometric contraction of the dorsiflexors before and four minutes after inducing injury to 
assess associated muscle strength lost. The maximal isometric force was retested at days 
3, 5, 7, 14 and 21 after treatment commenced (Hammond et al., 2009). 
 
All studies demonstrated greater muscular regeneration in intervention group 
compared to controls. Significantly higher level of MyoD and Myogenin detected in 
autologous PRP and PRFM treated muscles compared to controls (Gigante et al., 2012; 
Hammond et al., 2009). In addition Wright-Carpenter et al. (2004) observed increased 
satellite cells activation as early as 30 to 40 hours after injury. Accordingly, 
significantly higher number of CN myofibres (larger diameter fibres) was found in PRP 
and ACS treated rodents (Wright-Carpenter et al., 2004b) 
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Interestingly Hammond et al. (2009) found PRP therapy had little effect on 
muscle healing following single-repetition injury protocol. In the multiple-repetition 
injury protocol however, PRP treatment significantly improved contractile function at 2 
time points and effectively shortened the time to full recovery from 21 to 14 days 
(Hammond et al., 2009). 
 
 
2.3.3 Studies methodological quality 
 
Extensive search only resulted in a single human case control study; the 
particular study demonstrated several limitations including the use of retrospective data 
of athletes treated with Actovegin®/Traumeel® as controls. In addition the baseline 
participant’s characteristics (including age) was not available for analysis. Using the 
Newcastle Ottawa scale this study score a total of 4 of maximal 9 and represented a 
study of low quality. 
 
Interestingly our search did not found any human randomised controlled trial on 
PRP for acute muscle injuries. Furthermore only three in vivo laboratory studies were 
retrieved by the search. 
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Table 2.4 : Study characteristics and outcomes: Clinical and laboratory 
Studies 
 
Study design/target 
population 
Treatment Type of 
injury/location 
Outcome measures Results 
Case control study 
Wright-Carpenter et al. 
2004 
Pilot controlled-
clinical trial 
n = 16 (ACS); n = 
11(control)/ 
professional sportsmen 
ACS (combined with 
LA) injections vs. 
Traumeel/Actovegin 
(controls) injections 
both repeated every 
second day 
2nd degree muscle tears 
(MRI confirmed) 
most injuries to the 
hamstring and 
adductors muscle 
group 
Time to recovery based 
on the participant’s 
subjective judgement 
of readiness 
 
Time to recovery was 
significantly shorter in ACS 
(16.6 days) than control groups 
(22.3 days) 
No side effects of treatment 
Laboratory studies 
Wright-Carpenter et al. 
2004 
Controlled laboratory 
study  
n = 39(ACS) 
n = 39 
(control)/syngeneic 
C57B1/6 mice  
ACS vs. saline 
injections at 2, 24 & 48 
hrs. after contusion 
impact 
Iatrogenic contusion 
injury of the 
gastrocnemius muscles 
Regeneration 
quantification 
 Activated 
satellite cells 
 Size of 
regenerating 
myofibres 
Significant increased in satellite 
cells activation at 30 & 48 hrs. 
after injury 
Larger diameter of CN cells in 
ACS group after 1 week 
Hammond et al. 2009 Controlled laboratory 
study 
n = 72 Adult male 
Sprague-Dwaley rats 
No treatment vs. PRP 
vs. PPP injections at 
Days 0, 3, 5 & 7 after 
induced eccentric 
injury  
Iatrogenic eccentric 
injury of tibialis 
anterior muscle 
 Single 
repetition 
(large strain) 
 Multiple 
repetition 
(small strain)  
Functional recovery 
 Maximal 
isometric 
contraction 
Muscle regeneration 
 MyoD & 
myogenin 
markers 
Large strain injury 
PRP significantly improve 
contractile function at Day 3 
Small strain injury  
PRP significantly improved 
contractile function at Days 7 
and 14. Full recovery at Day 14 
Muscle regeneration MyoD and 
myogenin significantly 
increased in PRP treated  
Significantly higher number of 
CN cells in PRP group 
compared with PPP and no 
treatment 
Gigante et al. 2012 Controlled lab study  
n = 20 male Wistar rats 
PRFM vs. No 
treatment (control). 
Random allocation. 
Iatrogenic tear (pincer 
technique) bilateral 
longissimus muscle 
Blind assessment  
 Vascularizatio
n & muscle 
regeneration 
 Inflammation 
& fibrosis 
PRFM group 
More muscle regeneration at D5 
& D10 
More neovascularization at D40 
& D60 
Less fibrosis at D10 
No differences in inflammation 
ACS = autologous conditioned serum; LA = local anaesthetic; MRI = magnetic resonance imaging; CN =  centronucleated.
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2.4 Discussion  
 
 
2.4.1 Summary of main results 
 
From the available evidences presented in this review, the number of well-
designed trials on use of PRP therapy for acute muscle injury is limited. Only one 
human study was identified while the remaining three studies were in vivo laboratory 
studies on rodents. All studies reviewed suggested positive effects of PRP on muscle 
recovery following injury.   
 
 In vivo study on rodents induced with either single repetition (large strain) or 
multiple repetition (small strain) injury on to the tibialis anterior muscle found PRP 
therapy effective in reducing the time to full recovery only in the multiple-repetition 
injured animals. The author suggests PRP therapy is effective only when injury repair 
requires muscle regeneration such as those occurring following multiple-repetition 
contraction injuries. Since single large strain injury only requires sarcolemmal repair 
without muscle regeneration the effect of PRP for such injury might not be clinically 
evident.  
 
 All in vivo studies evaluated the amount and size of regenerated myofibres 
(histologically) as indicator of healing. Despite different histological methods used to 
quantify muscle regeneration, all studies showed significant acceleration of muscle 
regeneration in the intervention groups (ACS, PRP and PRFM) compared with controls. 
Whether such finding is also applicable in humans is uncertain, as evidence to support 
similar observation is not available.  
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In the pilot study on professional sportsmen diagnosed with second-degree 
muscle strain, athletes treated with repeated injections of ACS reported earlier 
subjective readiness to resume exercise at competitive level than those treated with 
Actovegin®/Traumeel®. Result from this trial must be interpreted cautiously as the study 
demonstrated several limitations including, lack of randomisation, non-blinded and 
atypical control group.  
 
Based on this review there is no evidence with good methodological quality to 
suggest that PRP therapy is effective in accelerating functional muscle recovery after 
injury. 
 
 
2.4.2 Applicability of evidence 
 
 This review identified a single case control and three in vivo laboratory studies 
that evaluated PRP therapy effect on muscle injury. All in vivo studies were conducted 
on rodents. 
 
 The methodological quality of the pilot case control study was rated as poor 
quality based on Newcastle-Ottawa scale with a score of 4/10. Several limitations were 
detected including lack of randomisation, absence of concealment of treatment 
allocation, absence of baseline data characteristics between subjects in both groups, and 
lack of blinding (subjects, therapists or assessors). Further, trials with inadequate 
methodological approach are known to be associated with bias (Schulz et al., 1995). 
Professional sportsmen receiving ACS therapy reported significantly faster subjective 
impression of readiness to resume exercise at competitive level than controls. This 
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finding must be interpreted cautiously as the conclusion was based only on 18 
participants. Also lack of assessors blinding might lead to reporting biases. A more 
objective assessment such as validated symptoms questionnaires and functional 
assessment (muscle strength assessment) might be useful in these circumstances, as it 
allows more objective and standardise assessment of readiness to participate in pre-
injury level activities.  
 
 The methodological quality of the in vivo studies varies. Studies differ in 
methods of preparation of injectable (ACS, PRP & PRFM), as well as the nature of 
injury induced onto the animals. Using immuno-histochemical marker to quantify 
muscle healing/recovery, all in vivo studies demonstrated significant acceleration of 
muscle regeneration. Only one study however showed concurrent significant 
improvement in contractile function and faster time to full recovery in animals with 
small strain injury treated with ACS injection (Hammond et al., 2009). Whether similar 
cellular changes observed in these studies would occur in humans remains unanswered. 
Replicating such study in humans will be challenging in view of substantial ethical 
consideration on the need to biopsy the injured muscle especially involving competitive 
athletes. In conducting such study one must also consider the importance between 
cellular recoveries versus functional recovery.  
 
 
2.4.3 Limitation of review 
 
 There are limitations from this review. Only peer-reviewed papers published 
until December 2012 and published in English were included in the data extraction, 
hence a possibility of selection bias may exist. Even though the searches were done 
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thoroughly through multiple major databases with cross-referencing; there is a 
possibility that some papers were not included due to the criteria used. 
 
 
2.5 Conclusion  
 
 In conclusion, there are limited studies on the effects of PRP therapy for acute 
muscle injury. Three in vivo studies that vary in methodology were reviewed. Despite 
this, significantly faster muscle recovery among animals in the experimental group was 
reported. Whether such findings could be translated into humans, remain to be 
answered. 
 
 Only one pilot human case control study was available at the time of review 
(Wright-Carpenter et al., 2004). Although this study found significant reduction in DRP 
among athletes treated with ACS, the study design is questionable (Engebretsen et al., 
2010; Andia et al., 2011; Hamilton & Best, 2011) as it lacks robustness that restricts 
generalisation of the findings. 
 
 
2.6 Summary 
 
 Based on the systematic review conducted, the efficacy of PRP therapy on 
muscle recovery in humans is still unanswered. There is some evidence to suggest 
acceleration of muscle recovery (both histologically and functionally) with local 
injection of ACS, PRP and PRFM from in vivo laboratory studies.  
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 More studies using robust clinical design are needed (Engebretsen et al., 2010; 
Andia et al., 2011) to demonstrate the efficacy or otherwise of PRP for the treatment of 
muscle injury. Hence a randomised controlled trial (RCT) to study the effect of PRP on 
muscle recovery was performed as phase 4 of this research project.   
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Chapter 3  Pattern of Muscle Injuries and Predictors of Return-to-Play among 
Malaysian Athletes: A Retrospective Study 
 
3.1 Introduction 
 
Muscle injury is one of the most common injuries affecting athletes (Järvinen, 
2005; Orchard et al., 2010; Liu et al., 2011). They account for up to 36.4 % of injuries 
in sports events (Garrett et al., 1989; Woods et al., 2004; Volpi et al., 2004; Eirale et 
al., 2013; Ekstrand et al., 2013). Contusion and strain are two common causes of muscle 
injuries. Muscle strain often occurs especially during sprinting or jumping when muscle 
is under tension while lengthening (eccentric contractions) (Zarins & Ciullo, 1983). 
Earlier studies identified several factors that predisposes to muscle injury including, 
history of muscle strain, increasing age and dominant leg (Orchard, 2001; Engebretsen 
et al., 2010; Warren et al., 2010). Muscle injuries often occur at the muscle-tendon 
(myotendinous) junction, affecting mainly muscles that span across two joints such as 
the rectus femoris, semitendinosus, and gastrocnemius. The diagnosis and grading of 
muscle injuries are usually made through clinical assessment (Woods et al., 2004).  In 
addition, ultrasonography is recommended in localising and characterising injury 
severity (Aspelin et al., 1992). 
 
In professional sports, muscle injuries can lead to significant pain and disability 
resulting in time away from participation (training and competition) and increased 
medical costs (Schmikli et al., 2009). Not surprisingly, athletes and coaches are 
concerned about the time taken to achieve full recovery. Unfortunately, issues on 
duration to return-to-play (DRP) often not directly discussed during consultation with 
the medical team (Fisher, 1988). Predicting DRP not only important for planning of 
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rehabilitation program but also allows the coaching staff to restructure team for 
competition.  
 
Studies have identified several factors that may help in estimating DRP. An 
observational study of 59 players from 10 Victorian-based Australian Football League 
clubs showed, time taken to walk pain-free was a significant predictor of DRP after 
hamstring injury (Warren et al., 2010). Unfortunately, the authors did not discuss 
severity of muscle injury sustained by their athletes and the details of rehabilitation 
program used. In a prospective study among athletes with grades-1 to -4 hamstrings 
injury, researchers found the active knee range of motion deficit provides accurate 
prediction of DRP (Aspelin et al., 2005; Warren et al., 2010; Valle, 2011). 
 
Identifying the pattern of muscle injury including the extent of the problem is an 
important early step in any injury prevention program (Figure 3.1). While it is 
recognised that muscle injury particularly hamstring muscle group is one of the most 
common injury affecting athletes (Table 3.1) (Brooks et al., 2005; Ekstrand, 2008; 
Ekstrand et al., 2011c; Orchard & Seward, 2011; Eirale et al., 2013). It is reminded that 
current available data on muscle injuries were gathered from population outside 
Malaysia. Local information on pattern of injuries, current treatment and the DRP after 
muscle injury among Malaysian athletes is limited (Shariff et al., 2009). Differences in 
physical build, climate, dietary intake, training regimen and injury management 
between local and foreign athletes might influence the pattern of muscle injury and DRP 
observed between different populations. Therefore a cross-sectional study was 
conducted to examine pattern of muscle injuries in Malaysian athletes. Information 
gathered in this study was used in designing the RCT component of this research. The 
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findings from this study were published in the Singapore Medical Journal recently 
(Shariff et al., 2013) (Appendix F). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Typical flow in an injury preventive scheme (Adapted from van Mechelen et 
al., 1992, p. 94) 
 
 
 
 
 
 
 
Determine extent of the 
injury problem 
Establishing the aetiology and  
mechanisms of injury 
mechanism  
Introduce preventive measure  
Assess effectiveness of  
preventive measure 
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Table 3.1 : A summary of Patterns of muscle injuries.  
Author Sports Country Common injuries 
Askling et al., 2004 Soccer  Hamstring injuries: 13/30 (43 %) 
Brooks et al., 2006 Rugby union United 
Kingdom 
Muscle and tendon injuries: 203/395 
(51.4 %) 
Ligamentous injuries: 150/395 (38.0 
%) 
Feeley et al., 2008 American football America Knee sprain: 120/728 (16.5 %) 
Hamstring injuries: n = 85 (21.8 %) 
Alonso et al., 2010 Track & field Germany Muscle injuries: 54/247 (21.8 %) 
 Hamstrings: n = 37 (14.9 %) 
Cloke et al., 2012 Soccer United 
Kingdom 
Muscle injuries: n = 1288 
 Hamstrings: n = 525 (40.8 %) 
 Quadriceps: n = 442 (34.3 %) 
 Adductors: n = 266 (20.7 %) 
Murphy et al., 2012 Gaelic football Ireland Muscle injuries: n = 1014 
 Hamstrings: n = 432 (42.6 %) 
Orchard & Seward, 
2013 
Australian football  Australia Muscle injuries: n = 2841 
 
Ekstrand et al., 2013 Soccer Europe Muscle injuries: n = 1791/8029 (22.3 
%) 
 Hamstrings: n = 1025 (12.8 
%) 
 Quadriceps: n = 404 (5.0 %) 
 Calf: n = 362 (4.5 %) 
Eirale et al., 2013 Soccer Qatar Muscle injuries: 79/217 (36.4 %) 
 Hamstrings: n = 17 (21.5 %) 
 
 
 
 
3.1.1 Specific objective of study 
1. to examine patterns of muscle injury, and 
2. to explore predictors of DRP among Malaysian athletes 
 
 
3.2 Methods 
 
 
3.2.1 Study design 
 
A retrospective study was performed to examine the pattern of muscle injuries 
and factors that predict duration to return-to-play (DRP) among Malaysian athletes.  
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3.2.2 Study setting 
 
The study was conducted at the National Sports Institute (NSI) Clinic, Kuala 
Lumpur, Malaysia from January to May 2010. Set up in 1992, the NSI primary role is to 
provide health care for national athletes, at both elite and developmental levels. In 
addition, the clinic acts as a referral centre for the nearby Bukit Jalil Sports School and 
for the Bandar Penawar Sports School in southern Malaysia.  
 
 
3.2.3 Data source 
 
The ultrasound registration records from June 2006 to December 2009 were 
reviewed. Medical records of athlete diagnosed with muscle injuries on ultrasonography 
were evaluated. Clinical information on muscle injuries including date of injury, date of 
first consultation, injury severity, events leading to injury, injury mechanism and date of 
return-to-play were extracted. In addition, athletes’ socio-demographic background such 
as age, gender, playing level (school, club, state or national) and sports were recorded in 
a structured form (Appendix G).  
 
Athletes were under the care of sports medicine specialists at the NSI. A visiting 
musculoskeletal radiologist with fourteen years’ experience performed all 
ultrasonography assessments. Ultrasonography assessments were performed using 
Siemens Acuson Alcantares ultrasound system with a 4 cm linear transducer set at 8 to 
10-MHz. Severity of muscle injury was described based on ultrasonography appearance 
using Peetron’s grading system (2002) (Table 3.2). The University of Malaya Medical 
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Centre Ethics Committee and the National Sports Institute of Malaysia approved the 
study (Appendices H and I). 
 
Table 3.2 : Grading of muscle injuries on ultrasound (Peetrons, 2002). 
Grade Ultrasonography findings 
0 No ultrasound features of muscle injury 
1 
Small foci of muscle disruption (< 5 % area) appearing as low reflectivity areas 
within muscle 
2 
Partial tear with muscle fibre disruption (> 5 %) but not affecting the whole muscle. 
Associated with hematoma formation 
3 
Complete tear of the muscle with bunching of muscle on dynamic stress and frayed 
margins. 
 
 
3.2.4 Statistical analysis 
 
Data were analysed using the Statistical Package for Social Science (SPSS Inc., 
version 19.0 for Mac, Chicago).  Data were described descriptively, and normality test 
performed with the Shapiro-Wilk test. Duration to return-to-play (DRP) of less than 6 
weeks was used as the cut-off value for adequacy of DRP. This definition of adequacy 
was based on a recent systematic review conducted by Prior et al. (2009). Also, athletes 
who return-to-play more than 6-weeks following injury had significantly lesser chance 
(3.1 %) of sustaining injury recurrence compared to those who resumed at 2-weeks (8.1 
%) or 3-weeks (6.8 %) (Orchard & Best, 2002). 
 
The association between DRP with gender, age group (≥ 18 vs. < 18 years), and 
duration before first consultation (≤ 1 week vs. > 1 week) were assessed using Mann-
Whitney U test. Meanwhile, the association between DRP and sports, playing level 
(national, state, school and others), new vs. recurrent injury, region of injury (upper 
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limb, lower limb and trunkal muscles) and ultrasound grading of injury (grades 0 – 3) 
were determined using the Kruskal-Wallis test. 
 
A stepwise logistic regression analysis was performed to identify predictors of 
DRP. Variables that were less than 0.25 on univariate testing were included in the 
multivariate logistic regression model as recommended by previous researchers 
(Orchard & Best, 2002; Bursac et al., 2008). Adjusted odds ratios (AORs) and 95 % 
confidence intervals (CIs) of the ORs were calculated, with significance level set at p < 
0.05. 
 
 
3.3 Results 
 
A total of 562 medical records of athletes with suspected muscle injuries were 
screened. Only 360 medical records (237 men and 123 women) were included in the 
final analysis. The remaining 202 medical records were excluded for reasons including; 
incomplete medical information (n = 25); missing ultrasound report (n = 75) and 
injuries involving structures other than muscles (ligaments and tendons)(n = 102).  
 
Three hundred ninety-seven (397) cases of muscle injuries were diagnosed 
among 360 athletes. The median age of athletes at time of injury was 20.0 ± 
interquartile range (IQR) 6.0 years. Most injuries occurred among national-level 
athletes (Table 3.3).  
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Table 3.3 : Muscle injury characteristics among athletes. 
Factor No. (%) 
Gender  
 Men 237 (65.8) 
 Women 123 (34.2) 
Sports Category  
 Track and Field 109 (30.3) 
 Hockey 64 (17.8) 
 Racket Sports 41 (11.4) 
 Martial arts 24 (6.7) 
 Soccer 20 (5.6) 
 Weightlifting 18 (5.0) 
 Swimming 15 (4.2) 
 Gymnastics 17 (4.7) 
 Others 52 (14.4) 
Level of play  
 National  324 (90.0) 
 University/School  17 (4.7) 
 State 10 (2.8) 
 Others 9 (2.5) 
New vs. recurrent   
 New 218 (60.6) 
 Recurrent 142 (39.4) 
Injured region  
 Lower limb  253 (70.3) 
 Upper limb  64 (17.8) 
 Back 29 (8.1) 
 Abdomen 14 (3.9) 
Injuries event  
 Nontraumatic 338 (93.9) 
 Traumatic 20 (5.6) 
 Others 2 (0.6) 
Activitiy  
 Training 297 (82.5) 
 Competition 55 (15.3) 
 Others 8 (2.2) 
Ultrasound grading of injury  
 Grade 1 24 (6.7) 
 Grade 2 333 (92.5) 
 Grade 3 3 (0.8) 
Management  
 Conservative  357 (99.2) 
 Surgical  3 (8.0) 
Frequency of physiotherapy session   
 Daily 236 (65.6) 
 Once a week 65 (18.1) 
 Twice a week 49 (13.6) 
 Thrice a week 10 (2.8) 
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Muscle injuries chiefly diagnosed among track and field (30.3 %) athletes, 
followed by hockey (17.8 %), racket sports (11.4 %), martial arts (6.7 %), soccer (5.3 
%), weightlifting (5.0 %), gymnastics (4.7 %) swimming (4.2 %) and other sports (14.4 
%). Majority (60.6 %) of muscle injuries classified as new injury. Injuries often affected 
the lower limb muscles especially the hamstring and adductors muscle groups (Table 
3.4). Clinical assessments performed on athletes with a primary complain of lower back 
pain (n = 29). In addition, a plain radiography of the lumbosacral region performed to 
rule out any bony pathology. Magnetic resonance imaging (MRI) was performed only 
when clinical assessment suspected neurological involvement (n = 3) as suggested by 
The American College of Physician and American Pain Society (Chou et al., 2007). Of 
these three cases, the MRI was normal in two athletes and a sacrospinalis tear found in 
the third. Later all athletes underwent ultrasonography assessment of the lumbosacral 
region using a simple grading for severity (Schwartz et al., 1999; Peetrons, 2002). The 
reliability and accuracy of ultrasound in diagnosing acute back muscle strain however 
has not been documented (Brandt et al., 1996). Therefore, possibly other conditions 
such as intervertebral discs and facet joints’ abnormalities might have been missed or 
overlooked. 
 
The median time to first consultation was 7.0 days ± IQR 12.0 after injury onset 
and median time for ultrasonography evaluation was 17.0 days ± IQR 29.0 after initial 
injury. Majority of muscle injury were grade-2 (n = 368) muscle injury, followed by 
grade-1 (n = 26) and less often grade-3 (n = 3).  
 
Most (93.9 %) muscle injuries related to sporting activities, with majority (82.5 
%) occurred during training or practice sessions.  Majority of the track and field athletes 
(69.7 %) injured during sprinting, and less often during jumping (13.8 %) and weight 
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training (5.5 %). A similar finding noted among hockey players with 75 % of muscle 
injuries occurred while sprinting. In contrast only 40 % of racket sports players’ 
sustained injury during jumping smash. 
 
Table 3.4 : Muscle injury according to body region. 
Body region Muscle group No. of injuries (%) 
Lower limb  Hamstrings  
Adductor  
Calf  
Quadriceps 
Others (anterior tibialis, posterior tibialis, 
peroneal muscles) 
 
145 (36.5) 
43 (10.8) 
49 (12.4) 
31 (7.8) 
11 (2.8) 
Upper limb  Deltoid 
Biceps  
Triceps  
Rotator cuff 
Others (pectoralis, rhomboids, small 
muscles of the hand)  
15 (3.8) 
6 (1.5) 
4 (1.0) 
15 (3.8) 
35 (8.8) 
Abdomen Rectus abdominis  
Others (external obliques, transversus 
abdominis) 
12 (3.0) 
2 (0.5) 
Back  Muscles of the back (erector spinae, 
quadratus lumborum) 
29 (7.3) 
 
 
Nearly all muscle injuries (99.2 %) were treated conservatively. Most athletes 
(66.4 %) received a short course (less than 1 week) of analgesia (for example Non-
steroidal anti-inflammatory drugs) combined with at least one form of 
electrotherapeutic modality. Electrotherapeutic used include therapeutic ultrasound, 
interferential current, transcutaneous nerve stimulation and short wave diathermy. A 
physiotherapy session typically started with range of motion stretching exercises 
followed by progressive muscle strengthening. In addition various combination of 
electrotherapeutic modalities often incorporated by the treating physiotherapists during 
these sessions. Most session ended with 20 to 30 minutes of cryotherapy. Only three 
athletes with complete muscle rupture underwent surgical intervention. 
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Dates of the return-to-play were documented only in 168 athletes. The 
remaining 192 athletes were lost to follow up; hence the dates of return-to-play were not 
available. Approximately 40 % (n = 67) of athletes allowed full RTP within six weeks 
after injury. Athletes DRP ranges from 1 to 72 weeks, with a median of 7.4 ± IQR 8.5 
weeks. No significant difference in DRP found (H (26) = 25.32, p = 0.50) across the 
different sports. Interestingly, the DRP was not affected by the frequency of weekly 
physiotherapy session (H (3) = 0.44, p = 0.93).  
 
Further analysis revealed athletes loss to follow-up were significantly older (U = 
13197, z = -3, p = 0.03). A moderate, significant positive relationship between time to 
first consultation and DRP (U = 2023, p < 0.001) noted. In addition, significant 
relationship between DRP and muscle region (limb versus trunkal) demonstrated (χ2 = 
6.8, p = 0.04) (Table 3.5).  
 
Gender, duration to first consultation, injury classification (new versus 
recurrent), injury severity, number of muscle involved, and side of injury, met the 
criteria for inclusion in a multivariate model. A delay of the first consultation of more 
than 1 week, recurrent muscle injury and women athletes identified as significant 
predictors of DRP more than six weeks (Table 3.6). No interactions found between 
predictors. All other variables were eliminated by the stepwise procedure.  
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Table 3.5 : Factors associated with duration to return-to-play (DRP). 
Factor
 
No. (%) U*/ χ2§ p value 
Gender* 
 Men 
 Women 
 
107 (63.7) 
61 (36.3) 
2898 0.23 
Age group (years)*  
 < 18  
 Above 18  
 
52 (31.0) 
116 (69) 
2730 0.32 
Duration before consultation (week)* 
 1 week or less 
 > 1 week 
 
91 (54.2) 
77 (45.2) 
2023 < 0.001 
Injury type* 
 New 
 Recurrent 
 
104 (61.9) 
64 (38.1) 
2908 0.17 
Injurious event* 
 Traumatic  
 Non-traumatic 
 
10 (6.0) 
158 (94.0) 
646 0.34 
Injury grade (Ultrasound)*  
 Grade 1 
 Grade 2 
 
12 (7.1) 
156 (92.9) 
681 0.12 
No. of muscle injured* 
 One  
 Two 
 
147 (87.5) 
21 (12.5) 
1144 0.07 
Activity leading to injury§ 
 Training 
 Competition 
 Others 
 
140 (83.3) 
26 (15.5) 
2 (1.2) 
0.69 0.71 
Affected side§ 
 Right 
 Left 
 Bilateral 
 
73 (43.5) 
84 (50.0) 
11 (6.5) 
3.50 0.18 
Region affected§ 
 Upper limb 
 Lower limb 
 Trunkal 
 
31 (18.5) 
121 (72.0) 
16 (9.5) 
6.8 0.04 
Level of play§  
 National 
 State 
 School 
 Other 
 
155 (92.3) 
3 (1.8) 
7 (4.1) 
3 (1.8) 
0.24 
 
0.97 
Physiotherapist session§  
 Daily 
 Once a week 
 Twice a week 
 Thrice a week 
 
119 (70.8) 
21 (13.1) 
21 (12.5) 
6 (3.6) 
0.60 0.90 
* Mann-Whitney U test 
§ Kruskal Wallis test 
 
 
Table 3.6 : Predictors of duration to return-to-play more than six weeks after 
muscle injury. 
Determinant B (SE) p AOR 95 % CI 
Duration to consultation > 1 week  1.29 (0.32) < 0.001 3.63 1.80 – 7.30 
Recurrent injury  0.76 (0.37) 0.038 2.14 1.04 – 4.38 
Women 0.74 (0.37) 0.048 2.09 1.01 – 4.34 
SE = standard error, AOR = adjusted odds ratio, CI = confidence interval. 
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3.4 Discussion 
 
The pattern of muscle injury among Malaysian athletes is comparable to earlier 
studies (Garrett 1996; Dick et al., 2007; Alonso et al., 2010; Liu et al., 2012; Ekstrand 
et al., 2012). 
 
In this study, most frequently diagnosed muscle injury of the lower limb is the 
hamstring muscle injury followed by the adductor and calf muscles. Similar findings 
were noted among intercollegiate hockey players (Dick et al., 2007). In addition, lower 
extremity muscle strain was the most frequent injury diagnosed at the 2007 
International Association of Athletics Federations World Athletics Championships 
(Alonso et al., 2010). Further, an 11-year cohort study of 27 Union of European 
Football Associations (UEFA) soccer clubs (1743 players) reported hamstring and 
adductor muscles were the two most common muscles injured (Ekstrand et al., 2013).  
 
Excessive tensile forces on contracting muscles fibres (eccentric contraction) 
during fast bursts of speed suggested as the main cause of muscle injury (Garrett 1996; 
Liu et al., 2012). Muscle injury especially affects muscles that cross two joints, such as 
the biceps femoris, semimembranosus, semitendinosus, gastrocnemius and rectus 
femoris (Anderson et al., 2001; Orchard et al., 2002; Miller, 2007).  
 
Eccentric contraction that occurs during sports (including running and jumping) 
can overstretch muscle fibres leading to membrane, sarcoplasmic retinaculum, 
transverse tubule and sarcolemmal damage (Proske et al., 2001; Proske et al., 2005). 
Most muscle injury observed in this study occurred while running or jumping. Similar 
observations were reported by previous studies (Verrall et al., 2003; Woods et al., 2004; 
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Gabbe et al., 2004). Askling et al. (2007) noted all athletes (n = 18) in their case series 
suffered hamstring injury while sprinting at maximal or close to maximal speed. 
Interestingly in all 18 sprinters, injury primarily involved the long head of biceps 
femoris (Askling et al., 2006). In a cohort study of 12 English Premiership rugby union 
clubs (546 players), Brooks et al. (2006) reported majority (68 %) hamstring injury was 
sustained during running activities (Brooks et al., 2006).  
 
Grade-2 muscle injury was the most common (92.9 %) injury diagnosed in this 
study. Using similar method of injury classification, a lower frequency (35.5 %) of 
grade-2 muscle injury was reported in a prospective cohort study among elite track and 
field athletes (Malliaropoulous et al., 2010). In a muscle injury study among 
professional footballers, Ekstrand et al. (2011) found majority of injury was classified 
on MRI as grade-1 (57 %) followed by grade-2 (27 %) and grade-3 (3 %). 
 
A possible explanation for the difference observed could be due to the different 
study designs. Current study was a retrospective where relevant information about 
muscle injury was extracted from the athlete’s medical records in the NSI Clinic. Being 
the main referral centre for sports medicine, possibly only more severe injuries were 
referred to this clinic, and athletes with less severe muscle injury may have received 
treatment elsewhere.   
 
Most muscle injuries noted in the current study was sustained during training 
rather than competition. As most athletes would spend more time training for 
competition, such observation is expected (Shariff et al., 2009). Previous studies 
however reported the opposite (Gabbe et al., 2004; Brooks et al., 2006; Askling et al., 
2006; Dick et al., 2007; Alonso et al., 2010; Eirale et al., 2013). Gabbe et al. (2006) 
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reported majority (76.9 %) of hamstring injuries among community level Australian 
footballers occurred during competition (Gabbe et al., 2004). Woods et al. (2004), in a 
cohort of 91 professional football clubs noted approximately two third (67 %) of 
hamstring injuries were sustained during matches (Woods et al., 2004). Brooks et al. 
(2006) reported hamstring injury rate of 0.27 injuries/1000 player hours during training 
and 5.6 injuries/1000 player hours in professional rugby players. The author attributed 
lower injury rate during training to high volume of low-risk training activities 
performed by their players (Brooks et al., 2006).  
 
Several explanations could be responsible for differences observed between the 
current and previous studies. First, the cross-sectional nature of the current study does 
not allow hamstring injury rate to be reported. Second, most athletes in the current study 
were non-professional athletes from various sports participating at different playing 
levels. Hence, training activities including duration of each training session, frequency 
of training (per week) and activities performed (high-risk versus low-risk) is expected to 
be different. A prospective cohort study design is recommended to better explore 
hamstring injury incidence. Further, since the current study was based on information 
available in the outpatient clinic, injuries treated during sports events and may have 
been missed. 
 
The median DRP of 7.4 ± IQR 8.5 weeks noted among Malaysian athletes in 
this study is comparatively longer than earlier studies (Malliaropoulos et al., 2010; 
Warren et al., 2010; Silder et al., 2013; Rettig et al., 2013). A study conducted in 
Greece reported an average of 2.1 weeks lost from training and competition among 
elite-level track-and-field athletes. Shorter DRP reported by could be because of higher 
proportion (64.5 %) of low-grade muscle injury (grade 1) in their study (Malliaropoulos 
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et al., 2010). In a randomised clinical trial, Silder et al. (2013), reported a mean DRP of 
3.8 weeks (ranges: 13 - 49 days) among participants with grade-II hamstring injury 
treated with two different rehabilitation programs (progressive agility and trunk 
stabilization (PATS) versus progressive running and eccentric strengthening (PRES). 
The previous study however defined DRP as the period from injury to completion of 
rehabilitation instead of return to competition or training (current study). The mean 
DRP of 3.1 weeks observed among professional football players diagnosed with acute 
grade-II hamstring injury (Ekstrand et al., 2011). A study on hamstring injury among 
Australian footballers found median time to return to competition of 3.7 weeks. The 
authors however did not describe the severity of muscle injury sustained by their 
athletes (Warren et al., 2010). 
 
In this study, athletes who delayed medical consultation by more than one week 
(after the onset of injury) took significantly longer period to recover (more than six 
weeks) than those who seek treatment earlier. A study involving 30 elite-level Swedish 
athletes reported a median DRP of 31 weeks among athletes who presented 12 weeks 
after sustaining hamstring injury. Also, 47 % of athletes in the study decided to retire 
after a follow-up period of 63 weeks (Askling et al., 2008). Early management of 
muscle injury were shown to affect the extent of injury and amount of scar tissue 
formation, which influences the duration of muscle healing (Hawkins et al., 2001; Deal 
et al., 2002; Järvinen, 2005). Early immobilisation (less than one week) following injury 
shown to limit the size of connective tissue (scar) formed within the site of injury in rat 
gastrocnemius muscle (Deal et al., 2002). Further, early cryotherapy is associated with 
significantly smaller haematoma, lesser inflammatory reaction and tissue necrosis and 
hastens early recovery (Hocutt et al., 1982; Järvinen, 2005). Increasing athlete and 
coaches’ awareness on the importance of early medical consultation following injury 
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and improving medical accessibility (on-site medical team support) may shorten the 
duration between injury and first consultation period which might positively affect the 
DRP.  
 
History of previous muscle injury is one of the most important risks for 
subsequent muscle injury. In this study more than one-third (38.1 %) of athletes 
diagnosed with hamstring injury had similar episode of in the past. Hamstring reinjury 
rate of 12 to 44 % has been reported by researchers (Woods et al., 2004; Askling et al., 
2008; Petersen et al., 2010; Elliott et al., 2011; Ekstrand et al., 2012). Athletes with 
history of muscle strain are two to six times more likely to experience recurrent strains 
(Orchard, 2001; Verrall et al., 2006). Reduced tensile strength of scar tissue, reduced 
muscle strength, and reduced muscle flexibility suggested to explain these observations. 
In addition possible adaptive changes including altered biomechanics and motor 
patterns of movements after injury are responsible for increasing risk of injury 
recurrence (Dick et al., 2007). 
 
In this study athletes with history of muscle injury were more likely to take more 
than six weeks to return-to-play than those diagnosed with new injury. Similar 
observation reported in the National Football League (NFL) training camp injuries 
prospective study. Significantly longer recovery time was noted among athletes 
diagnosed with hamstring re-injuries (56 days) than those with first-time injury (16.5 
days) (Rettig et al., 2008). Laboratory study showed absence of satellite cells within the 
fibrotic tissue (scar) and failed migration of neighbouring myogenic satellite cells into 
the scare as the phenomenon responsible for the delay in healing of recurrent muscle 
injuries (Grefte et al., 2009). 
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Female athletes with muscle injury took more than six weeks to recover 
compared with male. The reason for this association is unclear. One possible 
explanation could be related to the difference in the circulating sex hormones between 
female and male. Significantly less inflammatory cells (neutrophils and granulocytes) 
infiltrated the vastus lateralis of female university students after a standardised pain 
inducing eccentric exercise compared to men (Stupka et al., 2000). Leucocytes and 
macrophages infiltration into injured muscle are important for satellite cells activation 
and initiation for muscle regeneration. Therefore, oestrogen-attenuating effects on 
leucocyte infiltration may delay important stages in muscle healing and recovery 
(Schneider et al., 1999; Tiidus, 2000; Tiidus, 2005). Further, a study on 16 
premenopausal university students showed significant hamstring muscle extensibility 
changes throughout different phases of menstrual cycle that increases the likelihood of 
sustaining acute hamstring injury (Bell et al., 2009). 
 
Interestingly, the frequency of weekly physiotherapy sessions did not affect the 
DRP. In contrast to our findings, a study involving 80 athletes with grade-2 hamstring 
injury noted significantly shorter recovery time among athletes who received more 
intensive stretching program (Malliaropoulos et al., 2004). The attending 
physiotherapists in this study did not use a standard treatment protocols. Each 
physiotherapist has their own treatment regimen based on anecdotal report and personal 
experience. The treatment protocol differs on the types; sequence of exercises 
prescribed, duration of the treatment session and type/s of electrotherapeutic modalities, 
which further complicates comparisons between the different regimens. 
 
The high loss to follow-up rate (53 %) is of major concern especially when it 
involved national-level athletes. There is a possibility that athletes’ loss to follow-up in 
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this study have achieved full recovery and recommenced usual activities. It is also 
possible that these athletes decided to retire or sought treatment elsewhere. A 
prospective study to explore on factors associated with loss to follow-up is underway.  
 
This study found the timing of first consultation, history of muscle injury 
(recurrence) and women gender were significant factors in predicting the DRP among 
Malaysian athletes.  
 
 
3.5 Conclusion 
 
Grade-2 lower limb muscle injury was the commonest injury diagnosed among 
national-level athletes. Athletes with muscle injury responded well with conservative 
treatment approach. The median DRP of athletes with muscle injuries in this study was 
7.4 weeks. Athletes who waited more than 1 week before first consultation, athletes 
with recurrent muscle injury and female athletes were significantly more likely to take 
more than six weeks to return-to-play after muscle injuries. Incorporating these 
important parameters in early assessments of muscle injuries is useful in predicting 
recovery. Strategic steps needed to ensure early consultation and commencement of 
treatment as soon as an injury occurs. Increasing awareness on factors associated with 
DRP among athletes, coaches and to those involve in the care of athletes is 
recommended. 
 
A prospective study with a larger sample size could better show the associations 
between clinical assessments and treatment outcomes including potential variables with 
small to moderate effects. 
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3.6 Summary 
 
 Limited information is available on muscle injury among Malaysian athletes. A 
retrospective study of the medical records of athletes with muscle injury was performed 
to explore pattern of muscle injury among local athletes. The pattern of muscle injury 
and injury management were comparable to previous studies. Lower limb muscle injury 
particularly the hamstring group was the commonest muscle injured among athletes. 
Despite these similarities, the DRP for Malaysian athletes is relatively longer compared 
to other studies. Duration before initial consultation, recurrent muscle injuries and 
female athletes can significantly predicts the DRP among Malaysian athletes. 
Incorporating these factors in clinical setting can be useful in predicting recovery after 
muscle injury.  
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Chapter 4  Reliability of active knee extension (AKE) test among healthy adults: 
A cross sectional study 
 
4.1 Introduction 
 
Based on the current knowledge, risks of hamstring muscle injury include 
previous hamstring injury, muscle strength imbalance, increasing age, inadequate 
warm-up, and muscle fatigue (Gabbe et al., 2004; Croisier et al., 2010; Cross et al., 
2010). Other factor such as hamstring muscle tightness has also been suggested to 
contribute to hamstring injury. The interaction between hamstring flexibility and knee 
flexion angle-torque was examined in 20 healthy volunteers (Alonso et al., 2009). This 
study noted the angle-torque curve shifted to the left in less flexible hamstring (Figure 
4.1). The less flexible hamstring group had higher torque at shorter muscle length but 
lower torque at longer muscle length. Possibly lower torque produced by the less 
flexible hamstring may not be able to withstand the passive lengthening forces 
especially during eccentric muscle contraction and increases the risk of injury. 
 
The relationship of hamstring flexibility with hamstring injury is still 
inconclusive, as studies have shown conflicting results (Burkett, 1970; Ekstrand & 
Gillquist, 1983; Hennessey & Watson, 2005; Jonhagen et al., 2006; van Beijsterveldt et 
al., 2012).  
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Figure 4.1. Angle-torque relationship for maximum isometric knee flexion contractions: 
tight vs. normal hamstrings. Mean standard error displayed (Source: Alonso et al., 
2009, p. 254). 
 
 
 
Worrell et al. (1991) compares hamstring isokinetic strength and flexibility in 32 
male athletes found athletes with history of hamstring injury had less hamstring 
flexibility than the noninjured group. They also noted that the injured extremity was 
significantly less flexible than the noninjured side within the hamstring injured group. A 
prospective cohort study of 146 professional soccer players found players with 
hamstring and quadriceps muscle injury had significantly lower flexibility in these 
muscles before the start of season. The author concluded soccer players with tight 
hamstring or quadriceps have a higher risk of injury (Witvrouw et al., 2003).  
 
In contrast, Burkett (1970) found no significant association between hamstring 
flexibility and hamstring injuries in a cross-sectional study of football players and track 
athletes. Similar observations were reported in more recent prospective cohort studies 
(Orchard et al., 1997; Gabbe et al., 2006; Yeung et al., 2009; Engebretsen et al., 2010).  
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Despite this, hamstring flexibility assessments are used regularly during routine 
preparticipation examination and in deciding athletes’ readiness to return-to-play 
following an injury (Croisier et al., 2002; Drezner, 2003; Mendiguchia & Brughelli, 
2010). Thus, a simple and reliable method of hamstring flexibility assessment is still 
relevant. 
 
 There are several methods of hamstring flexibility assessments described in the 
literature. The three most common methods of flexibility assessments are the straight-
leg-raising (SLR), sit and reach (SR) and active knee extension (AKE) tests (Gajdosik 
& Lusin, 1983; Booher & Thibodeau, 1985; Baltaci et al., 2003). Each test has its own 
advantages and disadvantages.  
 
 The SLR test is usually performed with the patient lying in supine and both 
lower extremities extended. The examiner passively flexes the hip joint, while keeping 
the ipsilateral knee in extension. To avoid neural tension, the ankle is kept in slight 
plantarflexion throughout the test. At the end of passive movement, the hip joint angle 
is measured with either a universal goniometer or a gravity inclinometer (Figure 4.2) 
(Davis et al., 2008). Despite the simplicity of performing the SLR test, questioned rose 
on the test specificity as this test is also widely used as a neurological test (Malanga & 
Nadler, 2006). Further, cinematographic on 11 healthy subjects (9 men and 2 women) 
showed significant pelvic rotation occurred during an SLR test. The authors concluded 
that when assessment of hamstring flexibility is made with SLR, pelvic rotation should 
either be prevented (stabilised) or accounted for (Bohannon, 1982).  
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Figure 4.2. The straight leg raise test (Source: Bohannon, 1982, p. 1270). 
 
 
 Many variations exist in performing the SR tests. The classical SR test requires a 
measuring box with a mounted ruler. The subject sits on a flat surface (floor or plinth) 
with both knee extended and feet placed flat against the device (Figure 4.3). Subject is 
asked to reach forward slowly with both hands as far as possible and hold the position 
for 2 seconds. Using the plantar surface of the feet as reference point the most distant 
point reached with the fingertips is recorded.   
 
 Although hamstring flexibility assessment can easily be performed using the sit 
and reach (SR) test, the validity of this test was considered poor (Lemmink et al., 2003; 
Clark, 2008; Mier, 2011). Moreover, the criterion-related validity of the SR test and 
modified SR test for estimating hamstring flexibility was found to be weak among 
children and adolescents aged 6 – 17 years (Pinero et al., 2009). 
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Figure 4.3. The sit and reach test (Sources: http://www.habdirect.co.uk/products/fitness-
testing/sit-reach-box-steel and http://www.fitnessbydesign.ie/images/sit-and-reach.jpg). 
      
 
 The AKE test is an active test that involves movement at the knee joint. The test 
is performed while subject in supine with the leg not examined strapped on the 
examination couch. The centre of the knee joint is marked over the lateral joint line. 
Two lines are drawn from this point to the greater trochanter of the femur and another to 
the tip of the lateral malleolus. The subject is asked to bend the knee and hip to 90 °. 
While keeping the hip joint in 90°, subject is instructed to extend the leg as far as 
possible and hold the position for a few seconds. The angle of the knee extension is 
measured using a universal goniometer positioned along the lines marked earlier (Figure 
4.4). Most researchers consider this test safe as the patient dictates the end point of 
movement. Further, the AKE test aided by metal rig and straps (to limit pelvic and leg 
motion) showed good interater and intrarater reliability as demonstrated by previous 
studies (Gajdosik & Lusin, 1983; Kuilart et al., 2005; Davis et al., 2008; Reurink 2012). 
Others though, questioned the practicality of the AKE test, as the apparatus used by 
researchers are complicated and rarely available in clinic setting (Figure 4.5) (Worrell et 
al., 1990). Therefore, a reliable and easy to perform method of hamstring flexibility 
assessment is much relevant.  
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Figure 4.4. The active knee extension (AKE) test (Norris & Matthews, 2005 p. 258). 
 
In the Sports Medicine Clinic, University Malaya Medical Centre (UMMC), 
most patients are arranged to come in for their follow-up appointment once a week. At 
each follow-up session, a doctor or physiotherapist in charge attends to patients. Usually 
the same health care provider provides continuity of care for the patient. However, in 
some occasions this may not be feasible. Therefore developing an efficient, practical 
and reliable method of AKE assessment will be valuable under these circumstances.  
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Figure 4.5. The active knee extension (AKE) test using metal rig (Kuilart 2008 p. 92). 
 
 
The interater and intrarater reliability of the AKE test used in this study was 
published in the Journal of Physical Therapy Science in 2013 (Hamid et al., 2013) 
(Appendix J). 
 
 
4.1.1 Specific objective of study 
 
1. to design and set up a simple apparatus that would allow a single assessor to 
perform assessment of AKE easily  
 
2.  to determine the intrarater and interater reliability of proposed method of AKE 
assessment 
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4.2 Methods 
 
4.2.1 Construction of AKE apparatus 
 
A simple, portable and easy to use apparatus (to help stabilise the pelvic and hip 
motion) was designed and constructed to aid in AKE assessment. The apparatus is made 
of 15 mm polyvinyl chloride (PVS) pipe (STAR uPVC: BS3505 Class 7) (Figure 4.6), 
as it was cheap, easy to handle and lightweight, enabling the apparatus to easily 
transport to any location. The apparatus when used with a universal goniometer 
(Sammons Preston ♯7514) (Figure 4.7) allowed a single assessor to perform AKE test 
easily. 
 
The designed of the apparatus was based on those used in previous study 
(Gajdosik & Lusin, 1983). It consisted of a single horizontal bar attached to two vertical 
poles on either side. The vertical poles anchored to the sides of the plinth by means of 
four tubing clips. These clips were attached to the plinth by four screws (Figure 4.8). 
The vertical poles position can be adjusted proximally or distally by slotting the 
horizontal bar into the appropriate connection on the side of the plinth. The horizontal 
bar should be place aligning the patient’s anterior superior iliac spines (ASIS) during 
measurement.  
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Figure 4.6. Apparatus used to aid active knee extension (AKE) test constructed from 
polyvinyl chloride (PVC) tubes. 
 
 
4.2.2 Participants 
 
 Sixteen healthy participants (10 men and 6 women) volunteered in this study. 
Participants’ age ranges from 28 to 39 years old. Participants were either Sports 
Medicine postgraduate students or the staffs at the Faculty of Medicine, University of 
Malaya. All participants were free from any orthopaedic or neurological disorders. 
 
4.2.3 Determination of AKE measurement reliability 
 
 The University of Malaya Medical Centre Ethics Committee approved the study 
(MEC Ref no.835.11). 
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Figure 4.7. A standard perspex goniometer. 
 
 
Figure 4.8. Horizontal poles anchored to the sides of the plinth. 
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All assessments were conducted at the Sports Medicine Clinic, University of 
Malaya Medical Centre. Prior to participation, the purpose of the study and testing 
procedure involved were explained to all participants, and each signed an informed 
consent. The preferred leg for physical activities (jumping or kicking a ball) was 
recorded as the participants’ dominant leg. To ensure that all participants would be 
assessed in the standard manner, both assessors attended a half-day workshop on a 
standardised method of AKE test conducted by the main author.  
 
A sport physician (SAH) and a physiotherapist (LPC) performed all the AKE 
tests independently. All assessments were conducted between 9.00 to 11.00 am at room 
temperature (22.7 ° C and 85.7 % humidity). All participants were asked to avoid from 
any physical activities on the day of AKE test and remain hydrated (Rakos et al., 2001). 
This is because previous study showed changes in biomechanical characteristics of 
collagen and muscles viscoelastic properties after warming-up, and might affect AKE 
measurement.  
 
 Participants were assessed on a plinth in the supine position with both knees 
extended. Both anterior superior iliac spines were positioned aligning with vertical bars 
of the apparatus (Figure 4.9). The lower extremity not being measured was secured to 
the plinth with a strap across the lower third of the thigh. Each assessor marked the 
lateral knee joint line with washable ink. From here, two lines were drawn, first, to the 
greater trochanter and another to the top of lateral malleolus. Participants were told to 
flex his or her hip until their thigh touches the horizontal bar (Figure 4.10). While 
maintaining contact between thigh and the horizontal bar, the participant was asked to 
extend the leg as far as possible (point of discomfort), keeping their foot relaxed, and 
held the position for about 5 seconds.  
  90 
 
 
 
Figure 4.9. Participant position at the beginning of active knee extension (AKE) test. 
 
 
 
A standard universal goniometer was placed over the previously marked joint 
axis and the goniometer arms aligned along the femur and fibula (Figure 4.11). The 
AKE measurement was defined as the degree of knee flexion from terminal knee 
extension. Each knee was measured twice, and the mean angle of AKE test was used for 
analysis. All participants attended two testing sessions one week apart to allow for 
establishment of test-retest reliability of the method. The order in which the rater 
assessed the participants was randomly assigned in the first session and maintained 
thereafter. 
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4.2.4 Data analysis 
 
Data were analysed using Statistical Package for the Social Sciences (SPSS Inc., 
version 20.0 for Mac, Chicago). The average AKE angles of two measurements for each 
knee were used for statistical analysis. Data were described descriptively, and normality 
testing performed using Shapiro-Wilks test. Paired t-tests were performed to compare 
differences between tests and retest measurement within and between raters.  
 
 Two different types of measures of reproducibility were assessed: measures of 
agreement and measures of reliability. The interater agreement quantified by calculating 
the mean difference between the two raters (raters 1 – 2) and the standard deviation 
(SD) of this difference. Further, the 95 % limits of agreement were calculated according 
to the method of Bland & Altman (Bland & Altman, 1986). These limits represent the 
range in which 95 % of the differences between the two raters fall.  
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Figure 4.10. Participant flexing the hip until thigh touches the horizontal bar. 
 
 
 
Figure 4.11. Participant extending the knee while maintaining thigh position. 
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Plots of differences between raters against the corresponding mean of the two 
raters for each participant were produced to examine homoscedascity as proposed by 
Bland-Altman (Bland & Altman, 1986). Further, the frequency of agreement of the 
raters within 5 and 10 ° was calculated. Differences exceeding 10  was determined as 
being unacceptable as they are likely to affect decisions on patient management as 
suggested by previous study (Weijer et al., 2003).  
 
The AKE test reliability was evaluated by computing the Intraclass Correlation 
Coefficients (ICC). The ICC analyses consistency of quantitative measurements. An 
ICC, two-way random model was used to establish reliability ICC, and one-way random 
model was chosen to evaluate reliability (Portney & Watkins, 2000). The ICC value of 
the standard error of measurement (SEM) was calculated to express magnitude of 
disparity between measurements (Shrout & Fleiss, 1979). The SEM was calculated 
using the formula; SEM = SDavg (√1 – ICC) where SD corresponds to the pooled 
standard deviation and ICC is the reliability coefficient (Portney & Watkins, 2000). A 
smaller value of SEM suggests greater agreement between measurements (Atkinson & 
Nevill, 1998). The minimum detectable change (MDC) was calculated using the 
formula MDC = (1.96) (SEM) √2 (Macedo & Magee, 2008). 
 
 
4.3 Results 
 
Only 14 (8 male and 6 female) participants were able to complete the AKE test 
and retest sessions.  Two participants were excluded from the final analysis as one 
suffered a hamstring injury, and the other had a road traffic accident. Table 4.1 
summarizes the results of the normality testing of continuous variable. The median age 
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of the participants was 31.0 (range: 28.0 – 39.0). A significant difference in body weight 
between men (Mean = 77.69, SD =12.86) and women (Mean = 63.42, SD = 10.27) 
participants; t = 2.23, p = 0.046 was noted. 
 
Table 4.1 : Test of normality for continuous variables. 
Continuous variables Shapiro - Wilks 
Statistics Degree of 
freedom 
P value 
Age (years) 0.873 14 0.046* 
Weight (kg) 0.942 14 0.448 
Height (cm) 0.950 14 0.556 
BMI 0.945 14 0.487 
AKE dominant knee 0.911 14 0.161 
AKE non-dominant knee 0.908 14 0.145 
AKE differences  0.954 14 0.629 
Note: * P ≥ 0.05 = Normal distribution. 
 
 
  
 General description of participant’s physical characteristics is displayed in Table 
4.2. The means AKE measurements of the dominant and non-dominant side were 
compared. No significant difference in AKE angle between both sides was found (t = 
0.59, p = 0.487). Furthermore, no significant difference was observed between test and 
retest sessions for both dominant (t = 0.77, p = 0.46) and non-dominant (t = -1.01, p = 
0.33) knees (Table 4.3). 
 
 
 
Table 4.2 : Descriptive data participant's physical characteristics 
 All participants Male Female 
Variables Mean (SD)/ 
Median (IQR)
†
 
Range Mean (SD)/ 
Median (IQR)
†
 
Mean (SD)/ 
Median (IQR)
†
 
Age (years)† 31.00 (2.50) 28-39 32.00 (3.01) 30.00 (2.43) 
Body weight (kg) 71.57 (13.54) 54-100 77.69 (12.87) 63.42 (10.27) 
Height (cm) 168.40 (6.06) 159-181 170.94 (5.82) 165.00 (4.90) 
Body mass index (BMI) 25.09 (3.50) 19.13-31.83 26.49 (3.36) 23.23 (2.99) 
AKE† dominant knee (°) 24.06 (7.43) 13.0-42.0 25.48 (8.90) 22.17 (5.01) 
AKE non-dominant knee (°) 24.22 (9.72) 15.1-42.5 26.23 (8.62) 21.54 (4.41) 
AKE difference (°) -0.16 (2.41) -3.38-4.75 -0.75 (1.81) 0.63 (3.03) 
SD = Standard deviation; IQR = interquartile range; AKE = Active knee extension.  
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Table 4.3 : Active knee extension (AKE) measurements of dominant and non-
dominant knees 
Side Mean AKE angle SD Range 
Dominant 24.063 7.43 13.00 – 42.00 
Non-dominant  24.223 7.29 15.13 – 42.50 
AKE = active knee extension; SD = standard deviation. 
 
 
 
4.3.1 Interater agreement and reliability 
 
Results of raters 1 and 2 from the testing sessions were compared. Table 4.4 
displays the results of these comparisons. No significant difference between raters was 
observed for both lower limbs AKE tests. A summary of the interater agreement 
observed in this study is displayed in Table 4.5. Both raters had similar measurements 
of AKE, with the limits of agreement of 0.1 ± 12.9 (SD) for the dominant and -1.1 ± 
15.7 for non-dominant knees. The percentages of agreement within 10  for these 
measurements were 93 and 79 % for the dominant and non-dominant knee respectively. 
 
 
Table 4.4 : Mean, standard deviation (SD), mean differences between raters and 
the frequency of agreement within 5 and 10 degrees. 
AKE test Rater 1  
Mean (SD) 
Rater 2  
Mean (SD) 
Rater 1 – 2  
Mean (SD) 
Upper and 
lower limit of 
agreement 
% of agreement 
     5
 
10 
Dominant knee () 24.9 (9.3) 24.8 (10.1) 0.1 (6.9) -13.4 – 13.6 43 93 
Non-dominant knee () 23.7 (8.1) 24.9 (7.2) -1.1 (7.2) -15.2 – 13.0 43 79 
AKE = Active knee extension; SD = Standard deviation. 
 
 
The AKE measurement differences between raters were plotted against the mean 
value of both raters for both the dominant and non-dominant knees (Figures 4.12 and 
4.13). Errors of measurement for both knees were independent of the magnitude of the 
range of measurements demonstrating homoscedascity. 
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Figure 4.12. Bland-Altman plot of the differences versus means of the dominant AKE 
measurements. 
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Figure 4.13. Bland-Altman plot of the differences versus means of the non-dominant 
AKE measurements. 
 
 
 
 The AKE measurements by raters 1 and 2 from the first testing session were 
compared (Table 4.5). No significant differences between raters were observed for both 
lower limbs. The AKE test interater reliability was excellent, with ICC2,1 values of 0.87 
(0.58 – 0.97; 95 % CI) for the dominant and 0.81 (0.41 – 0.94; 95 % CI) for the non-
dominant knees and standard error of measurement (SEM) values of 3.5  (18.0  – 
31.7; 95 % CI) and 3.8  (16.9  – 31.7 ; 95 % CI) respectively. Minimal detectable 
change was between 9.7 and 10.5 . 
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Table 4.5 : Inter-rater reliability of active knee extension (AKE) test.  
AKE
  
 measurements 
Rater 1, 
mean (SD) 
Rater 2, 
mean (SD) 
p value ICC2,1 95 % CI
 
 ICC 
SEM 95 % CI 
SEM 
Dominant knee (o) 24.9 (9.3) 24.8 (10.1) 0.95 0.87 0.58 – 0.97 3.5 18.0 – 31.7 
Non-dominant knee 
(o) 
23.7 (8.1) 24.9 (9.5) 0.56 0.81 0.41 – 0.94 3.8 16.9 – 31.7 
AKE = Active knee extension test; SD = Standard deviation; ICC = Intraclass correlation coefficient;  
CI = Confidence interval; SEM| = Standard error measurement. 
 
 
 
4.3.2 Test-retest reliability 
 
The AKE measurements by raters 1 and 2 from the first testing session were 
compared. No significant differences of the mean AKE measurements between the first 
and second testing sessions were found for both raters (Table 4.6). The ICC3,1 values 
ranges from 0.78 to 0.92.  
 
 
Table 4.6 : Active knee extension (AKE) test, test-retest reliability of both raters. 
AKE test Rater Session 1, 
mean (SD) 
Session 2, 
mean (SD) 
p value IC
C3,1
‡
  
95% CI
§
 
ICC 
SEM
||
 95% CI 
SEM 
AKE dominant 
knee (o) 
1 24.9 (9.3) 24.0 (6.8) 0.46 0.92 0.76 – 0.97  2.3 19.9 – 29.0 
2 24.8 (10.1) 22.3 (6.2) 0.21 0.78 0.32 – 0.92 3.9 16.0 – 31.2 
AKE non-
dominant knee (o) 
1 23.7 (8.1) 25.2 (8.6) 0.33 0.88 0.45 – 0.92 2.9 18.8 – 30.2 
2 24.9 (9.5) 23.1 (5.9) 0.31 0.82 0.46 – 0.94 3.3 17.5 – 30.5 
AKE = Active knee extension test; SD = Standard deviation; ICC = Intraclass correlation coefficient;  
CI = Confidence interval; SEM = Standard error measurement. 
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4.4 Discussion 
 
Despite conflicting observation on the association of poor hamstring flexibility 
and the risk of hamstring injury, assessment of hamstring flexibility continues to be 
routinely done during athlete’s physical assessment. Furthermore, hamstring flexibility 
is frequently used in deciding athlete’s readiness to return-to-play following an injury 
(Croisier et al., 2002; Drezner, 2003; Mendiguchia & Brughelli, 2010). The AKE test is 
considered by some to be the gold standard for hamstring flexibility assessment (Davis 
et al., 2008).  
 
 With the aid of a simple stabilizing apparatus and a universal goniometer, we 
have shown that a single assessor could perform the AKE test easily. In uninjured 
participants we have demonstrated that the AKE angle between the dominant and non-
dominant is comparable (range of differences -3.38 to 4.75 °). Further, no significant 
difference in AKE angle of the dominant and non-dominant knees between genders was 
observed. The interater reliability ICC2,1 values of 0.87 and 0.81 were found for the 
dominant and non-dominant knees respectively. In addition, the standard error of 
measurement were 3.5 ° for the dominant and 3.8 ° for the non-dominant knee. Hence, a 
good level of agreement between raters was established.    
 
Test-retest reliability of the AKE test in this study was excellent with ICC3,1 
values ranges from 0.78 to 0.92 for both raters. Our findings are in agreement with 
earlier studies. Gajdosik et al. 1983, reported the AKE test Pearson product-moment 
correlation coefficient of 0.99 for both lower extremities. Higher reliability coefficient 
value in the previous study could be explained by the different statistical methods used 
by the author. A very short interval between the first AKE test and retest sessions (30 
minutes apart) used in previous study did not reflect true clinical setting and may have 
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introduced systematic bias and affected reliability (Askling et al., 2004). In this study 
we chose an interval of one week between the test and retest sessions as it reflects our 
clinical practice, where majority cases are reviewed on weekly basis. 
 
 Using the mean value of both lower limbs AKE measurements, Gabbe reported 
excellent test-retest reliability with ICC3,1 values of 0.94 – 0.96 (Gabbe et al., 2004). In 
contrast to Gabbe et al., 2004, the current study evaluated each knee separately to 
explore any potential differences between the dominant and non-dominant knees, and 
such difference in method may explain the wider ICC3,1 values noted in this study.   
 
A pilot study conducted by Davis et al., (2008) reported an excellent intrarater 
reliability of knee extension angle (KEA) test, with ICC3,1 of 0.94.
 The method of 
hamstring flexibility assessment employed by the previous author differs from the 
current study. They measured the KEA using two gravity inclinometers placed 
immediately superior to the patella, and another was placed on the distal anterior tibia. 
Moreover the examiner performed both hip flexion and knee extension passively, 
whereas participants actively performed all movements in the current study.  
 
Our findings on interater reliability was consistent to those reported by earlier 
studies (Sullivan & DeJulia, 1991; Gabbe et al., 2004). Gabbe et al. (2004), reported an 
interater reliability ICC2,1 of 0.93 and 4 ° SEM for the AKE test in 15 healthy 
participants of comparable age group (mean age: 31.6 years). Similarly, in a study to 
determine the effect of pelvic positioning and stretching method on hamstring 
flexibility, Sullivan & DeJulia (1991) reported an interater reliability ICC1,1 and SEM of 
0.93 and 4.81° respectively for the AKE test among 12 healthy subjects. On the other 
hand, Rakos et al., (2001), performed the AKE test with the aid of an intricate 
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stabilizing apparatus demonstrated a good interater reliability with an ICC2,1 of 0.79 
among children age 10 to 13 years old.  
 
Despite demonstrating excellent interater and test-retest reliability, a wide range 
of CIs was noted for some of the point estimates in this study. Such finding suggests 
that further research with larger samples size may be necessary to determine the 
reliability estimates with greater precision (Hopkins, 2000). Second, the reliability 
displayed in this study was based on assessment of healthy and non-injured volunteers.    
 
 
4.5 Conclusion 
 
The current study demonstrated that a single assessor could perform the AKE 
test easily using a simple, portable and inexpensive stabilizing apparatus and have 
excellent interater and intrarater reliability.  The interater reliability intraclass 
correlation coefficients (ICC2,1) were 0.87 for the dominant and 0.81 for the non-
dominant knee. In addition, the intrarater (test-retest) reliability ICC3,1 values’ ranges 
between 0.78 - 0.92 and 0.75 – 0.84 for raters 1 and 2 respectively. Further this study 
demonstrated no significant differences of the AKE angles between the dominant and 
non-dominant sides in healthy individuals. A difference of less than 10 ° between the 
sides can be considered as healthy, and can be use to guide athlete recovery following 
injury. Therefore, we recommend the use of the AKE test (with apparatus) described in 
this study by health care providers for assessment of hamstring flexibility. 
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4.6 Summary 
 
 Hamstring flexibility assessment is performed during athlete’s preparticipation 
evaluation. In addition this test is also used in deciding athlete readiness to return-to-
play following an injury. Several hamstring flexibility assessment methods is currently 
available, each with their own advantages and disadvantages. A simple active knee 
extension (AKE) test aided by a cheap, portable and easy-to-use stabilising apparatus 
was proposed. This method demonstrated excellent interater and intrarater (test-retest) 
reliabilities with ICC values’ ranges from 0.81 – 0.87 and 0.75 – 0.97 respectively. 
Further, a difference of < 10 ° in AKE angles between the dominant and non-dominant 
sides was noted in 14 healthy volunteers. The proposed AKE test is a reliable test that 
could be used to monitor hamstring flexibility and guide practitioners on the decision to 
allow return-to-play following an injury.     
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Chapter 5  Platelet-rich plasma (PRP) for the treatment of hamstring injury: A 
randomized controlled trial 
 
5.1 Introduction  
 
The cross-sectional study on pattern of muscle injuries among Malaysian 
athletes is in agreement with other studies  (Garrett 1996; Dick et al., 2007, Alonso et 
al., 2010, Liu et al., 2012; Ekstrand et al., 2013). Hamstring is the commonest muscle 
injured among Malaysian athletes (Chapter 3). In addition, information on athlete’s 
demographics, current injury management and duration to return-to-play (DRP) among 
local athletes were gathered. Further, the preliminary study revealed several factors that 
predict earlier DRP among Malaysian athletes (Shariff et al., 2013).  
 
Despite of it’s frequent occurrence, the best treatment of hamstring injury is not 
known. Current approaches involve rest, intermittent cryotherapy (ice), compression 
and elevation (RICE) especially in the early stage following an injury. The objectives of 
the RICE treatment are to limit extent of injury and for pain control. In addition, short-
term painkillers are often prescribed for pain control in this early stage. Following this 
acute phase, treatment usually focuses on pain control, regaining full range of 
movement and strength of the affected muscle.  In most cases patients are prescribed 
with range of movement and strengthening exercises. These approaches are often 
combined with the various electrotherapeutic modalities such as transcutaneous 
electrical nerve stimulation (TENS), therapeutic ultrasound and interferential current to 
name a few. Clinical evidence to suggest efficacy of these treatments however is limited 
(Zuluaga, 1995: Reynolds et al., 2008). 
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More recently (past two decades) autologous biological substances have 
received much attention for soft tissues injury. Biological substances such as autologous 
blood (AB), preparation rich in growth factors (PRGF), preparation rich in fibrin matrix 
(PRFM) and platelet-rich plasma (PRP) are currently used by researchers and 
physicians to hasten recovery (Wright-Carpenter et al., 2004a; Kaspriske, 2010; “Tiger 
Admits to Platelet-Rich Plasma,” 2010; Ekstrand et al., 2011; Eirale et al., 2013).  
 
Muscle tissue heals through intricate balance of scar tissue formation and muscle 
cells regeneration (Järvinen et al., 2005). New muscle cells are formed from activation 
and differentiation of the dormant satellite cells found within the basal lamina (Tiidus et 
al., 2008). Activated satellite cells’ proliferates and differentiates into mature myoblasts 
in response to various growth factors and cytokines. Autologous biological substances 
contain growth factors such as, insulin-like growth factor-1 (IGF-1), platelet derived 
growth factors (PDGF), vascular endothelial growth factor (VEGF), epidermal growth 
factor (EGF) basic fibroblasts growth factors and transforming growth factor beta-1 
(TGF-β1) and various cytokines that are responsible for muscle healing (Järvinen 2005; 
Tiidus et al, 2008). It is believed that increasing the amount of the various growth 
factors and cytokines in an injured area would speed up healing process allowing faster 
and more complete recovery. Currently there are some evidences demonstrating 
autologous biological substances efficacy for tendon injury (Mishra & Pavelko, 2006; 
deAlmeida et al., 2010; Filardo et al., 2010; Gaweda et al., 2010; Peerbooms et al., 
2010; Mishra et al., 2013). However, clinical evidence to suggest efficacy for muscle 
injury is limited to laboratory and case control studies (Zarins & Ciullo, 1983; Wright-
Carpenter et al., 2004a; Wright-Carpenter et al., 2004b; Hammond et al., 2009; Gigante 
et al., 2012; Rettig et al., 2013). Further, there is no randomised controlled clinical trial 
available on PRP use for muscle injury (Chapter 2).  
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The effect of autologous PRP injection for treating hamstring muscle injury was 
explored in this chapter. A randomised controlled clinical trial (phase 3) was conducted 
to examine the effect platelet-rich-plasma (PRP) injection on the duration of return-to-
play (DRP) following an acute grade-2 hamstring muscle injury. This study protocol 
has been registered with the Current Controlled Trials (ISCRTN66528592) (Hamid et 
al., 2012) (Appendices K and L).  
 
   
5.1.1 Specific objective of study 
 
1. to investigate the effect of single platelet-rich plasma (PRP) injection combined 
with progressive agility and trunk stabilisation (PATS) rehabilitation program 
on the duration to return-to-play (DRP) after grade-2 hamstring injury 
 
2. to explore the effect of single PRP injection combined with PATS rehabilitation 
program on changes in signs and symptoms associated with grade-2 hamstring 
injury over time. 
 
 
5.2 Materials and methods 
 
A randomised assessor-blinded controlled trial was designed to explore the 
effect of single intralesional injection of autologous PRP combined with a standard 
rehabilitation program versus standard rehabilitation programme alone on the DRP after 
an acute grade-2 hamstring injury. 
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5.2.1 Study setting 
 
The trial was conducted in the Sports Medicine Clinic, University Malaya 
Medical Centre (UMMC). This clinic is one of the pioneer Sports Medicine Clinics in 
providing sports related injury care in Malaysia. The Sports Medicine Clinic, UMMC is 
located in the heart of Kuala Lumpur, the capital city of Malaysia and bordering the 
State of Selangor, which is the most populous state in Malaysia. Federal Territory of 
Kuala Lumpur and the state of Selangor has a combine population of 8.13 million (25.2 
%) of the total Malaysian population (Malaysia, 2011). The Sports Medicine Clinic, 
UMMC played a central role in providing medical services during the XVI 
Commonwealth Games, Kuala Lumpur in 1998, the 15th Asean University Games in 
2008, Asia Cycling Tournament and International Rugby Tournament in 2012 including 
several other local and international sport events. 
 
In addition, over the past years this clinic has developed strong working 
relationships with the National Sports Institute and the National Sports Council of 
Malaysia in Bukit Jalil, Kuala Lumpur.  
 
 
5.2.2 Participants and recruitment 
 
Study notice (Appendix M) and invitation (Appendix N) to take part in this 
study were distributed to all sports medicine practitioners (sports physicians and 
physiotherapists) within the Klang Valley, Malaysia between November and December 
2011. Participant’s recruitment began from January 2012 until May 2013. Patients with 
confirmed or suspected hamstring muscle injury were invited to take part in this study. 
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Sports medicine practitioners were encouraged to refer patients that fulfilled the clinical 
criteria of hamstring muscle strain as described by Askling et al., (2006), these include:  
 
a) Acute (within seven days) onset of posterior thigh pain suffered during 
training or competition; 
b) Tenderness on palpation of the hamstring muscle; 
c) Pain with stretching of the hamstring muscle; and 
d) Pain with resisted contraction of the hamstring muscle.  
 
All potential participants underwent a screening process conducted by the 
research team to determine eligibility and to ensure safety of participation in the study. 
This screening process was based on the predetermined inclusion and exclusion criteria 
using a structured clinical report form (Appendix O).  
 
The screening process involved clinical and radiological assessment of the 
current injury. Potential participants were required to provide detail clinical history on 
the current injury. Following this, a sport physician and a physiotherapist examined and 
graded the severity of the injury using clinical grading as recommended by previous 
authors (Järvinen et al., 2000; DeLee, 2003). Participants clinically diagnosed with 
grade-2 hamstring injury were referred to the Department of Radiology for confirmatory 
ultrasonography. An experienced musculoskeletal radiologist conducted all diagnostic 
ultrasound assessment using the Philips IU 22 ultrasound with 10 MHz, l4 cm linear 
probe to confirm the diagnosis. Severity of hamstring injury was determined using the 
ultrasonography grading system used in UMMC (Peetrons et al., 2002) (Table 5.1). 
Diagnostic ultrasound assessment was conducted 24 to 48 hours after completion of 
physical examination (Figure 5.1). Ultrasonography findings were documented in a 
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standard ultrasound report form (Appendix P). Patients who met the criteria were 
invited to take part in the study. 
 
Table 5.1 : Grading of muscle strain injuries on ultrasound used at UMMC. 
Grade Ultrasound findings 
          0 No ultrasound features seen 
          1 Muscle oedema only 
          2a Partial tears of muscle fibres, disruption involving <  33 % 
          2b Partial tears of muscle fibres, disruption involving ≥ 33 – 66 % 
          2c Partial tears of muscle fibres, disruption involving ≥  66 – 99 % 
          3 Complete tear of muscle 
  
 
 
Figure 5.1. Typical ultrasonography appearance of a grade-2 muscle injury. 
 
 
 
Before enrolment, potential participants were required to agree on the following 
requirements: 
 to comply with the rehabilitation program prescribed and record sessions in the 
rehabilitation diary. 
 to attend weekly clinical assessment and complete series of questionnaires 
throughout the study period. 
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 to avoid any sports participation or any other physical activities except for the 
rehabilitation exercise program prescribed until participants considered fit to 
return-to-play. 
 
The selection criteria’s during the screening process are listed in Table 5.2.  
 
Table 5.2 : List of participants' selection criteria. 
Inclusion criteria 
1. Grade-2 hamstring injury diagnosed on clinical assessment and confirmed on ultrasonography 
2. Aged ≥ 18 years 
3. Acute hamstring muscle injury (≤ seven days) 
4. Able to understand and follow the study protocol and had completed the written informed consent 
form 
Exclusion criteria  
1. Had received any form of injection therapy for the current injury 
2. Using anti-inflammatory drugs (NSAIDs) within one week before randomization 
3. Unable to fulfil weekly follow-up appointments and comply rehabilitation program 
4. Significant cardiovascular, renal, hepatic disease, malignancy, history of anaemia, and previous 
muscle surgery 
 
 
5.2.3 Randomisation 
 
Participants were randomly allocated into one of the two groups:  
i. Autologous platelet-rich plasma (PRP) group or;  
ii. Control group.  
 
Platelet-rich plasma (PRP) was chosen as the intervention of choice as PRP has been 
shown to contain the highest amount of platelets (the active ingredients in accelerating 
cellular repair and regeneration). No placebo control was used in this study since 
withdrawing blood and discarding it has raised ethical concerns. 
Randomisation was performed after eligible participants had read and understand 
the trial information (Appendix Q) and signed the written informed consent (Appendix 
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R). A computer generated block randomisation of four was used to create a 
randomisation schedule (Appendix S). Treatment assignment was conducted by the trial 
manager MS. 
 
5.2.4 Intervention 
 
5.2.4 (a) Platelet-rich plasma (PRP) group 
 
Participants in the PRP group were prescribed with rehabilitation exercise 
programme at enrolment by a sports physiotherapist. Participants were advised to 
perform the exercises at home at least once a day. The rehabilitation programme 
prescribed in this study focused on progressive agility and trunk stabilisation (PATS) 
exercises (Table 5.3). The PATS programme is based on a set of exercises used in an 
earlier study (Sherry & Best, 2004). This rehabilitation programme was found to be 
more effective than a programme that only emphasised on hamstring stretching and 
strengthening in promoting earlier return-to-play and in preventing injury recurrence in 
athletes with an acute hamstring strain (Sherry & Best, 2004). Clarifications on some of 
the movements in the PATS exercise protocol were made through email communication 
with the original author. In addition, permission to use the PATS rehabilitation 
exercises in this clinical trial was obtained from the original author (Appendix T). An 
instructional video and booklet on the PATS rehabilitation exercises was made available 
and distributed to each participant at enrolment (Figure 5.2). All participants were asked 
to continue with their unsupervised daily home rehabilitation exercises as prescribed 
and to keep a record of these sessions.  
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Figure 5.2. Rehabilitation booklet and instructional video. 
 
 
Besides the rehabilitation exercises, participants in the PRP group also received 
a single injection of autologous PRP administered under ultrasound guidance. The 
injection was administered once, on randomisation of the treatment group (day 1 of the 
study).  
 
 Autologous PRP preparation 
 
Autologous PRP was prepared using the Biomet GPS® III Platelet Separation 
System (Figure 5.3) in accord with the manufacturer guideline. With an 18 G needle, 54 
millilitres (ml) venous blood were collected from the participants’ cubital vein and 
transferred into a 60 ml syringe primed with 6 ml of anticoagulant citrate dextrose 
solution (ACD-A) (Figure 5.4). Another 2 ml of the venous blood were collected and 
sent to the hospital laboratory for determination of platelets and leucocytes (white blood 
cells) count. 
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Table 5.3 : Rehabilitation exercises prescribed to all patients. 
Phase 1 
1. Low to moderate-intensity sidestepping, 3 x 1 min 
2. Low to moderate-intensity grapevine stepping (lateral stepping with the train leg going over the 
lead leg and then under the leg), both directions, 3 x 1 min 
3. Low to moderate-intensity steps forward and backward over a tape line while moving sideways, 2 
x 1 min 
4. Single-leg stand progressing from eyes open to eyes closed, 4 x 20 sec 
5.  Prone abdominal body bridge (performed by using abdominal and hip muscle to hold the body 
face-down straight-plank position with the elbows and feet as the only point of contact), 4 x 20 sec 
6. Supine extension bridge (performed by using abdominal and hip muscles to hold the body in a 
supine hook lying position with the head, upper back, arms, and feet as the points of contact), 4 x 
20 sec 
7. Side bridge, 4 x 20 sec on each side 
8. Ice in long-sitting position for 20 min 
Phase 2* 
1. Moderate to high-intensity sidestepping, 3 x 1 min 
2. Moderate to high-intensity grapevine sidestepping, 3 x 1 min 
3. Moderate to high-intensity steps forward and backward while moving sideways, 2 x 1 min 
4. Single-leg stand windmill touches, 4 x 20 sec of repetitive alternate hand touches 
5. Push-up stabilization with trunk rotation (performed by starting at the top of a full push-up, then 
maintain this position with 1 hand while rotating the chest toward the side of the hand that is being 
lifted to point toward the ceiling, pause and return to the starting position), 2 x 15 reps on each side 
6. Fast feet in place (performed by jogging in place with increasing velocity, picking the foot only a 
few inches off the ground), 4 x 20 sec 
7. Proprioceptive neuromuscular facilitation trunk pull-downs with Thera-Band, 2 x 15 to the right 
and left 
8. Symptom-free practice without high-speed manoeuvres 
9. Ice for 20 min if any symptoms of local fatigue or discomfort present 
Key: Low intensity, a velocity of movement that was less than or near that of normal walking; moderate 
intensity, a velocity of movement greater than normal walking but not as great as sport; high intensity, a 
velocity of movement similar to sport activity. 
* Participants were allowed to progress from phase 1 to 2 when they could walk with a normal gait 
pattern and perform a high knee march in place without pain. (Source: Sherry & Best, 2004, p.119)
  
 
 
The collected blood was transferred into the disposable separation tube (Figures 
5.5 & 5.6) and spun using a centrifuge (Biomet/Drucker Centrifuge 755VES - 230V, 
Biomet Biologics, Germany) at 3200 rpm at room temperature for 15 minutes. 
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Figure 5.3. Biomet GPS III Platelet Separation System Kit. 
 
 
Figure 5.4. Venous blood collection from an antecubital vein. 
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Figure 5.5. The collected blood was transferred into a separation tube. 
 
     
 
Figure 5.6. The collected blood was centrifuged at 3200 rpm for 15 minutes. 
 
 
Centrifugal force separates the blood components into three distinct layers based 
on their particular densities (Marieb, 2001; Harmening, 2002). The heaviest particles, 
the red blood cells (erythrocytes) sunk at the bottom of the tube, the least dense 
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Platelet-poor plasma 
(PPP) 
Platelet-rich plasma 
(PRP) 
Red blood cells 
constituents the platelet-poor plasma (PPP) move to the top of the tube, while the 
platelet-rich plasma (PRP) remained at the centre (Figure 5.7). 
 
 
           Before centrifugation    After centrifugation 
      
Figure 5.7. Platelet-rich plasma (PRP) preparation. 
 
 
 
The whole PPP was extracted into a 30 ml syringe and discarded. Following 
this, PRP was extracted into a 10 ml syringe. Since an acidic anticoagulant 
(Anticoagulant Citrate Dextrose Solution – Solution A [ACD-A]) was added during the 
collection of venous blood, collected PRP was buffered to increase the pH to normal 
physiological levels, just before injection. This was accomplished by adding 8.4 % 
sodium bicarbonate solution in a ratio 0.05 ml of sodium bicarbonate to 1 ml of PRP. 
No activating agent was added to the PRP before administration. The time taken to 
prepare PRP was about 30 minutes. A standard 60 ml GPS® III kit produced roughly 6 
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ml of PRP. This method shown to produced PRP with platelets content five times 
higher than peripheral blood (Mishra & Pavelko, 2006; Thanasas et al., 2011). 
 
In this study, 3 ml of the extracted PRP were injected into the injured area under 
ultrasound guidance. One ml was sent to the hospital laboratory for platelets and 
leucocytes count.  The remaining 2 ml were stored at - 20 ° C for analysis of growth 
factors; basic fibroblast growth factor (bFGF); insulin-like growth factor-1 (IGF-1); 
transforming growth factor-β1 (TGF- β1), which were performed later. 
 
As a recent study showed local anaesthetic agent (lidocaine and bupivacaine) 
significantly decreases tenocyte proliferation and cell viability, no local anaesthetic 
agent was given before PRP injection in this study (Carofino et al., 2012).  
 
 
 Platelet-rich plasma (PRP) injection technique 
 
Based on previous studies 3 ml of PRP was injected direct into the injured area 
using a 21 G ultrasound needle (USB120-21) using peppering technique (Figures 5.8 & 
5.9) (Sanchez et al., 2005; Hamilton et al., 2010). All injections were performed under 
aseptic condition. Immediately after injection, patients were kept in supine position for 
10 to 15 minutes. Patients were advised to rest and limit their activities for the next 48 
hours. Only acetaminophen was allowed for pain control, should participants need. 
Patients were advised to avoid non-steroidal anti-inflammatories (NSAIDs) medications 
as laboratory studies have showed delayed tibialis anterior and gastrocnemius muscle 
healing in animal models (Almekinders & Gilbert, 1986; Jarvinen et al., 1992).  
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Following PRP injection, participants were reassessed for any adverse reactions 
(including increased pain and signs of infection over the site of injection) three days 
after receiving the PRP.  
 
 
 
 
Figure 5.8. Platelet-rich plasma injection under ultrasound guidance. 
 
 
 
Figure 5.9. Ultrasound guided PRP injection. White arrowheads: shadow of the 
ultrasound needle. 
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5.2.4 (b) Control group  
 
Participants in the control group were prescribed with the same rehabilitation 
exercise programme as the PRP group. Participants in the control group however, did 
not receive any PRP injection into their injured area.  
 
 All participants (PRP and control groups) were asked to attend a weekly follow-
up assessment and rehabilitation sessions with a physiotherapist until full recovery was 
achieved or the end of week-16. At each visit, patients completed the brief pain 
inventory scale - short form version (BPI - SF) (Appendix U). Permission to used BPI - 
SF questionnaire was obtained from the original author (Appendix V). 
 
A physiotherapist who was blinded of the treatment allocation performed 
standard clinical examinations to assess participant’s readiness to return-to-play 
(outcome measures). In addition, participant’s rehabilitation exercise programme was 
reinforced under the same physiotherapist’s supervision. Each follow-up session lasted 
between 45 – 60 minutes.  
 
A physiotherapist (with five years of clinical experience) was trained to assess 
the outcome measures and deliver PATS rehabilitation exercise programme. The 
training involved a half-day course delivered by the principal researcher and a treatment 
manual was given to the physiotherapist. The manual contained a brief summary of the 
study, standard assessment methods and hamstring rehabilitation exercises (PATS) 
based on the protocols described by Sherry & Best, 2004.  
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Patients in both groups were asked to track their exercise compliance and report 
any difficulties or problems faced at each follow-up visit.  
 
 
5.2.5 Blinding 
 
   A sports physiotherapist (LPC) acted as the outcome measure assessor for all 
participants. The assessor also involved in providing standard rehabilitation programme 
to all participants but was unaware (blinded) about the participants’ group allocation. 
Participants were asked not to disclose details of their treatment and group. Assessor 
blinding was considered appropriate to reduce differential assessment of outcomes 
(ascertainment bias). 
 
 
5.2.6 Potential risks discomfort and inconveniences 
 
 The risk of blood reaction is small since PRP was prepared from the patient’s 
own blood (autologous). In addition an aseptic technique was used during PRP injection 
to reduce the risk of infection. Patients however were told to expect slight discomfort or 
pain during blood withdrawal and during injection of PRP into the injured area. 
 
 
5.2.7 Potential benefits 
 
For the participants: 
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Participants who received treatment for their injury were under constant supervision 
from the study team of experts and all treatment costs covered by the study. 
For the researchers: 
The study provides information on the clinical effectiveness of the intervention in 
hastening muscle recovery after injury. 
 
 
5.2.8 Ethical consideration 
 
 The University of Malaya Medical Ethics Committee (Appendix W) approved 
the methods and materials set up for the randomised controlled trial. Verbal and written 
consents were obtained from all participants before the conduct of the study. 
Confidentiality of the participants was ensured. All participants were assigned with non-
identifiable identification codes for data entry and data analysis. All consent forms, 
clinical report forms, and completed questionnaires were stored in a locked filing 
cabinet accessible only by the researcher and the supervisors. 
 
 
5.2.9 Study outcomes measures 
 
5.2.9 (a) Primary outcome: Duration to return-to-play (DRP) 
 
The primary outcome for this study was the duration of return-to-play (DRP). 
DRP was defined as the duration (days) from the date of injury onset until the 
participants fulfilled the return-to-play (RTP) criteria. As there are limited scientific 
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studies that examined the outcome of various RTP strategies (Orchard et al., 2005; 
Engebretsen et al., 2010), it was necessary to set criteria for RTP. The RTP criteria 
proposed in this study were adapted from recent clinical sports medicine 
recommendations (Croisier et al., 2002; Drezner, 2003; Croisier, 2004; Brukner & 
Khan, 2010; Mendiguchia & Brughelli, 2010). The criteria were based on participant’s 
symptoms of pain, full range of movement (flexibility) of the affected knee and 
hamstring strength (Table 5.4). 
 
Table 5.4 : Criteria for return-to-play (RTP). 
Sign General Recommendation 
Pain  Pain-free (on direct palpation) 
Pain free on hamstring contraction (resisted isometric hamstring muscle 
contraction) 
Range of 
movement  
Symmetrical with unaffected site (difference between affected and unaffected side 
of   10o) 
Strength Isokinetic strength within 5 % (Hamilton et al., 2010; Harmon et al., 2010) to 10 % 
(Drezner, 2003) of contralateral side 
 
 
 
 
 Symptom of pain 
 
Direct palpation of the hamstring muscle was performed with participants in 
prone position. Palpation started over an area close to the injury site and gradually 
moved to the injured area (Figure 5.10). Pain elicited during this test was recorded in 
the participants’ clinical research form (CRF). In addition, pain provocation test was 
also performed during physical assessment. This test was performed in prone lying 
position with the knee flexed at 15° (Figure 5.11) (Warren et al., 2010). The participants 
were asked to actively contract the hamstring muscles against resistant. The test was 
considered positive if the participant reported pain while performing the movement.    
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 Range of movement test (Flexibility) 
 
Hamstring range of movement (ROM) was assessed using the active knee 
extension (AKE) test. The AKE test involves movement of the knee joint with the hip 
stabilised, unlike the straight-leg raise (SLR) test which involves movements of both 
hip and knee joints.  AKE test is an active test and is considered safe as the participants 
dictate the end point. This test has been recommended and often used to measure 
hamstring tightness (Cameron & Bohannon, 1993; Gajdosik et al., 1993; Gajdosik et 
al., 2008; Alonso et al., 2009). The AKE test used in this study has been described in 
detail in Chapter 4.  
 
 
Figure 5.10. Direct palpation of hamstring. 
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Figure 5.11. Hamstring pain provocation test . 
 
 
 
 Hamstring strength assessment 
 
Participants in both group whose symptom of pain have subsided and were pain 
free during the clinical assessment including attainment of full range of movement 
assessed for isokinetic muscle strength. 
 
Hamstring muscle strength was assessed using an isokinetic dynamometer 
(System 4 Pro, Biodex Medical System, NY, USA). Assessment of hamstring and 
quadriceps muscles performed on the uninjured leg followed by the injured leg. The test 
started with two minutes slow cycling on a stationary cycle ergometer as warm up. 
Participants were allowed to familiarise with the experimental protocol before testing. 
During the familiarisation period, participants practised with submaximal effort. The 
participants’ knee joint centre was kept aligned with the axis of the dynamometer crank 
arm. The dynamometer was set at 90° with the knee range of movement limit from 0  – 
100°. 
 
The testing protocol assessed maximum voluntary strength of both legs, with the 
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uninjured leg tested first. Muscle strength test was performed under concentric effort at 
three angular speeds of 60, 180 and 300°/second, representing slower, moderate and fast 
contraction speed respectively (Figure 5.12). Each participant performed five maximum 
contractions at angular speeds of 60°/s, ten maximum contractions at angular speeds of 
180°/s, and fifteen maximal contractions at angular speeds of 300°/s. Participants were 
given a 60 seconds rest between each angular speed test. At each speed, quadriceps 
muscles were tested first followed by the hamstrings. The participants did not receive 
any visual feedback during the test; however, verbal encouragements were given to all.  
 
Participants who have fulfilled all criteria for RTP were allowed to resume 
training activities and progressively increase their training load until reaching their 
preinjury levels. Participants were advised to take it easy over the next six weeks to 
reduce risk of injury recurrence (Orchard & Best, 2002; Peetrons, 2002). Participants 
who have not met the RTP criteria by the end of week 16 were allowed to continue their 
treatment in UMMC until fully recovered (Figure 5.13). 
 
5.2.9 (b) Secondary outcomes 
 
 Brief pain inventory – Short Form (BPI-SF) 
 
The BPI - SF is a self-reported or interview questionnaire that assesses the 
severity of pain and the impact of pain on daily functions. In addition, pain medications 
and amount of pain relief in the past 24 hours or the past week were also assessed. 
 
The BPI - SF was validated in more than three-dozen languages (including 
Malay) by examining the consistency of its two-factor structures; the severity of pain 
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and the impact of pain. The Cronbach alpha reliability of BPI - SF ranges from 0.77 to 
0.91 (Cleeland, 2009). 
 
 PRP classification 
 
To allow comparison with other studies, the PRP prepared in this study was 
classified according to the current classification system described in literatures (Dohan 
et al., 2009: DeLong et al., 2012). The amount of platelets present in venous blood and 
PRP were determined using the Sysmex XN-10 and XN-20 (Sysmex Co, Japan) high 
performance automated haematology analyser in UMMC outpatient laboratory. The 
ratio of platelet levels in venous blood to PRP was calculated to determine the ability of 
GPS III® kit (Biomet Biologics, Warsaw, Indiana, USA) to concentrate platelets. Also 
the amount of leucocytes present in PRP was performed using similar method. 
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Figure 5.12. Isokinetic hamstring strength test using a Biodex System. 
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Figure 5.13. Summary of the trial design. 
Assessed for eligibility by 
          1. Clinical assessment  
          2. Diagnostic ultrasound 
Randomization 
Ineligible  
1. Fail inclusion criteria 
   2. Meet exclusion criteria 
PRP  Control 
Single PRP injection 
administered under 
ultrasound guidance 
Weekly individual 
rehabilitation session 
with a physiotherapist  
Weekly individual 
rehabilitation session 
with a physiotherapist  
Weekly assessment by a 
physiotherapist  
Weekly assessment by a 
physiotherapist 
Full recovery criteria met  
or end of 16 weeks 
Study completed   
 Full recovery 
criteria not met  
 Full recovery 
criteria not met  
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 Growth factors 
 
About 2 ml of PRP were stored in the freezer at – 20 ° C. These samples were 
used to quantify the level of three types of growth factors; insulin-like growth factor-1 
(IGF-1); basic fibroblasts growth factor (bFGF) and transforming growth factor - β1 
(TGF- β1). The level of each growth factors were determined using the Human Insulin-
like Growth Factor-1 (IGF-1)(CSB-E04580h, Cusabio Biotech Co., Ltd, China), Human 
basic fibroblast growth factor (bFGF)(CSB-E08000h, Cusabio Biotech Co., Ltd, China) 
and Human Transforming Growth Factor β1 ELISA (TGF- β1) (CSB-4725h, Cusabio 
Biotech Co., Ltd, China) kits respectively.  
  
 
5.2.10 Statistical  
 
5.2.10 (a) Sample size 
 
 Sample size was determined using the formula as shown in Equation 5.1  
(Lwanga & Lemeshow, 1991):  
   
   [ (     )    (   ) ]
 
  
        
    …………………….Equation 5.1 
Where, 
N = the sample size in each of the groups 
 (      )  of 0.05 = 1.96 (percentage points of the normal distribution for statistical 
significance level of 0.05) 
 (   )  of 80 % = 0.84 (percentage points of the normal distribution for statistical power 
of 80 %) 
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μ1 = population mean in treatment Group 1 
μ2 = population mean in treatment Group 2 
μ1 – μ2 = the mean difference 
σ2 = population [standard deviation (SD)] (Wright-Carpenter et al., 2004) 
The total number of participants required for this study was 24 (12 participants per 
group). After considering 30 % estimation of attrition rate, 14 participants in each group 
were required, giving a total of 28 participants for the study. 
 
5.2.10 (b) Data analysis 
 
The main researcher performed all data collection and recording in this RCT. 
The researcher checked and corrected (if needed) all data. Double entry was performed 
for data verification. Identification of data errors and outliers was conducted using 
descriptive techniques. Missing data were specified as 999.00 and participants who 
withdrew from the study contributed to the missing data in this study. No missing data 
was noted among the participants who completed the study. All analyses conducted 
were two-tailed with significant level set at p - value < 0.05.  
 
5.2.10 (c) Descriptive analysis 
 
Descriptive analysis of participants’ characteristics was performed. Continuous 
variable including participant’s demographic, clinical history and baseline variables 
were reported using means and standard deviations (SD) or median and interquartile 
range (IQR) depending on the data distribution based on the Shapiro-Wilk test of 
normality. Categorical data on the other hand were presented as frequencies and 
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percentages. Normal distribution of the data is assumed when the Shapiro-Wilk test has 
a p - value ≥ 0.05.  
 
Comparison between participants who completed and withdrew from the study 
was made using Chi-square or Exact test (for unbalanced data) for categorical variables 
and independent t-test for continuous data. Assumptions for independent t-test were 
checked, which include: 1) group independency, 2) data continuity, 3) normally 
distribution of data, and 4) homogeneity of data. A Mann-Whitney U tests were 
performed for variables that violated these assumptions. 
 
The homogeneity of the participants’ characteristics at baseline was determined 
using Chi-square or Exact test (for unbalanced data) for categorical variables and 
independent t-test for continuous data. Assumptions for independent t-test were checked 
as mentioned earlier. 
 
5.2.10 (d) Duration to return-to-play (Primary outcome measure) 
 
A survival analysis employing intention-to-treat principles was used to 
determine the effectiveness of the intervention across the study periods (Hamilton et al., 
2010; Tabachnick & Fidell, 2012). Also a survival analysis is more robust to the 
potential bias from missing and unbalanced data compared with the more conventional 
methods of imputation for missing data (Almekinders & Gilbert, 1986; Singer & 
Willett, 2003). 
 
Participants who completed the study and achieved full recovery were identified 
as completers whereas those who withdrew from the study were censored. A Kaplan-
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Meier survival curve was plotted to display graphic representation of survival functions 
of the two groups. Comparison of the survival functions between groups was performed 
using the Log-Rank test. 
 
Cox regression survival analysis was performed to evaluate the effects of 
treatment and other covariates on DRP. Covariates including participants age, gender, 
duration of injury, pain score (at enrolment), length of injury (measured during MRI 
assessment), the AKE angle (at enrolment), and previous hamstring injury were 
analysed. These covariates were reported by previous study as significant predictors of 
muscle recovery (Verrall et al., 2003; Schneider-Kolsky, 2006; Reynolds et al., 2008; 
Warren et al., 2010).  
 
Covariates other than treatment were entered first into the Cox regression 
models, followed by treatment as this allow a likelihood-ratio test of the effect of 
treatment, after statistical adjustment for the other covariates (Sherry & Best, 2004; 
Tabachnick & Fidell, 2012). The survival analysis effect size was represented as R2 and 
calculated using the formula as shown in Equation 5.2 (Heiser et al., 1984; Tabachnick 
& Fidell, 2012): 
 
      (
   
 ⁄ ) …………………………… Equation 5.2 
Note: R2 = effect size, G2 = [- 2 log-likelihood for smaller model) – (- 2 log -
likelihood for larger model)], n = number of participants. 
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5.2.10 (e) Secondary outcome measures 
 
The secondary outcome was changes in participant’s symptoms and signs 
associated with hamstring injury. This includes pain intensity, pain interference with 
daily activity and the range of movement (flexibility) of the affected knee. Participants’ 
symptoms of pain severity were based on the mean scores of Q3 to 6 of the brief pain 
inventory scale – short form (BPI - SF). Meanwhile symptoms of pain interfering with 
daily activities were the composite mean of Q9A to 9G of BPI - SF questionnaire. 
Changes in the range of movement (ROM) of the knee were represented by the active 
knee extension (AKE) angle measured at each follow-up appointment. Analyses of 
symptoms and signs changes were performed with linear mixed model (LMM) using 
the principles of intention-to-treat (Singer & Willett, 2003). The LMM was chosen 
based on the nature of data collected (repeated measures) and to address potential 
missing data for this RCT. LMM is also more robust to the potential bias from missing 
data compared with conventional methods of missing data imputation such as the last 
observation carried forward (Mallinckrodt et al., 2003). The models were used to assess 
the effectiveness of the interventions over time with two stages analysis of change. In 
the first stage of analysis, known as level 1, the main effects of between-group change 
and change over time across the study were determined.  The second stage of analysis, 
known as level 2, determined the interaction between group and change over time 
across the study periods.  
 
The assumptions for LMM were checked and fulfilled, which included: 1) linear 
relationship between residuals of different levels, 2) residuals are normally distributed, 
3) equal variances of residuals at each levels), 4) no multicollinearity, and 5) no 
influential outliers. The models’ overall fit was tested using the change in the Chi-
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square likelihood ratio test and the critical values of the Chi-square were obtained from 
Tabachnick & Fidell, (2012). The adjusted R2 was calculated to determine the cross 
validation. The statistical significance was set at p < 0.05. The effect sizes were 
presented as eta squared and were calculated using the formula shown in Equation 5.3 
(Tabachnick & Fidell, 2012): 
 
    
  
    
 
  
   ………………………….. Equation  5.3 
Note: 2 = eta squared, s1 = residual variance of null model, s2 = residual variance of 
final model 
 
The effect sizes were reported according to Cohen’s definition with d = 0.20, d = 
0.50 and d = 0.80 as small, medium and large effect sizes respectively (Cohen, 1992). 
Data were analysed using the IBM Statistical Package for Social Sciences (SPSS) 
version 20.0 (IBM Corp. Armonk, NY, USA). 
 
 
5.3 Results 
 
 
5.3.1 Description of the study participants 
 
Following the CONSORT guidelines on reporting findings from a randomised 
controlled trial; description of participants who completed and withdrew from the study 
is presented. More importantly descriptions of participants of both groups at baseline 
were compared. 
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5.3.2 Participants’ recruitment and retention  
 
Thirty-four patients with hamstring muscle injury were approached and screened 
in this study. Patients responded to a notice about this study, referred by other 
physicians or approached through personal communication by the clinic staff. Out of the 
34 patients, two (5.9 %) patients were excluded, as they did not meet the study’s 
criteria. While another four patients (11.8 %) refused participation. Twenty-eight (82.4 
%) patients who fulfilled the study criteria were invited and subsequently agreed to 
participate in this study. Table 5.5 summarises the reasons for non-participation after 
initial screening. The twenty-eight patients enrolled in this study then underwent 
baseline assessment and randomisation.   
 
Table 5.5 : Reasons for non-participation after screening. 
Reasons for non-participation 
Not fulfilling study criteria,   
N = 2 (5.9 %) 
 Extensive tear that involved hamstring and adductor 
longus muscles 
 Severe grade 3 tear of the hamstring muscle 
Refuse to participate,  
N = 4 (11.8 %) 
 Will be studying interstate University soon 
 Unable to comply with study protocol 
 
 
A total of 24 participants remained at completion of the study representing 85.7 
% retention from baseline. Two participants in each group withdrew from the study. 
Two participants in the control group did not attend their scheduled follow-up and 
cannot be contacted. One participant in the PRP group recommenced physical activities 
without prior clearance from the study protocol while the other received other form of 
physical therapy outside the study protocol. Figure 5.14 illustrates the flow of study 
participants’ during this RCT. 
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Figure 5.14. Flow diagram of randomised controlled trial (RCT) participants. 
 
 
5.3.3 Test of normality  
 
The baseline continuous variables were tested with Shapiro-Wilk test of 
normality to determine if the data has normal distribution meeting the assumptions of 
parametric tests such as independent t-test. Non-parametric tests such as Mann Whitney 
U or Kruskal Wallis tests were performed on not normally distributed data. Normal 
2 excluded due to not 
fulfilling criteria 
4 refused to participate 
 
Randomization (n = 28) 
 
Screening of eligible 
participants (n = 34) 
Control, CG  
(n = 14) 
 
PRP 
(n = 14) 
 
Full recovery  
achieved (n = 12) 
 
Full recovery  
achieved (n = 12) 
 
Completed study 
 (n = 12) 
 
Completed study 
 (n = 12) 
 
Withdrew 
(n = 2) 
 
Withdrew 
(n = 2) 
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distribution of the data was assumed when the p-value from Shapiro-Wilk test was 0.05 
or greater. Variables that were normally distributed at enrolment were the duration of 
injury (in days), pain intensity score, pain interference scores (as assessed by the BPI -
SF questionnaire), active knee range of movement of the non-injured side (as assessed 
by the AKE test), distance of injured site from ischial tuberosity, and length of injury 
(determined during ultrasound assessment). Table 5.6 summarises the results of the 
normality tests of the baseline continuous variables.  
 
 
5.3.4 Characteristics of study participants 
 
Participants’ socio-demographic (ethnicity, sports, participation level, leg 
dominance), clinical characteristics and information on current injury is described 
below.  
 
5.3.4 (a) Participants clinical characteristics 
 
Twenty-four (85.7 %) participants achieved full recovery and completed this 
study. The median age of participants in this study was 21.00 ± IQR 8.50 (range: 18 - 
49 years). More than two-third (71.4 %) of the participants were of Malay ethnicity. 
Majority of the participants were men (85.7 %). Most participants were national level 
athletes (53.6 %) while the rest were athletes at school (pre-university)(28.6 %), state 
(10.7 %) and club (7.1 %) levels.  
 
The size of the injured area was examined using an ultrasound  where the length, 
width and depth of the lesion were documented. With the assumption that the lesion is 
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ellipsoid in nature, the volume of the lesion was estimated using mathematical formula 
as below: 
 
                        
 
 
          ……………… Equation 5.4 
 
 
Table 5.6 : Normality testing of baseline continuous variables. 
Continuous variables Shapiro-Wilks 
Statistics Degree of 
freedom 
P value 
Age (year) 
 Control 
 PRP 
 
0.703 
0.613 
 
14 
14 
 
< 0.001 
< 0.001 
Weight (kg) 
 Control 
 PRP 
 
0.963 
0.674 
 
14 
14 
 
0.779 
< 0.001 
Height (cm) 
 Control 
 PRP 
 
0.875 
0.937 
 
14 
14 
 
0.049 
0.381 
BMI (kg/m2) 
 Control 
 PRP 
 
0.955 
0.720 
 
14 
14 
 
0.634 
0.001 
Sporting experience (year) 
 Control 
 PRP 
 
0.789 
0.699 
 
14 
14 
 
0.004 
< 0.001 
Period of injury before study enrolment* 
(day) 
 Control 
 PRP 
 
0.899 
0.921 
 
14 
14 
 
0.110 
0.231 
Pain intensity (BPI-SF)* 
 Control 
 PRP 
 
0.891 
0.956 
 
14 
14 
 
0.084 
0.656 
Pain interference (BPI-SF)* 
 Control 
 PRP 
 
0.935 
0.947 
 
14 
14 
 
0.357 
0.517 
Knee ROM (AKET): Injured side (°) 
 Control 
 PRP 
 
0.963 
0.789 
 
14 
14 
 
0.768 
0.004 
Knee ROM (AKET): Non injured side*(°) 
 Control 
 PRP 
 
0.961 
0.883 
 
14 
14 
 
0.742 
0.064 
Knee ROM difference between injured and 
injured side (°) 
 Control 
 PRP 
 
0.946 
0.769 
 
14 
14 
 
0.496 
0.002 
Distance of injured site from ischial 
tuberosity* (cm) 
 Control 
 PRP 
 
0.960 
0.950 
 
14 
14 
 
0.717 
0.568 
Width (w) of injured area (cm) 
 Control 
 PRP 
 
0.788 
0.835 
 
14 
14 
 
0.004 
0.014 
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Continuous variables Shapiro-Wilks 
Statistics Degree of 
freedom 
P value 
Length (l) of injured area* (cm) 
 Control 
 PRP 
 
0.973 
0.930 
 
14 
14 
 
0.914 
0.300 
Depth (d) of injured area (cm) 
 Control 
 PRP 
 
0.908 
0.785 
 
14 
14 
 
0.145 
0.003 
Estimated volume of injured area# (cm3) 
 Control 
 PRP 
 
0.923 
0.849 
 
14 
14 
 
0.239 
0.022 
Note: *P ≥ 0.05 = Normal distribution; PRP = platelet-rich plasma; BMI = body mass index; BPI-SF = 
Brief Pain Inventory Scale-Short Form; ROM = range of movement; AKET = Active knee extension test.  
*Injured area estimated volume based on Equation 5.4.  
 
 
Most (92.9 %) athletes were right side dominant. Interestingly, 17.9 % of 
athletes in this study reported history of cigarette smoking. Table 5.7 summarises the 
study participants’ socio-demographic.  
 
5.3.4 (b) Characteristics of hamstring injury 
 
 Twelve (42.9 %) participants were soccer players; nine (32.1 %) track and field 
athletes, and three (10.7 %) hockey players. The remaining participants were netball, 
rugby, basketball and tennis players. The mean duration of injury before the athletes 
enrolled into the study was 4.6 ± 2.15 days (range: 0 - 7 days).  
 
More than half (60.7 %) of athletes classified their current injury as a new 
injury, while the rest has had similar episode in the past (> 6 months ago). Most athletes 
reported that their injury occurred suddenly while engaging in sports. Most injuries 
occurred during training or practice sessions (64.3 %) while the remaining happened 
during competitions (35.7 %).  Majority of the injury occurred while athletes were 
running (82.1 %), other injury mechanisms were jumping (7.1 %), stretching (3.6 %) 
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and kicking (3.6 %). Only one athlete injured his hamstring after a slipped while he was 
walking. 
 
In this study, hamstring injury most often affected the biceps femoris (67.9 %), 
followed by semimembranosus (17.9 %), semitendinosus (10.7 %) muscles. While one 
athlete in the PRP group (3.5 %) injured the semimembranosus with slight 
semitendinosus extension. The summary of baseline injury characteristics is displayed 
in Tables 5.8 & 5.9. 
 
Table 5.7 : Participant's socio-demographic characteristics. 
Characteristics  Mean±SD
†
/Median±IQR
††
 (range) Frequency (%) 
Age (year) 20.50 ± IQR7.00 (18 - 49)  
Sex 
 Men 
 Women 
 
 
 
24 (85.7) 
4 (14.3) 
Ethnicity 
 Malay 
 Chinese 
 Indian 
 Others 
 
 
 
20 (71.4) 
2 (7.1) 
3 (10.7) 
3 (10.7) 
Type of sports 
 Soccer 
 Track and field 
 Field hockey 
 Netball 
 Rugby 
 Basketball 
 Tennis 
  
12 (42.9) 
9 (32.1) 
3 (10.7) 
1 (3.6) 
1 (3.6) 
1 (3.6) 
1 (3.6) 
Experience (year) 8.50 ± IQR7.00 (2.5 - 38)  
Level of sports participation 
 National 
 State 
 Club 
 School 
  
15 (53.6) 
3 (10.7) 
2 (7.1) 
8 (28.6) 
Leg dominance 
 Right 
 Left 
  
26 (92.9) 
2 (7.1) 
Smoking 
 Yes 
 No 
  
5 (17.9) 
23 (82.1) 
Note: SD = standard deviation; IQR = interquartile range. 
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Table 5.8 : General injury characteristics. 
Characteristics Mean±SD†/Median ± 
IQR
††
 (range) 
Frequency (%) 
Duration of injury before enrolment 
(day) 
4.50 ± SD2.15 (0 - 7.0)  
Weight (kg) 66.02 ± IQR10.71 (50.70 -
127.25) 
 
Height (cm) 170.00 ± IQR11.88 (161.00 
- 184.2) 
 
BMI 22.70 ± IQR2.07 (19.10 - 
37.60) 
 
Current injury 
 New injury 
 Recurrent injury 
  
17 (60.7) 
11 (39.3) 
Injury circumstance 
 Training/practice 
 Competition 
  
18 (64.3) 
10 (35.7) 
Injury mechanism 
 Running 
 Jumping 
 Stretching 
 Shooting 
 Slipped 
  
23 (85.7) 
2 (7.1) 
1 (3.6) 
1 (3.6) 
1 (3.6) 
Injury involved specific muscle 
 Biceps femoris  
 Semimembranosus 
 Semitendinosus 
 Semimembranosus & 
semitendinosus 
  
19 (67.9) 
6 (21.4) 
3 (10.7) 
1 (3.5%) 
Note: SD = standard deviation; IQR = interquartile range; BMI = body mass index.  
 
 
Table 5.9 : Participant's injury clinical characteristics. 
Characteristics Mean±SD†/Median ± IQR†† 
(range) 
Frequency 
(%) 
Pain intensity (BPI-SF) 4.10 ± SD1.82 (0 - 6.75)  
Pain interference (BPI-SF) 3.32 ± SD1.91 (0.14 - 7.00)  
Distance of injured site from ischial 
tuberosity (cm) 
19.15 ± SD6.66 (7.50 - 36.00)  
Width (w) of injured area (cm) 1.10 ± IQR0.71 (0.55 - 2.99)  
Length (l) of injured area (cm) 2.85 ± SD1.17 (0.52 - 4.83)  
Depth (d) of injured area (cm) 1.25 ± IQR0.86 (0.55 - 3.12)  
Estimated volume of injured area 
(cm3)* 
18.25 ± IQR23.87 (2.87 - 51.51)  
Side involved 
 Dominant 
 Non-dominant 
  
15 (39.3) 
17 (60.7) 
Knee ROM (AKET): Injured side 
(°) 
30.00 ± IQR22.63 (12.50 - 78.00)  
Knee ROM (AKET): Non-injured 
side (°) 
17.10 ± SD6.37 (5.00 - 30.00)  
Knee ROM (AKET) difference 
between injured and non-injured 
side (°) 
12.50 ± IQR16.16 (0 - 54.50)  
Note: SD = standard deviation; IQR = interquartile range; BPI-SF = Brief Pain Inventory  
Scale-Short Form; ROM = range of movement; AKET = Active knee extension test.  
*Injured area estimated volume based on Equation 5.4.  
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The mean duration of injury before enrolment into the study was 4.60 ± SD 2.15 
days. The mean score of pain intensity and pain interference was 4.10 ± SD1.82 and 
3.32 ± SD1.91 (out of maximum score of 10) respectively. The mean estimated volume 
of the injured area was 18.25 ± IQR 23.87 (2.87 - 51.51) cm3. 
 
Most injury affected the non-dominant (60.7 %) than the dominant (39.3 %) leg. 
Higher AKE angle represent lesser ability of knee extension (greater limitation). A 
difference in AKE angle of ≥ 10 ° between injured and non-injured side was considered 
a positive AKE test. Interestingly, the AKE test was only positive in 11 (39.3 %) 
participants with grade-2 hamstring injury. A significant difference in the AKE angle 
between the injured and non-injured side was found. The AKET angle of the injured 
hamstring was higher (median = 30.00) than the non-injured side (median = 17.50), z = 
- 4.38, p < 0.01, r = - 0.59.  
 
 
 
5.3.5 Summary of study participants 
 
 Most participants in this study were Malay male athletes participating either in 
soccer or track and field events. More than half of injuries were new injury. Majority 
sustained the injuries while running during training or practice sessions. Injury often 
affected the non-dominant side of the leg. Biceps femoris was the most frequent muscle 
injured followed by semimembranosus and semitendinosus. The estimated mean 
volume of muscle tear was 18.25 ± IQR 23.87 cm3. The time that athletes waited before 
enrolling into the study ranges from 0 to 7 days (mean = 4.50 ± SD 2.15 days).  
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Despite suffering grade-2 muscle injury, athletes rated the pain severity and how 
much the pain interfered with their daily activities rather low. The mean score for pain 
severity and interference in daily life were 4.10 and 3.32 (out of maximum score of 10) 
respectively.  
 
 
5.3.6 Baseline comparison between participants who completed and withdrew 
from study 
 
 Participants who completed and withdrew from the study were analysed and 
comparison made based on their baseline socio-demographic and injury characteristics.  
 
 
 
 5.3.6 (a) Comparison between participants completed and withdrew from the 
study by socio-demographic characteristics  
 
No significant differences were observed between athletes who completed and 
those who withdrew on age, years of experience, gender, ethnic background, level of 
sports participation and leg dominance. Table 5.10 summarises these findings. 
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Table 5.10 : Comparisons between participants who completed and withdrew by 
socio-demographic characteristics. 
Characteristics Status of participants Mann Whitney U
†
 / 
Chi square test
‡
 
Complete  
(N = 24) 
Withdrew 
(N = 4) 
z /2   P value 
Age†, median ± IQR (year)  21.00 ± 7.00 19.00 ± 6.50 -0.84 0.402 
Sex‡, n (%) 
 Men 
 Women 
 
22 (88.0) 
3 (12.0) 
 
2 (66.7) 
1 (33.3) 
 
0.99 
 
0.382 
Ethnicity‡, n (%) 
 Malay 
 Chinese 
 Indian 
 Others 
 
18 (72.0) 
1 (4.0) 
3 (12.0) 
3 (12.0) 
 
2 (66.7) 
1 (33.3) 
0 (0) 
0 (0) 
 
3.96 
 
0.304 
Experience, median ± IQR 
(year)‡ 
8.5 ± 9.25 9.0 ± 8.13 -0.30 0.767 
Level of participation‡, n (%) 
 National  
 State 
 Club 
 School 
 
13 (52.0) 
3 (12.0) 
2 (8.0) 
7 (28.0) 
 
2 (66.7) 
0 (0) 
0 (0) 
1 (33.3) 
 
0.73 
 
0.865 
Foot dominance 
 Right 
 Leg 
 
23 (92.0) 
2 (8.0) 
 
3 (11.5) 
0 (0) 
 
0.26 
 
0.611 
Note: IQR = interquartile range; P value < 0.05 = statistically significant. 
 
 
 
 
 5.3.6 (b) Comparison between participants who completed and withdrew 
from the study by injury profiles 
 
There was no significant difference between participants who completed or 
withdrew in the duration of injury before enrolment, weight, height, body mass index 
(BMI), injury history, injury circumstances, injury mechanisms and muscle injured. 
Summary of these comparisons is displayed in Table 5.11. 
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Table 5.11 : Participant’s injury profiles between completers and withdrawals. 
Characteristics Status of participants t-test
†
/ Mann 
Whitney U
‡
/ 
Chi square test
♯
 
Complete  
(N = 24) 
Withdrew  
(N = 4) 
t/z 
/2   
P value 
Duration of injury before 
enrolment (day) † median ± SD 
4.50 ± 3.50 6.50 ± 3.25 -
1.01 
0.315 
Weight (kg) ‡, median ± IQR 65.50 ± 11.27 72.20 ± 11.28 -
1.18 
0.237 
Height (cm) ‡, mean ± SD 170 ± 11.63 173 ± 14.00 -
0.44 
0.664 
BMI‡, median ± IQR 22.50 ± 2.20 23.30 ± 1.70 -
1.48 
0.139 
Current injury♯, n (%) 
 New injury 
 Recurrent injury 
 
15 (60.0) 
10 (40.0) 
 
2 (66.7) 
1 (33.3) 
 
0.99 
 
0.382 
Injury circumstance‡♯, n (%) 
 Training/practice 
 Competition 
 
16 (64.0) 
9 (36.0) 
 
2 (66.7) 
1 (33.3) 
 
0.00
8 
 
1.00 
Injury mechanism♯, n (%) 
 Jumping 
 Running 
 Stretching 
 Shooting 
 Slipped 
 
20 (80.0) 
1 (4.0) 
1 (4.0) 
1 (4.0) 
1 (4.0) 
 
3 (100.0) 
0 (0) 
0 (0) 
0 (0) 
 
0.73 
 
1.00 
Muscle injured♯, n (%) 
 Biceps femoris 
 Semimembranosus 
 Semitendinosus 
 
17 (68.0) 
6 (24.0) 
2 (8.0) 
 
2 (66.7) 
0 (0) 
1 (33.3) 
 
2.33 
 
0.391 
Note: SD = standard deviation; IQR = interquartile range; P value < 0.05 = statistically significant. 
 
 
 
 5.3.6 (c) Comparison between participants who completed and withdrew 
from the study by clinical injury characteristics 
 
No significant difference in the pain intensity score, pain interference score, 
distance of injured site from ischial tuberosity, dimensions on injured area (width, 
length, depth and estimated volume of injured area) and ROMs of both knees between 
participants who completed and those withdrew from the study. Summary of these 
comparisons are displayed in Table 5.12. 
 
  145 
Table 5.12 : Participant's clinical injury characteristics between completers and 
withdrawals. 
Characteristics Status of participants t-test
†
 / Mann 
Whitney U
‡
/ 
Chi square test
♯
 
Complete  
(N = 24) 
Withdrew 
(N = 4) 
t/z /2   P 
value 
Pain intensity†, mean ± SD (BPI - SF)  4.00 ± 3.19 5.40 ± 2.88 -1.08 0.292 
Pain interference†, mean ± SD (BPI - 
SF) 
3.00 ± 2.89 4.50 ± 5.04 -0.89 0.382 
Distance of injured site from ischial 
tuberosity†, mean ± SD (cm) 
18.90 ± 9.38 22.50 ± 
11.25 
-0.35 0.728 
Width of injured area‡ (cm), median 
± IQR 
1.10 ± 0.97 1.10 ± 0.58 -0.33 0.743 
Length of injured area†, mean ± IQR 
(cm) 
3.00 ± 1.92 3.20 ± 1.89 -0.42 0.675 
Depth of injured area‡ (cm), median 
± IQR 
1.30 ± 1.33 0.90 ± 0.82 -0.99 0.325 
Estimated volume of injured area 
(cm3) †, median ± IQR 
19.50 ± 24.53 14.30 ± 
24.16 
-0.72 0.470 
Side involved♯, n (%) 
 Dominant 
 Non-dominant 
 
9 (36.0) 
16 (64.0) 
 
2 (66.7) 
1 (33.3) 
 
1.06 
 
0.543 
Knee ROM (AKET): Injured side 
(°)‡, median ± IQR 
 
31.30 ± 24.38 27.50 ± 
17.00 
-0.40 0.693 
Knee ROM (AKET): Non-injured 
side, mean ± SD (°)† 
17.50 ± 9.00 15.00 ± 
10.25 
1.32 0.198 
Knee ROM (AKET) difference 
between injured and non-injured side 
(°)‡, median ± IQR 
12.30 ± 24.63 20.00 ± 
15.75 
-0.66 0.510 
Note: SD = standard deviation; IQR = interquartile range; BPI – SF = Brief Pain Inventory Scale-Short 
Form; ROM = range of movement; AKET = Active knee extension test.  
*Injured area estimated volume based of formula in Equation 5.4.  
 
 
 
 
5.3.7 Summary of differences between participants who completed and withdrew 
from study 
 
Three men and one-woman participants withdrew from the study, as they could 
not comply with the study protocol. No significant difference was found in all measured 
parameters between participants who completed and withdrew from the study. 
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5.3.8 Comparison between participants’ baseline characteristics and the different 
groups 
 
Homogeneity of the data at baseline between the control and PRP groups, 
including the participants’ socio-demographic characteristics, injury characteristics, was 
analysed.   
 
 5.3.8 (a) Baseline socio-demographic characteristics in different groups 
 
The baseline socio-demographic characteristics between the participants in the 
two groups were compared as shown in Table 5.13. There was no significant difference 
in the baseline socio-demographic characteristics across the two groups. 
 
Table 5.13 : Baseline socio-demographic characteristics between intervention 
groups. 
Characteristics Study group Mann Whitney U
†
 / 
Chi square test
‡
 
Control  
(N = 14) 
PRP  
(N = 14) 
z /2   P value 
Age†, median  ± IQR 
(year)  
21.00 ± 8.50 20.00 ± 6.50 - 0.28 0.778 
Sex‡, n (%) 
 Men 
 Women 
 
11 (78.6) 
3 (21.4) 
 
13 (92.9) 
1 (7.1)  
 
1.17 
 
0.280 
Ethnicity‡, n (%) 
 Malay 
 Chinese 
 Indian 
 Others 
 
9 (78.6) 
1 (7.1) 
1 (7.1) 
1 (7.1) 
 
9 (64.3) 
1 (7.1) 
2 (14.3) 
1 (7.1) 
 
0.87 
 
0.833 
Experience, median ± 
IQR (year)‡ 
7.00 ± 10.75 10.00 ± 7.00 - 0.30 0.764 
Level of participation‡, n 
(%) 
 National  
 State 
 Club 
 School 
 
7 (50.0) 
1 (7.1) 
1 (7.1) 
5 (35.7) 
 
8 (57.1) 
2 (14.3) 
1 (7.1) 
3 (21.4) 
 
0.90 
 
0.825 
Foot dominance‡, n (%) 
 Right 
 Leg 
 
13 (92.9) 
1 (7.1) 
 
13 (92.9) 
1 (7.1) 
 
<0.0001 
 
1.000 
Note: IQR = interquartile range; P value < 0.05 = statistically significant. 
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 5.3.8 (b) Baseline injury profiles and characteristics  
 
The length of injury (measured during ultrasonography assessment) was 
significantly longer in the PRP group (p = 0.017). However, the difference did not reach 
significance level when the volume of injured area was estimated (Equation 5.4). There 
was no statistically significant difference between the two groups for other variables. 
Tables 5.14 & 5.15 summarise the baseline injury profiles and characteristics across the 
different groups. 
 
 
 
Table 5.14 : Baseline injury profiles between intervention groups. 
Characteristics Study Group  Mann Whitney U
‡
/ 
Chi square test
♯
 
Control  
(N = 14) 
PRP 
(N = 14) 
z /2   P value 
Duration of injury before 
enrolment (day) ‡, median ± IQR 
5.00 ± 3.00 5.00 ± 3.00 -0.94 0.348 
Weight (kg) ‡, median ± IQR 66.50 ± 13.87 66.00 ± 10.21 -0.39 0.696 
Height (cm) ‡, median ± IQR 169.50 ± 19.38 171.00 ± 
10.88 
-0.21 0.836 
BMI‡, median ± IQR 22.50 ± 2.63 22.80 ± 2.55 -0.89 0.370 
Current injury♯, n (%) 
 New injury 
 Recurrent injury 
 
11 (78.6) 
3 (21.4) 
 
6 (42.9) 
8 (57.1) 
 
3.74 
 
0.053 
Injury circumstance♯, n (%) 
 Training/practice 
 Competition 
 
9 (64.3) 
5 (35.7) 
 
9 (64.3) 
5 (35.7) 
 
<0.001 
 
1.00 
Injury mechanism♯, n (%) 
 Running 
 Stretching 
 Jumping 
 Shooting 
 Slipped 
 
10 (71.4) 
1 (7.1) 
1 (7.1) 
1 (7.1) 
1 (7.1) 
 
13 (92.9) 
0 (0) 
1 (7.1) 
0 (0) 
0 (0) 
 
3.40 
 
0.495 
Muscle injured♯, n (%) 
 Biceps femoris 
 Semimembranosus 
 Semitendinosus 
 
11 (78.6) 
1 (7.1) 
2 (14.3) 
 
8 (57.1) 
5 (35.7) 
1 (7.1) 
 
3.47 
 
0.176 
Note: SD = standard deviation; IQR = interquartile range; P value < 0.05 = statistically significant. 
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Table 5.15 : Baseline injury characteristics between intervention groups 
Characteristics Study Group t-test
†
 / Mann 
Whitney U
‡
/ 
Chi square test
♯
 
Control  
(N = 14) 
PRP 
(N = 14) 
t/z /2   P value 
Pain intensity†, mean ± SD (BPI - SF)  4.30 ± 1.85 3.90 ± 1.83 0.54 0.595 
Pain interference†, mean ± SD (BPI - 
SF) 
3.60 ± 2.35 3.00 ± 1.36 0.87 0.391 
Distance of injured site from ischial 
tuberosity†, mean ± SD (cm) 
19.30 ± 7.93 19.00 ± 5.40 0.13 0.898 
Width of injured area‡ (cm) , median 
± IQR 
1.20 ± 0.98 1.00 ± 0.63 - 0.78 0.435 
Length of injured area†, mean ± SD 
(cm) 
2.30 ± 1.04 3.40 ± 1.09 - 2.56 0.017* 
Depth of injured area‡ (cm) , median 
± IQR 
1.50 ± 0.86 1.20 ± 0.65 - 1.22 0.223 
Estimated volume of injured area** 
(cm3) †, median ± IQR 
19.50 ± 23.14 15.30 ± 
34.24 
- 0.37 0.713 
Side involved♯, n (%) 
 Dominant 
 Non-dominant 
 
5 (41.7) 
7 (58.3) 
 
4 (33.3) 
8 (66.7) 
 
0.18 
 
1.000 
Knee ROM (AKET): Injured side 
(°)‡, median ± IQR 
35.80 ± 21.75 25.00 ± 
15.63 
-1.48 0.140 
Knee ROM (AKET): Non-injured 
side, mean ± SD (°)† 
17.80 ± 7.10 16.40 ± 5.71 0.60 0.553 
Knee ROM (AKET) difference 
between injured and non-injured side 
(°)‡, median ± IQR 
16.30 ± 18.88 10.00 ± 
27.00 
-1.13 0.259 
Note: SD = standard deviation; IQR = interquartile range; BPI-SF = Brief Pain Inventory Scale-Short 
Form; ROM = range of movement; AKET = Active knee extension test.  
*P value < 0.05 = statistically significant. 
**Injured area estimated volume based of formula in Equation 5.4. 
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5.3.9 Summary of differences in participants’ baseline characteristics between 
groups 
 
 The control and PRP group were comparable in socio-demographic background, 
injury profiles and characteristics. The extent and severity of hamstring injury as 
measured by clinical assessment (AKE), diagnostic ultrasound as well as by BPI - SF 
questionnaire demonstrated no statistical significant difference between the two groups. 
 
 
5.3.10 Overall summary of participants characteristics 
 
Most participants in this study were national level athletes. The participants’ 
median age was 21.00 ± IQR 8.50 (range: 18 - 49 years) with a median of 8.50 ± IQR 
7.00 (range: 2.5 - 38 years) experience in their sports. The participants’ mean duration 
of injury before enrolment was 4.50 ± 2.15 days (range: 0 - 7.0 days). Injury often 
affected the non-dominant leg. Biceps femoris was the most frequent muscle injured 
followed by semimembranosus and semitendinosus.   
 
 At baseline, no significant difference in the socio-demographic background as 
well as injury profiles and characteristics were noted between participants in the control 
and PRP groups. 
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5.3.11 Effectiveness of the Platelet-rich plasma 
 
The primary outcome of interest in this study was the duration of return-to-play 
(DRP). In addition, potential predictors of DRP were analysed. Changes in clinical 
signs and symptoms associated with the injury assessed using the Brief pain inventory – 
short form (BPI - SF) questionnaire and the active knee extension (AKE) test was 
included as secondary objectives of this study. Characteristics of PRP produced were 
also examined and presented below. 
 
 
5.3.12 Duration to return to play (DRP) 
 
 The effect of PRP on DRP was analysed using survival analysis statistical 
procedures. Survival functions of the two groups were compared using the log - rank 
(Mantel - Cox) test.  
 
A Cox proportional hazard-model (Cox regression) was performed to explore 
the effect of covariates on the DRP. Previous literatures have identified several factors 
that predict (predictors) recovery following muscle injury. Dedrick & Clarkson, (1990) 
reported increasing age as significant predictors of muscle recovery. Our cross-sectional 
study among national level athletes found duration of injury before enrolment 
significantly predicts DRP (Shariff et al., 2013). Other researchers also reported pain 
severity, length of injured area, the AKE angle, distance of injury from the ischial 
tuberosity, and previous hamstring injury as significant predictors of hamstring recovery 
(Verrall et al., 2003; Connell et al., 2004; Askling et al., 2006; Schneider-Kolsky, 2006; 
Askling et al., 2008; Malliaropoulos et al., 2010; Warren et al., 2010). 
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Before performing survival analyses the following assumptions were checked 
and fulfilled: 1) Normality of sampling distribution and missing data, 2) absence of 
influential outliers (univariate and multivariate), 3) equal variances of residuals at each 
levels), and 4) absence of multi-collinearity, and 5) absence of systematic differences 
between censored and completed cases. None of the covariates has missing data. All 
covariates, except for age, duration of injury before enrolment and AKE angle of 
injured side at enrolment were normally distributed (Table 5.16). Four participants were 
censored, as they were unable to comply with the study protocol or did not attend 
scheduled follow-up appointment. Regression analysis did not show any significant 
difference between completers and censored cases (Table 5.17).  
 
 
Table 5.16 : Normality tests for covariates of interest. 
Covariates Mean (SD) 
/Median (IQR)* 
Shapiro - Wilks 
Statistics Degree of 
freedom 
P value 
Age* (year) 20.50 (7.00) 0.821 28 < 0.001 
Length of injured area (cm)  2.85 (1.17) 0.971 28 0.614 
Duration of injury before 
enrolment* (day) 
5.00 (3.75) 0.890 28 0.007 
Pain intensity (BPI-SF) 4.10 (1.82) 0.959 28 0.332 
Pain interference (BPI-SF) 3.32 (1.91) 0.971 28 0.621 
AKE angle injured side at 
enrolment* (°) 
30.00 (22.63) 0.891 28 0.007 
Distance of injured site from 
ischial tuberosity (cm) 
19.15 (10.44) 0.975 28 0.721 
Note: *P ≥ 0.05 = Normal distribution; IQR = Interquartile range; BPI – SF = Brief Pain Inventory Scale-
Short Form; AKET = Active knee extension test.  
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Table 5.17 : Regression analysis for differences between completers and 
withdrawals. 
Model  Unstandardized 
coefficient 
Standardized 
coefficient 
 
t 
 
P 
B SE Beta 
(Constant) -0.068 0.906  -0.075 0.941 
Age (year) -0.002 0.011 -0.127 -0.215 0.832 
Length of injured area (cm) 0.050 0.074 0.163 0.669 0.513 
Duration of injury before 
enrolment (day) 
0.013 0.044 0.073 0.299 0.769 
Pain intensity (BPI-SF) 0.001 0.079 0.006 0.014 0.989 
Pain interference (BPI-SF) 0.056 0.079 0.301 0.714 0.485 
AKET angle injured side at 
enrolment (°) 
-0.003 0.006 -0.125 -0.464 0.649 
Distance of injured site from 
ischial tuberosity (cm) 
0.002 0.013 0.030 0.119 0.906 
Note: *P < 0.05 = Significant difference; BPI – SF = Brief Pain Inventory Scale-Short Form;  
AKET = Active knee extension test; SE = Standard error. 
 
 
Univariate analysis of covariates did not detect any influential outliers (z-score > 
3.29; p < 0.001, two-tailed test), therefore no logarithmic transformation was performed 
(Table 5.18) (Tabachnick & Fidell, 2012).  Similarly, Mahalanobis distance to access 
multivariate outliers using critical value of χ2 = 24.33 (degrees of freedom (df) = 7 at α 
= 0.001) did not detect any outliers (Malahanobis distance ranges: 3.41 to 16.43).  
 
 
Table 5.18 : Identification of univariate outliers. 
Covariates Minimum Maximum N 
Z-score: Age (year) - 0.653 2.888 28 
Z-score: Length of injured area (cm) - 1.984 1.687 28 
Z-score: Duration of injury before 
enrolment (day) 
- 1.946 1.110 28 
Z-score: Pain intensity (BPI-SF) - 2.255 1.459 28 
Z-score: Pain interference (BPI-SF) - 1.660 1.927 28 
Z-score: AKE angle injured side at 
enrolment (°) 
- 1.332 2.506 28 
Z-score: Distance of injured site from 
ischial tuberosity (cm) 
- 1.750 2.531 28 
Note: Z-score  > 3.29 (p < 0.001, two tailed test) = potential outliers; IQR = Interquartile range;  
BPI –SF = Brief Pain Inventory Scale-Short Form; AKE = Active knee extension.  
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Descriptive statistics were displayed in a Kaplan-Meier survival table (Table 
5.19) and a survival curve was plotted to show survival functions over time for all 
participants. Participants in the PRP group reach full recovery sooner than control 
(Figure 5.15). Half of the participants in the PRP group achieved full recovery after 21 
days of follow-up in contrast to only 4 (33.3 %) of the control. The medians DRP were 
34.0 ± IQR 37.3 and 21.0 ± IQR 13.0 days for control and PRP respectively and were 
compared using the Log Rank (Mantel-Cox) test. There was a significant difference in 
survival function between the two groups 2(1, N = 14) = 6.189, p = 0.013. 
 
 
Table 5.19 : Kaplan-Meier survival table. 
Study 
group 
DRP 
(day) 
Status Cumulative proportion 
injured at the time 
N of 
cumulative 
events 
N of 
remaining 
cases 
Estimate SE 
Control        
1 10.00 Injured - - 0 13 
2 13.00 Recovered 0.923 0.074 1 12 
3 14.00 Injured - - 1 11 
4 20.00 Recovered 0.839 0.104 2 10 
5 21.00 Recovered - - 3 9 
6 21.00 Recovered 0.671 0.135 4 8 
7 22.00 Recovered 0.587 0.142 5 7 
8 34.00 Recovered - - 6 6 
9 34.00 Recovered 0.420 0.143 7 5 
10 35.00 Recovered 0.336 0.137 8 4 
11 41.00 Recovered 0.252 0.126 9 3 
12 64.00 Recovered 0.168 0.108 10 2 
13 71.00 Recovered - - 11 1 
14 71.00 Recovered 0 0 12 0 
PRP       
1 6.00 Injured - - 0 13 
2 12.00 Recovered 0.923 0.074 1 12 
3 14.00 Injured - - 1 11 
4 16.00 Recovered - - 2 10 
5 16.00 Recovered - - 3 9 
6 16.00 Recovered 0.671 0.135 4 8 
7 19.00 Recovered 0.587 0.142 5 7 
8 21.00 Recovered - - 6 6 
9 21.00 Recovered 0.420 0.143 7 5 
10 26.00 Recovered 0.336 0.137 8 4 
11 29.00 Recovered - - 9 3 
12 29.00 Recovered - - 10 2 
13 29.00 Recovered 0.084 0.080 11 1 
14 34.00 Recovered 0 0 12 0 
Note: DRP = duration to return-to-play; SE = standard error. 
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Figure 5.15. Survival functions of the control and PRP groups. 
 
 
Regression analysis was conducted with status used to form dichotomous 
dependent variables (DV). Participants who withdrew from the study were given a value 
of 1 while all other cases score 0. Nine covariates including treatment group served as 
the independent variables (IV) for the regression analysis. Eight of these covariates 
were reported by previous study as significant predictors of muscle recovery (Dedrick 
& Clarkson, 1990; Verrall et al., 2003; Connell et al., 2004; Askling et al., 2006; 
Schneider-Kolsky, 2006; Askling et al., 2008; Malliaropoulos et al., 2010; Warren et 
al., 2010; Shariff et al., 2013).  
 
A Cox regression analysis was used to evaluate the effects of treatment and 
other covariates on DRP.  Covariates other than treatments were entered first, followed 
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by treatment as this allow a likelihood-ratio test of the effect of treatment, after 
statistical adjustment for the other covariates (Tabachnick & Fidell, 2012). The PRP 
therapy has a significant effect on the DRP of hamstring injury after considering the 
other covariates, G2 (1) = 8.517, p = 0.004. None of the other covariates significantly 
predicted hamstring recovery DRP. Table 5.20 shows regression coefficients, degrees of 
freedom, p value and hazard ratios for each covariate. 
 
 
Table 5.20 : Cox-regression analysis of other covariates on hamstring recovery. 
Covariate B df P value Odds ratio 
Age (year) 0.049 1 0.159 1.050 
Length of injured area (cm) -0.509 1 0.131 0.601 
Duration of injury before enrolment (day) 0.114 1 0.351 1.121 
Pain severity (BPI-SF) 0.498 1 0.051 1.646 
Pain interference (BPI-SF) -0.500 1 0.114 0.607 
AKE angle injured side at enrolment (°) -0.021 1 0.332 0.979 
Distance of injured site from ischial tuberosity (cm) -0.013 1 0.724 0.987 
History of previous injury -0.227 1 0.764 0.797 
PRP therapy  2.387 1 0.005* 10.882 
Note: *P ≥ 0.05 = Significant predictors; B = Regression coefficient; df = Degrees of freedom;  
IQR = Interquartile range; BPI – SF = Brief Pain Inventory Scale - Short Form; AKE = Active knee 
extension.  
 
 
The chance for participants in the PRP group to reach earlier DRP was 10.8 
times higher compared with the control group. The DRP was well predicted by PRP 
therapy, R2 = 0.262 with a small to moderate effect size (Cohen, 1992). Therefore, 
hypothesis 1 that participants received PRP injection combined with hamstring 
rehabilitation programme would show significantly shorter DRP (faster recovery) 
compared with group that received hamstring rehabilitation programme alone is 
accepted. 
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5.3.13 Effects of intervention on changes in pain severity, pain interference and 
AKE angle 
 
 5.3.13 (a) Changes in pain intensity score 
 
The secondary objectives of this study were to explore the effects of PRP on 
changes in pain severity and pain interference scores over time. A linear mixed model 
using intention-to-treat analysis was applied to determine the effectiveness of 
interventions across the different groups over time. The following assumptions were 
checked and fulfilled: 1) linear relationship between residuals of different levels, 2) 
residuals are normally distributed, 3) equal variances of residuals at each level), 4) 
absence of multicollinearity, and 5) absence of outliers.  
 
Both groups showed gradual improvement (lower score) in pain severity score 
over time (Figure 5.16). The pain severity mean score as assessed by BPI - SF, (Q2 - 6) 
was significantly different between control and PRP group at all time points, F (1, 
115.47) = 7.50, p = 0.007, 2 = 0.771) with a large effect size. Participants in PRP group 
had significantly lower pain severity score (M = 1.14 ± SE 0.19) than controls (M = 
2.31 ± SE 0.23) (mean difference =- 1.17 ± SE 0.30,p  < 0.001) across time. Therefore 
the hypothesis 2 that participant in the PRP group will display significantly faster 
improvement in pain severity score (BPI - SF) over time is accepted. The adjusted R2 
was 0.212 suggested small to moderate effect size (Cohen, 1992) and the final model 2 
(3) = 71.82, p < 0.001. All assumptions were checked and fulfilled. The final equation 
for mean BPI severity score (control group as reference) = 3.84 + (- 0.52)(Visits) + (- 0.39)(PRP 
group*visits) + 1.59. The mean BPI severity score reduces over the period of this study 
and the PRP group showed greater drop during the study compared with controls.   
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Figure 5.16. Comparisons of the mean pain severity scores between intervention groups 
across study period. 
 
 
 5.3.13 (b) Changes in pain interference score 
 
Gradual decreases in pain interference scores were observed in both groups. 
Even though the PRP groups showed lower pain interference mean score across time 
(Figure 5.17), the difference was not statistically significantly, F (1, 108.61) = 2.030, p 
= 0.157). Therefore hypothesis 3 that participant in the PRP group will display 
significantly faster improvement in pain interference score (BPI - SF) over time is 
rejected. 
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Figure 5.17. Comparisons of mean pain interference scores between groups across study 
period. 
 
 
 
 
 5.3.13 (c) Changes in active knee extension angle 
 
A higher mean AKE angle corresponds to greater limitation of knee extension. 
Both groups showed decrease in AKE knee angle suggesting full range of movement of 
the knee has been regained (Figure 5.18). The mean AKE angle in the first 4 weeks was 
comparable. Greater differences between groups were observed beyond the 4th week of 
follow up period. The difference in the AKE angle of the affected leg (as assessed by 
active knee extension test) throughout the study period was not statistically significant 
F(1, 111.78) = 1.350, p = 0.248).  Therefore the hypothesis 4 that participant in the PRP 
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group will show significantly faster improvement in the injured leg active knee 
extension angle over time is rejected. 
 
 
 
Figure 5.18. Comparisons of mean AKE angle between groups across study period. 
 
 
5.3.14 Platelet-rich plasma (PRP) characteristic 
 
 The PRP produced in this study was characterised using the PAW classification 
systems (DeLong et al., 2012). The PAW classification is one of the simplest methods 
in describing PRP characteristic. This system was based on several parameters 
including 1) the absolute number of platelets (P), the presence of activating agent during 
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PRP administration (A) and 3) the presence or absence of white blood cells (W) (Figure 
5.19).  
 
 
Figure 5.19. The PAW Classification System. Source: DeLong et al., 2012 (p.1006). 
 
 
5.3.14 (a) Platelet concentration. 
 
The amount of platelets in the venous whole blood and in the PRP produced 
from the GPS IIITM system ranges from 187.0 to 347.0 x 103/ μL and 936.0 to 1586.0 x 
109/μL respectively (Table 5.21). A Wilcoxon signed-rank test showed the Biomet GPS 
III kit could produce significantly higher number of platelets in PRP (Median = 1297 x 
103/ μL, IQR = 51.32 x 103/ μL) compared with whole blood (Median = 234 x 103/ μL, 
IQR = 491.75 x 103/ μL); (Z = - 3.2, p = 0.001). The method used in the current study 
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could produce PRP with mean platelets content of 5.37 ± 0.92 with ranges between 3.73 
to 6.93 times higher than the number present in whole blood (baseline).  
 
Table 5.21 : Amount of platelets in participant’s whole blood and PRP. 
Participants No. Platelet count  
Whole blood x 10
3
/ μL PRP x 103/ μL PRP :  Whole blood  
1 234.0 1276.0 5.45 
4 335.0 1252.0 3.73 
6 347.0 2021.0 5.82 
8 220.0 1002.0 4.55 
11 195.0 837.0 4.29 
12 229.0 1242.0 5.42 
13 234.0 936.0 4.00 
16 237.0 1454.0 6.14 
19 323.0 1873.0 5.80 
20 245.0 1380.0 5.63 
21 220.0 1318.0 5.99 
23 201.0 1397.0 6.95 
24 256.0 1586.0 6.19 
26 187.0 975.0 5.21 
PRP = Platelet-rich plasma. 
 
 
 
5.3.14 (b) Activating agent 
 
No exogenous platelets activator was used before administration of the PRP in 
this study. The interaction between platelets and tissue collagen may provide the 
appropriate endogenous clotting factors needed for activation. Further, endogenous 
activation resulted in slower platelet aggregation and more sustained release of growth 
factors (Harrison et al., 2011). 
 
5.3.14 (c) White blood cells (WBC) 
 
The complete result on the number of WBC present in venous whole blood and 
in PRP was available only in six participants in the intervention group (Table 5.22). The 
  162 
mean absolute number of WBC in the whole blood and in the PRP was 7.3 x 103/ μL ± 
1.3 x 103/ μL and 38.3 x 103/ μL ± 11.9 x 103/ μL respectively. A paired-samples t-test 
was conducted to compare the number of platelets present in PRP and the whole blood. 
Significantly higher number of WBC present in PRP (Mean = 7.3 x 103/ μL,  = 1.31 x 
103/ μL) compared with whole blood (Mean = 38.3 x 103/ μL = 11.87 x 103/ μL); t (6) = 
- 7.05, p = 0.001. Based on this finding the current method of PRP produced in this 
study contained total WBC above the level present in the peripheral blood. Therefore 
the PRP produced was classified according to PAW classification as below (Table 
5.23). 
 
 
Table 5.22 : Amount of white blood cells (WBC) in participant’s whole blood and 
PRP. 
Participants No. WBC count  
Whole blood x 10
3 
/ μL PRP x 103/ μL PRP :  Whole blood  
1 7.80 45.60 5.85 
4 7.90 43.10 5.46 
6 7.40 29.80 4.03 
8 9.20 55.70 6.05 
11 6.10 24.00 3.93 
12 5.60 31.30 5.59 
WBC = white blood cells; PRP = platelet-rich plasma. 
 
 
Table 5.23 : PAW classification of PRP used in the current study. 
Platelet 
Concentration 
Activation 
method 
WBC’s PAW 
Classification 
Total WBC 
Content 
Neutrophil 
Content 
Endogenous 
P4 Endogenous (x) A Not available P4-x-A 
WBC = white blood cells; P4 = Platelet level > 1250 x 103/ μL; A = WBC content above baseline. 
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5.3.14 (d) Growth factors. 
 
Despite carefully following the manufacturer’s guideline on performing the IGF-
1 test. We could not obtain a reliable reading, as the coefficient of determination was 
very low (R2 = 0.012). Therefore, the IGF-1 level is not reported. The coefficient of 
determinations for TGF- β1 and bFGF were R2 = 0.964 and 0.943 respectively. The 
TGF- β1 and bFGF levels from 11 participants are displayed in Table 5.24. The median 
(IQR) level TGF-β1 and bFGF were 50.34 ± IQR 54.00 ng/ ml and 42.73 ± IQR 25.51 
pg/ ml respectively. 
 
Table 5.24 : Amount of TGF-β1 and bFGF present in PRP. 
Participant No. Growth factors 
 TGF-β1 (ng/ ml) bFGF (pg/ ml) 
1 34.00 29.83 
4 36.34 27.62 
6 31.09 39.54 
8 42.21 32.58 
11 38.59 42.73 
12 80.46 55.23 
13 111.47 58.09 
16 224.71 46.28 
19 81.21 32.98 
20 50.34 91.42 
21 90.34 75.12 
TGF - β1 = transforming growth factor beta - 1; bFGF = basic fibroblast growth factor. 
 
 
 
5.3.15 Blinding success 
 
 The blinding index corresponds to percent incorrect guesses + percent undecided 
guesses (James et al., 1996). Blinding indices of  > 50 % suggest successful blinding. 
The blinding index for assessor in this study ranged from 78.6 to 85.7 %, suggesting 
successful blinding (Table 5.25). 
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Table 5.25 : Assessment of blinding  
Assessor’s guess Actual treatment 
PRP  Control  Total 
PRP 2 (14.3 %) 3 (21.4 %) 5 
Control 0 (0 %) 0 (0 %) 0 
Undecided 12 (85.7 %) 11 (78.6 %) 23 
Total 14 14 28 
Assessor was asked upon study completion to identify which treatment arm the patient was assigned. 
Blinding index equals (percent [incorrect] + percent [undecided]). When blinding exceeds 50 %, subjects 
have been successfully blinded (Hertzberg et al., 2008). 
 
 
 
5.4 Discussion 
 
Over the last decade the use of PRP has received increasing attention for it’s 
potential favourable effects on soft tissue healing. Platelet-rich plasma (PRP) is 
currently used to treat several soft tissue conditions including lateral epicondylitis 
(tennis elbow)(Gosens et al., 2011; Peerbooms et al., 2010; Thanasas et al., 2011), 
tendinopathies (Achilles, patellar and rotator cuffs)(Ark et al., 2011; Barber et al., 2011, 
Spang et al., 2011), osteoarthritis (Sampson et al., 2010; Wang-Saegusa et al., 2011), 
and acute muscle injuries (Wright-Carpenter et al., 2004a; Wright-Carpenter et al., 
2004b; Hamilton et al., 2011). With the exception of lateral epicondylitis (tennis elbow) 
the clinical evidence to support PRP use in other conditions are limited to experimental 
and Grade III – IV human studies. Also some studies showed contrasting effects of PRP 
for certain soft tissue injuries (Kon et al., 2009; Filardo et al., 2009; Gaweda et al., 
2010; deVos et al., 2010; deAlmeida et al., 2012). Lack of uniformity in method of PRP 
preparation, administration procedures and rehabilitation exercises programme post 
PRP injection have been implicated as reasons for differences between studies (Andia et 
al., 2011; Hamilton et al., 2011; Redler et al., 2011; Sheth et al., 2012). While the 
theoretical science seems to support PRP use for muscle injury (Ross et al., 1979; Allen 
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& Boxhorn, 1989; Husmann et al., 1996), clinical evidence to prove such effects is 
limited. Most data were based on experimental studies and sporadic cases reports 
(Wright - Carpenter et al., 2004a; Wright - Carpenter et al., 2004b; Creaney et al., 2008; 
Loo et al., 2009; Gigante et al., 2012). Therefore this RCT was conducted to bridge the 
gap in knowledge on PRP effects on acute muscle injury.  
 
 
5.4.1 PRP preparation and administration protocols 
 
Currently there are many commercially available kits to produce PRP. Some 
used the buffy coat methods (Biomet GPS III, Harvest SmartPRep 2 and 
Artericyte/Medtronic) while others rely on the plasma-based methods (Arthrex/ACP, 
Cascade/MTF Fibrinet and BTIPRGF). Investigators vary in the methods of PRP 
preparation. Accordingly the PRP quality produced by the various methods differs in 
the amount of platelets, white blood cells and even the level of growth factors (DeLong 
et al., 2012). These differences might affect the clinical outcome of PRP intervention 
(Mazzocca et al., 2012). Developing a standardised PRP classification system is much 
needed as it allows standardised comparisons between studies (Dohan et al., 2009; 
Engebretsen et al., 2010; DeLong et al., 2012). 
 
In this study, PRP was produced using a commercially available kit that used the 
buffy coat methods. Following the manufacturer guideline on the use of these kits, each 
60 ml kit was able to produce about 6 ml of PRP. The amount of platelet contained in 
the PRP ranges from 837 x 103/ μL to 2021 x 103/ μL. The mean platelet level was 1325 
x 103/ μL ± SD341 x 103/ μL. The PRP produced had 5.4 ± SD 0.92 times higher 
number of platelets than the peripheral venous blood. The level of platelet concentration 
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in this study corresponds to levels reported in the literatures (Woodell-May et al., 2005; 
Castillo et al., 2011; Schippinger et al., 2011; DeLong et al., 2012).  
 
The ideal amount of platelet necessary to demonstrate its potential useful effects 
is yet to be determined. Lack of standardisation of study protocols, platelet-separation 
techniques and outcome variables of the limited available literatures further complicates 
comparison between studies (Andia et al., 2011; Hamilton et al., 2011; Sheth et al., 
2012). Several in vivo, in vitro and clinical studies have showed beneficial effects of 
PRP when platelet concentration was 2 to 3 times higher than baseline (peripheral 
blood) (Anitua et al., 2005; Anitua et al., 2006; Sanchez et al., 2007; Anitua et al., 
2008; Mazzocca et al., 2012).  
 
Though it is tempted to suggest there is a linear relationship between amount of 
platelet and rate of tissues healing. Platelet concentration greater than 6 times may have 
paradoxical negative effect on tissue healing. Weibrich et al, (2004) found highly 
concentrated platelets (6 to 11 times higher than peripheral blood; 1852 to 3200 x 103 
platelets/ μL) had an inhibitory effect on osteoblast activity when compared with lower 
concentration (Weibrich et al., 2004).  
 
The mean platelet concentration of 5.4 ± SD 0.92 times higher than peripheral 
blood (1325 x 103/ μL ± SD341 x 103 platelets/ μL) produced in this study was well 
within the therapeutic level as described by previous authors (Weibrich et al., 2004; 
Anitua et al., 2006; Anitua et al., 2008; Andia et al., 2011; Hamilton et al., 2011; 
DeLong 2012).  
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As there were reports that levels of platelet growth factors not necessarily 
proportionate to the platelet count (Borzini et al., 2005; Weibrich et al., 2005) two types 
of growth factors; human transforming growth factor - β1 (TGF - β1) and basic 
fibroblasts growth factor (bFGF) levels were determined in the current study. Both 
growth factors were measured with enzyme-linked immunosorbent assay (ELISA) kits. 
The TGF - β1 and bFGF levels were analysed using SSB - E04725h and CSB - 
E08000h kits respectively (Cusabio, Wuhan, China). The plasma TGF- β1 and bFGF 
levels in healthy adults ranged between 1.9 ± 5.2 ng/ml and 1.89 ± 1.20 pg/ml 
respectively (Kropf et al., 1999; Larsson et al., 2002; Wakefield et al., 2005). The 
median level of TGF - β1 in the current study was 50.34 ± IQR 54.09 ng/ml 
representing a 90 to 260 % increase than previously reported level in plasma. 
Meanwhile the median bFGF level was 42.73 ± IQR 25.51 pg/ml, representing 22 fold 
increases than previous study.  
  
The effect of highly concentrated WBC within PRP preparations is not fully 
understood (Schneider et al., 2007; Ehrenfest et al., 2009). Although normal levels of 
WBCs have positive immunodulatory effect, higher level may contribute to harmful 
impact on soft tissue healing (Toumi et al., 2003; Tidball et al., 2004; Smith et al., 
2009). Others however suggested the large amount vascular endothelial growth factors 
(VEGF) produced by WBC is crucial for promotion of angiogenesis and healing 
(Werther et al., 2002; Peterson et al., 2010). Further WBC rich PRP has been 
successfully used for the treatment of tendonitis and delayed long bone healing (Mishra 
et al., 2006; Schnabel et al., 2007). The mean amount of WBC present in the PRP 
produced in the current study was 38.3 x 103/ μL ± SD 11.9 x 103/ μL which was 5 
times higher than the WBC level in the peripheral blood (7.3 x 103/ μL ± SD 1.3 x 103/ 
μL).  
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In summary, the PRP produced and used in the current study has a platelet and 
WBC level that was 5.4 and 5 times higher than peripheral venous blood respectively. 
Therefore the PRP in the study was classified as leucocyte rich-PRP (L-PRP) or Type 4 
PRP according to the classification described by Ehrenfest et al., (2009) or Mishra et 
al., (2012) respectively. Alternatively the PRP in the study could also be classified as 
P4 – x - B according to the more recent PAW Classification System (DeLong et al., 
2012).  
 
 
5.4.2 Hamstring injuries 
 
In this study hamstring injury mostly occurred among practitioner of sports that 
require rapid acceleration and changes in direction including soccer, track and field’s, 
hockey, netball, rugby, basketball and tennis. Similar observations reported by previous 
authors (Verrall et al., 2001; Seward et al., 2003; Gabbe et al., 2006; Liu et al., 2012). 
Most injuries (60.7 %) in the current study were classified as new injury. Hamstring 
recurrence injury was observed only in 39.3 % of athletes. Similarly 12 to 48 % 
recurrent hamstring injuries were reported among English professional soccer and 
Australian football players (Orchard et al., 2002a; Orchard et al., 2002b; Dadebo et al., 
2004; Askling et al., 2004; Woods et al., 2004; Ekstrand et al., 2011). The current study 
also noted that majority of hamstring injury involved the biceps femoris muscle (67.9 
%). This observation is similar to those documented by previous studies (Kalimo et al., 
1997; Hawkins et al., 2001; Henderson et al., 2010; Comin et al., 2012).  
 
 All athletes diagnosed with grade-2 hamstring injury in this study complained of 
pain (BPI - SF, Q2 - 6), which also interfered with daily activities (BPI - SF, Q9A - 
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9G). Interestingly, only 11 (39.3 %) participants displayed positive active knee 
extension (AKE) test (angle difference of  > 10 °) between the injured and non-injured 
sides. This finding was in agreement with earlier studies (Best et al., 1995; Kalimo et 
al., 1997; Tiidus, 2008). This finding suggests hamstring-grading systems that based 
solely on physical assessment (including AKE test) might underestimate injury severity. 
Therefore, a more comprehensive method of hamstring injury classification systems that 
incorporated physical assessment and radiological imaging (ultrasound and MRI) is 
recommended (Peetrons, 2002; Hurme et al., 2006; Järvinen et al., 2007; Cohen et al., 
2011; Chan et al., 2012; Meuller-Wohlfahrt et al., 2013).  
 
 
5.4.3 PRP effect on duration to return-to-play (DRP) after muscle injury  
 
The main outcome of this study was to investigate the effect of PRP therapy on 
the duration to return-to-play (DRP). The DRP was defined as duration (in days) from 
injury onset until participants’ reached full recovery. A set of criteria was used in 
deciding participant’s readiness to recommence preinjury activities. A significant 
difference in participants’ median DRP between the two intervention groups was found. 
Participants in the PRP group achieved DRP significantly earlier compared with 
controls (21.0 vs. 34.0 days). Unfortunately, no other RCT that explore the effect of 
PRP on DRP was available to allow comparison with the present finding.  
 
A significantly shorter recovery time was reported among athletes diagnosed 
with moderate hamstring strain (second-degree) treated with autologous conditioned 
serum (ACS) by Wright et al. (2004). The author reported athletes who received ACS 
injection every second day from study enrolment took 16.6 days to achieve full 
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recovery. Meanwhile participants in the control group took 22.3 days to recover 
(Wright-Carpenter et al., 2004a). The ACS was prepared using a technique that was 
clearly described by the researcher. While the authors did report higher content of 
several growth factors (including TGF - β1, FGF - 2 and IGF - 1), other ACS 
characteristics such as platelets and WBC levels was not stated (Wright - Carpenter et 
al., 2004a).  
 
Higher level of growth factors noted in the previous study could be attributed to 
the different methods of PRP preparation. The ACS preparation involved a 24-hour 
incubation period of the collected bloods on to glass beads. This incubation period 
initiated monocyte activation and cytokines release (Wehling et al., 2007). In contrast, 
the method used in the current study involved no incubation period; also no platelet 
activation was used before PRP administration.  
 
In addition, concurrent use of oral medication in the previous study may also 
have affected symptoms of pain allowing earlier DRP. Participants in the ACS study 
were allowed to take antipholgistics; bromelain during the study. Bromelain is a natural 
supplement with documented anti-inflammatory and analgesic actions (Brien et al., 
2004). Further, Bromelain has demonstrated clinical effectiveness in reducing 
symptoms of pain among patients with osteoarthritis (Singer et al., 2001; Tilwe et al., 
2001; Walker et al., 2002).  
 
Furthermore the criteria used by previous and the current study to determine 
recovery differs. Determination of muscle recovery was based entirely on the 
participant’s subjective readiness to resume activities at competitive level in the 
previous study. Such method is vulnerable to a range of individual response biases 
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(Furnham et al., 1982). Contrary the current study combined participant’s subjective 
assessment of pain (BPI - SF), standardised clinical assessment and objective hamstring 
strength (Biodex isokinetic machines) to determine participant’s readiness to return to 
preinjury activities. The criteria used in the current study were based on recent clinical 
sports medicine recommendations (Croisier et al., 2002; Drezner et al., 2003; Croisier 
et al., 2004; Brukner & Khan, 2010; Mendiguchia et al., 2010). In addition, to reduce 
risk of biasness, the physiotherapist who performed all the standardised clinical 
assessment was blinded to participant’s treatment group.  
 
In an abstract presented at the 2nd World Congress on Rehabilitation Medicine, 
Sanchez et al., (2005) reported full recovery after hamstring and adductor muscles 
injury was two-times faster in 20 professional athletes treated with preparation rich in 
growth factors (PRGF). Also the author noted smaller tears progressed well even after a 
single injection of PRGF. While medium to large size tears however needed two to 
three applications of PRGF at one-week intervals (Sanchez et al., 2005).  
 
The potential effects of PRGF to hasten muscle healing were also reported in 
several case reports (Loo et al., 2009; Hamilton et al., 2010; Borrione et al., 2011). 
Borrione et al., (2011) noted athletes with Grade III muscle strain treated with PRP 
injection therapy showed faster functional improvement and more complete recovery 
than those treated conservatively. Similarly, Hamilton et al. (2010) successfully treated 
an athlete with grade-2 semimembranosus muscle injury with a single 3 ml infiltration 
of platelet-enriched plasma (PEP) under ultrasound guidance. A repeated MRI 
approximately one week after PEP administration showed mild resolution of oedema. 
Further, 17 days after injection, the athlete was pain free and had attained full range of 
movement and could trained at his preinjury level one week later.  
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The potential effect of PRGF as adjunct treatment to speed up muscle recovery 
was also reported by Loo et al. (2009) in a 35-year-old professional bodybuilder 
diagnosed with right adductor longus rupture. The athlete was treated with serial PRGF 
injection once a week for 3 weeks combined with analgesia and physiotherapy. The 
athlete reported good pain relief and a repeat ultrasound revealed haematoma 
reorganisation and muscle healing. He returned to competitive training within one week 
after the third PRGF injections (Loo et al., 2009).  
 
Contrary, Rettig et al. (2013) reported no significant difference in the time to 
return-to-play (recovery) following hamstring injury (grades-1 and -2) between athletes 
treated either with combined single PRP injection and rehabilitation programme or 
rehabilitation programme alone. Several differences were identified between the study 
by Rettig et al. (2013) and the current study. First, the design of the study, Rettig et al. 
(2013) conducted a retrospective case control study of ten professional National 
Football League (NFL) players. Further, they included both grades of (MRI grades-1 
and -2) hamstring injuries. Whereas the severity of injury in the current study was more 
homogeneous as only grade-2 hamstring injury (US grading) was included. Even 
though both studies used similar commercial kit for PRP preparation, higher amount 
(0.5 ml for every 1 ml of PRP) of bicarbonate was added to the PRP prior to 
administration in the previous study. The main function of sodium bicarbonate addition 
was to buffer the effect of the anticoagulant citrate dextrose solution (ACD - A) used in 
earlier steps of PRP preparation. Higher amount of sodium bicarbonate might have 
affected the final pH of the prepared PRP, and influence platelets functions (Han et al., 
1974). Also, the author did not classify the PRP used in their study and concurrent use 
of PRP activating substance was not reported (Rettig et al., 2013).  
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Another difference between the two studies was the rehabilitation programme 
prescribed to participants. The rehabilitation programme used by Rettig et al., (2013) 
focussed on hamstring stretching and strengthening. In addition participants also 
received other forms of therapy including electrotherapeutic therapy, soft tissue 
massage, trigger point release and contrast bath types throughout the study. In contrast 
all participants (PRP and control groups) in the current study received a standard 
rehabilitation programme. This rehabilitation programme focussed on progressive 
agility and trunk stabilisation (PATS) exercises. The PATS rehabilitation programme 
has been shown to be more effective in accelerating hamstring recovery than the 
program that emphasise on stretching and strengthening. Further the PATS programme 
also reduces the risk of recurrent hamstring injuries (Sherry & Best, 2004). Also 
participants in the current study received no other treatment modalities.  
 
Finally, the definition of full return to play (DRP) in the current study was 
clearly stated. The DRP was based on athlete’s having fulfilled several clinical criteria 
including isokinetic strength assessment. More importantly the assessor was blinded to 
treatment received by athletes. While the RTP criteria used by Rettig et al., (2013) study 
was not clearly defined.    
 
 
5.4.4 PRP effect on symptoms of pain severity and pain interference after 
hamstring injury 
 
 The symptom of pain was assessed using the self-administered brief pain 
inventory – short form (BPI - SF) questionnaires. The BPI - SF assesses on the severity 
of pain (Q2 - 6) and effect of pain on daily function (interference) (Q9A - 9G).  
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 Over time participants in both groups showed gradual decline in pain scores. 
Participants in the PRP group however, displayed significantly lower mean pain 
severity scores than the control group throughout the study. Unfortunately previous 
studies on muscle injury only focussed on functional improvement and radiological 
changes. Often changes in symptoms of pain severity and effect of pain on daily 
function (interference) were not assessed (Wright - Carpenter et al., 2004a; Rettig et al., 
2013). Therefore comparisons can only be made with PRP intervention studies on other 
chronic conditions such as lateral epicondylitis, Achilles and patellar tendionpathies.  
 
 A prospective RCT to study the effect of PRP injection on rotator cuff healing 
was studied by Randelli et al., (2011). Patients were followed-up regularly until 24 
months post-operative. They found patients who received intraoperative PRP injection 
during arthroscopic rotator cuff repair had lower visual analogue score (VAS) for pain 
at 3, 7, 14, and 30 days after surgery than controls. Also, patients in PRP group showed 
significantly higher clinical (functional) outcomes assessed with Constant, strength in 
external rotation (SER), modified University of California (UCLA), simple shoulder 
test (SST) at 3 months after surgery. However, the difference between groups was not 
statistically significant at 6 and 12 months post-operatively.   
 
 The effect of PRP was also studied in a double-blind, prospective, multicentre 
controlled trial of 230 patients with chronic tennis elbow (Mishra et al., 2013). The 
effect of PRP was assessed using VAS for pain and the Patient-Rated Tennis Elbow 
Evaluation (PRTEE). The PRTEE is a 15 - item questionnaire designed to measure 
forearm pain and disability (MacDermid, 2007). Patients randomised into the PRP 
group reported more improvement in pain scores compared with controls throughout the 
study. The differences were statistically significant at 8 and 24 weeks of follow-up. 
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Patients in both groups also showed improvement in functional scores (PRTEE) with 
time. The PRP group reported more improvement over baseline at 8-, 12-, and 24-week 
follow-up. The differences in PRTEE scores between groups however were not 
statistically significant. The findings observed by Mishra et al., (2013) were consistent 
with those reported by other clinical studies (Mishra & Pavelko, 2006; Peerbooms et al., 
2010; Creaney et al., 2011; Thanasas et al., 2011). Similarly, Creaney et al., (2011) 
demonstrated clinically significant improvement in the mean PRTEE scores among 
patients with resistant elbow tendinopathies treated with either PRP or autologous blood 
(ABI) injections. The author further recommended PRP or ABI injections as a second 
line therapy for patients who are resistant to first-line therapy such as eccentric loading 
(Creaney et al., 2011).  
 
 In a different study de Almeida et al. (2012) examine the effect of PRP on 
patellar tendon healing. Patients were randomised using computer-generated sequence 
to receive (PRP group) or not (control) PRP in the harvest site during ACL 
reconstruction. The study found patellar tendon gap was significantly smaller in the 
PRP group than control. Further, patients in the PRP group had lower VAS pain scores 
in the immediate post-operative period. Both groups demonstrated clinically significant 
improvement in knee function scores at 6 months follow-up. The difference between 
groups however was not statistically significant. 
  
 The effect of PRP in improving pain associated with hamstring injury was 
obvious in the current study. This finding is consistent with those reported by previous 
studies (Mishra & Pavelko, 2006; MacDermid, 2007; Peerbooms et al., 2010; de 
Almeida et al., 2012; Randelli et al., 2011; Thanasas et al., 2011). The mean pain 
severity scores improved with time. Patient in the PRP group had significantly lower 
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pain severity scores throughout the study. In addition, participants in the PRP groups 
also showed lower pain interference scores at each time points. The group differences in 
pain interference scores however were not statistically significant (p = 0.248).  
 
 The mechanisms upon how PRP influence the symptoms of pain associated with 
soft tissue injury is uncertain (Peerbooms et al., 2010; Mishra et al., 2013). It has been 
postulated the bioactive substances within PRP responsible for enhancing soft tissue 
healing also positively improved function and reduces pain (Mishra et al., 2013). It is 
also suggested the accelerated haemostasis effect of PRP play a significant role in pain 
reduction (Gardner et al., 2007).   
 
 
5.4.5 PRP safety 
 
Autologous PRP used was described as safe treatment alternative for muscle 
injury (Aspenberg et al., 2004; Chan et al., 2005; Sanchez et al., 2007; deMos et al., 
2008; Majewski et al., 2009). Participants in the current study reported no severe 
adverse effect. Most participants only describe slight pain associated with blood taking 
(venepuncture) and during PRP injection. This finding is in agreement with those 
reported by other studies (Wright-Carpenter et al., 2004a; Loo et al., 2009; Hamilton et 
al., 2010; Mishra et al., 2013).  
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5.5 Study strength and limitation  
 
 One of the strength of the current study is the randomised controlled trial (RCT) 
design. The RCT design enables vigorous method for assessing cause-effect relation 
between treatment and outcome (Silverman et al., 1992). In addition the random 
allocation in RCT ensures no systematic differences exist between intervention groups 
(Schulz et al., 1995). The present study is the first RCT that evaluated the effectiveness 
of single PRP injection for treating acute grade-2 hamstring injury.   
  
 Homogeneity of the injury severity was achieved by only including participants 
with grade-2 hamstring injury. Further the severity of hamstring injury was based on 
combination of physical assessment and ultrasonography appearance of injured 
hamstring. This is important as grading of muscle injury based solely on physical 
assessment may underestimate injury severity (Best et al., 1995; Kalimo et al., 1997; 
Tiidus, 2008).  
 
 Currently there are several methods in preparing PRP (plasma based versus 
buffy-coat based) available in the market. The PRP prepared from the different kits 
varies in the contents (amount) of platelets, WBC, and growth factors levels (Dohan et 
al., 2009; Mazzucco et al., 2009; Zumstein et al., 2011; DeLong et al., 2012). The 
components of PRP produced in the current study was analysed and later classified 
according to the PAW classification system. Classification of PRP would allow 
comparisons of PRP efficacy between systems. In addition PRP classification is also 
useful for replication of study in the future.  
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 Few limitations require to be mentioned in interpreting the findings from this 
study.  First, the current study included only 28 participants with grade-2 hamstring 
injury. While a larger sample size may provide higher statistical power, shorter study 
period and limited financial support were the main constraints faced by the researchers. 
Since annual incidence of hamstring muscle injury in this centre was 35 cases and as the 
study recruitment period was only a year (later extended another 6 months), the target 
number of 28 participants was practical (Shariff et al., 2013). The high cost of the PRP 
commercial kit around RM 3000.00 each, further limits the number of participants 
included in the study. 
 
 Second, while it may appear that all participants were homogeneous in term of 
injury severity (only grade-2 injury was recruited). The type of muscle involvement 
varies; most injuries affected the biceps femoris muscles, followed by 
semimembranosus and semitendinosus. The anatomical, functional and histological 
(percentages muscle fibres types) difference between these muscles might affect the 
recovery (Tiidus, 2008).  
 
 Another limitation worth mentioning is compliance to the unsupervised daily 
home rehabilitation exercises. Despite incorporating a simple dairy (to record daily 
exercise session performed) into the PATS rehabilitation booklet provided to each 
participants. Less than 10 % of participants managed to complete the diary. Most 
participants stated that they performed their rehabilitation exercise at least once a day on 
verbal clarification.  
 
 Finally, even though the adverse effects of PRP experienced by the participants 
in the study was considered minor. Shorter duration of study follow-up did not allow for 
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any long-term potential adverse effects to be assessed.  In addition the long-term effects 
of PRP therapy on hamstring injury recurrence cannot be evaluated. 
 
 
5.6 Summary of the overall findings 
 
In this study, participants in the PRP group achieved full recovery (DRP) 
significantly earlier compared with participants in the control group even after adjusting 
for the other potential covariates. Further PRP therapy was the only significant 
predictors of DRP. Participants who received PRP injection had a 10.88 times higher 
chances of reaching earlier DRP compared with control.  
 
Participants in both groups demonstrated gradual improvement in the mean pain 
severity and mean pain interference scores over time. Statistically significant difference 
between groups was only demonstrated in the mean pain severity score.  Participants in 
the PRP group had significantly lower mean pain severity score at all time points 
compared with control.  Even though participants in the PRP demonstrated lower mean 
pain interference score and AKE angle across time, the difference observed did not 
reached significance level.  
 
In this study the PRP was produced using the buffy-coat methods. The PRP 
produced contained amount of platelet > 1250 x 103/μL and WBC level above baseline. 
The current method of PRP injection used no exogenous PRP activation and relies 
totally on endogenous activation. Therefore the PRP in this study can be classified as 
P4-x-A based on the PRP PAW classification system.  
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Chapter 6  General Discussion and Conclusion 
 
6.1 Introduction 
 
 The overall purpose of this thesis was to study the effect of autologous platelet-
rich plasma (PRP) injection on muscle recovery following injury. The current research 
comprises of four studies to address the objectives of this thesis. 
 
 First, a systematic review to explore the existing literatures on the role of PRP 
for muscle injury was performed. The results of which among others clearly showed 
lack of clinical evidence to support PRP use for muscle injury. Hence a randomised 
controlled trial (RCT) to investigate the effect of PRP for muscle injury among 
Malaysian athlete was planned.  
 
 In planning the RCT it was noted that several key information such as muscle 
injury prevalence, pattern of muscle injury including injury location and severity, 
treatment approaches and average recovery time among Malaysian athletes were not 
available. Thus, a cross-sectional study to explore the patterns of muscle injury and 
injury management among Malaysian athletes was conducted in the second study. In 
addition factors that predict early muscle injury recovery among local athletes were also 
explored.  
 
 Hamstring flexibility test is a clinical test commonly used in diagnosing and 
prognosticating hamstring injury. In this RCT the active knee extension (AKE) test was 
chosen as an objective assessment of hamstring flexibility. However several existing 
AKE tests to measure knee range of motion were complicated and require more than a 
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single person to perform. Therefore, a simpler and reliable tool for hamstring flexibility 
assessment was designed and constructed for the RCT. The reliability of this active 
knee extension (AKE) test was the primary objective in the third study.  
 
 Even though PRP have gained a lot of attention for treatment of soft tissue over 
the last two decades, controversies still exist. More conclusive evidence from clinical 
studies is needed to guide sports medicine practitioners on the role PRP in sports injury. 
Information on pattern of muscle injury among Malaysian athletes in Study 1 was used 
to develop the RCT.  Furthermore the excellent reliability of the newly designed AKE 
test supported the test inclusion in the RCT.  
 
 The primary objective of the RCT was to evaluate the effect of PRP therapy on 
hamstring muscle recovery after grade-2 injury.  
 
 
6.2 Systematic reviews on platelet-rich plasma therapy 
 
 A computerized literature search, citation tracking and hand searching for 
original studies assessing the effect of PRP on skeletal muscle injury were conducted. 
This systematic review was conducted according to the Preferred Reporting Items for 
Systematic reviews and Meta-Analyses (PRISMA) guideline using OvidMEDLINE, 
PubMed, EMBASE, SPORTDiscus and CINAHL databases. We could not identify any 
randomised controlled trial (RCT) on platelet-rich plasma (PRP) for acute muscle 
injury. As such the search criteria was extended to include case control and laboratory 
studies.  Even so only four relevant literatures were identified and reviewed. Few 
laboratory and animal studies showing positive effects of PRP for acute muscle healing. 
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The effect of PRP in humans however is not yet known. We concluded that currently 
there is not enough evidence to support or refute PRP use for acute muscle injury. More 
studies using robust clinical design were needed. This review further supports our plan 
to conduct a randomised controlled trial on PRP for acute muscle injury (Study 4). 
 
 
6.3 Muscle injury patterns and characteristics among Malaysia athletes 
 
From the literature search performed we noticed that several important 
information on muscle injury in the local setting were not available. The pattern on 
muscle injury including injury location and severity among Malaysian athletes had not 
been reported. Furthermore common treatment approaches and average recovery time 
from muscle injury had not been documented. Hence, a cross-sectional study to explore 
pattern of muscle injury among Malaysian athletes was performed. It was found that the 
pattern of muscle injury among Malaysian athletes was comparable to existing 
literatures. Grade-1 and -2 muscle injuries were the two most common types of injury 
sustained by athletes. Injury often affects the hamstring muscle group particularly the 
biceps femoris muscle. Most athletes responded well with conservative treatment that 
includes short term (less than 5 days) non-steroidal anti-inflammatories combined with 
electrotherapeutic modality. The median time to recovery among Malaysian athletes is 
considerably longer than those reported by other studies. Early consultation on injury 
onset, recurrent muscle injury and female gender were identified as significant 
predictors of recovery time.  
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Key information including type of muscle injury, location of injury, length of 
follow up period, treatment of injury and predictors of DRP gathered from this 
preliminary study were used to develop the final study (RCT).  
 
 
6.4 Reliability of the active knee extension (AKE) test 
 
 One of the test regularly used to assess hamstring recovery from injury is the 
hamstring flexibility test. Hamstring flexibility is often used to diagnose and 
prognosticate hamstring injury. The active knee extension (AKE) test developed by 
Davies et al. (2008) was considered as the gold standard for assessing hamstring 
flexibility.  However, previous AKE tests often require more than one person to 
perform. Moreover most of the existing AKE tests employ complicated apparatus to 
help stabilise the pelvis during the test. Therefore a standard method of AKE 
assessment using a simple and portable pelvic stabilising apparatus was constructed. 
The reliability of this AKE test was determined in the third study.  
 
  Our study showed the AKE test used in this study has excellent interater (ICC2,1 
values ranges from 0.81 to 0.87 [0.58 – 0.97; 95 % CI]) and test-retest (ICC3,1 values 
ranges from 0.78 to 0.92 [0.32 – 0.97; 95 % CI]) reliabilities. Subsequently, this test 
was included as one of the assessment method in the final study (RCT). 
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6.5 Effectiveness of platelet-rich plasma for the treatment of grade-2 hamstring 
injury (RCT)  
 
Despite receiving much attention for its potential benefits on soft tissue healing, 
evidence to show PRP effectiveness is scarce. Except for lateral epicondylitis, the 
clinical evidence to support PRP use in the other conditions was limited to experimental 
and Grades III – IV human studies. Realising this insufficiency, we conducted a 
randomised clinical trial to investigate the effect of PRP on hamstring injury.  
 
Twenty-eight athletes with acute (within seven days of injury onset) grade-2 
hamstring injury took part in this RCT. Participants were randomised to receive either a 
hamstring rehabilitation exercise program alone or combined with a single injection of 
PRP into the injured area. 
 
 The effect of PRP on the time taken for the participants to achieved full 
recovery (duration to return-to-play [DRP]) was evaluated.  
 
The following conclusion could be drawn from this study based on the stated 
hypothesis; 
 
H1: Patient group receiving PRP combine with hamstring rehabilitation program 
 will demonstrate significantly shorter DRP (faster recovery) compared with 
 group receiving hamstring rehabilitation program alone. 
  
 This hypothesis was accepted. Participants in the PRP group achieved full 
 recovery significantly (p = 0.013) earlier compared with controls (median  DRP 
  185 
 21 days versus 34 days). Further PRP therapy was shown to significantly (p = 
 0.004) predict DRP after acute hamstring injury. 
 
 
H2: Patient group receiving PRP combine with hamstring rehabilitation program 
 will demonstrate significantly faster improvement in pain severity score (BPI -
 SF) compared with group receiving hamstring rehabilitation program alone. 
 
 This hypothesis was accepted. Participants in both groups showed gradual 
 improvement in pain severity score over time. Participants in the PRP group 
 had significantly (p ≤ 0.001) lower (better) pain severity score (as assessed by 
 BPI - SF, Q2 - Q6) at all time points compared with controls. 
 
H3: Patient group receiving PRP combine with hamstring rehabilitation program 
 will demonstrate significantly faster improvement in pain interference (BPI-
 SF) 
  
 This hypothesis was rejected. Both groups showed gradual improvement in 
 pain interference score (as assessed by BPI - SF, Q9A - Q9G). Despite the PRP 
 group demonstrated lower pain interference score at all time points, the 
 difference was not statistically significant.  
 
H4: Patient group receiving PRP combine with hamstring rehabilitation program 
 will demonstrate significantly faster improvement in active knee extension 
 (AKE) test compared with group receiving hamstring rehabilitation program 
 alone. 
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 This hypothesis was rejected. Both groups showed gradual improvement in 
 hamstring flexibility (assessed using active knee extension [AKE] test). 
 However no significant difference between groups was detected. 
 
 
6.6 Limitations 
 
 1. In our systematic review (Study 1), only English language peer-reviewed articles 
published until 2012 were included in the data extraction, as such the possibility 
of selection bias might occur. 
 
 2. In the cross sectional survey on pattern of muscle injury among Malaysian 
athletes (Study 2), 53 % of the injured athletes were lost to follow-up. High loss 
to follow-up rate might have been responsible for the longer DRP compared 
with other studies. 
 
 3. Small samples size could have explained the wide range of confidence intervals 
(CI) for point estimates in our active knee extension (AKE) test reliability study 
(Study 3). Therefore a study with a larger samples size is recommended for 
future study. 
 
 4. Small sample sizes may have limit the statistical power of our randomised 
controlled trial (Study 4). However, small sample sizes have always been a 
challenge in RCT. Besides the number of participants in this RCT was 
calculated based on previous study. 
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 5. To ensure homogeneity of injury severity only acute grade-2 hamstring injury 
was included in this study. However this may not be fool proof as the hamstring 
muscle group consists of four individual muscles that differ functionally and 
physiologically which might affect rate of recovery. 
 
 6. For logistical reasons we were unable to design a study with longer follow-up 
period. Hence any long-term adverse effects related to PRP therapy could not be 
assessed. 
 
 
6.7 Clinical implication 
 
Several clinical implications can be drawn from studies performed in this thesis, 
in relation to PRP used for sports related muscle injuries. First, muscle injury is one of 
the most common sports related injuries, which mainly affects muscle of the lower limb 
especially the hamstring muscle groups. Majority of muscle injuries can be classified as 
moderately severe or grade-2 injury. Further, it is comforting to know that most muscle 
injuries responded well to conservative (non-surgical) treatment.  
 
Second, muscle injury classification system that is based entirely on physical 
assessment may misclassify injury severity leading to false negative impression and 
affect injury management. A comprehensive method of muscle injury classification 
systems that combined physical assessment and radiological (ultrasound or MRI) is 
therefore recommended.  
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Third, active knee extension (AKE) test proposed demonstrated excellent 
interater and intrarater (test-retest) reliability for assessing hamstring flexibility. Further, 
with the aid of a simple, portable and inexpensive stabilising apparatus a single person 
can performed AKE test easily. So AKE test should be incorporated in the clinical 
assessment of hamstring flexibility. 
 
Fourth, delaying medical consultation by more than one-week places an athlete 
at higher risk of taking longer time to full recovery. Hence, athlete with suspected 
muscle injuries must be assessed immediately and treatment commenced within one 
week if not as soon as possible after injury onset.  
 
Fifth, progressive agility and trunk stabilisation (PATS) exercise program is 
effective for treating grade-2 hamstring muscle injury. All participants in the control 
group (PATS program alone) achieved full recovery by 71 days of follow-up period 
(median = 34.0  ± IQR 37.3 days). Therefore PATS is recommended to be included as 
part of hamstring muscle injury rehabilitation.  
 
Finally, PRP therapy combined with PATS rehabilitation program was effective 
for treating acute hamstring injury. The DRP of participants with acute grade-2 
hamstring injury was significantly shorter compared with controls. Therefore PRP can 
be used as a treatment modality for acute muscle injury. 
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6.8 Recommendations for future research 
 
Based on the encouraging findings of this study, a single PRP intralesional 
injection has a positive effect on grade-2 hamstring muscle recovery. Multicentre RCT 
is recommended in future as more participants can be recruited which increases the 
statistical power of the findings.  
 
This study proved that PRP therapy is safe as participants reported only minor 
adverse effect (pain during venesection and during PRP administration).  However, 
future study of longer follow-up is much recommended to establish more 
comprehensive assessments of both short- and long-term effects of PRP therapy. 
Further, study with longer follow-up period would also allow risk assessments of 
muscle injuries recurrence to be conducted. This is important, as the risk of recurrence 
hamstring muscle injury is great. 
 
The protocol for PRP production and the method of delivery including the dose 
and the frequency of delivery was clearly described. It is reminded that the best dose 
and frequency of PRP therapy is yet to be determined. Future study using different 
dosages and frequency of PRP injection/s is needed to find out the best methods of PRP 
therapy for muscle injury.  
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6.9 Conclusion  
 
 In accordance with the primary and secondary objectives, the following overall 
conclusions were drawn: 
 
 1. Grade-2 hamstring muscle injury is one of the commonest types of  injury among 
Malaysian athletes.  
 
 2. Single 3 ml injection of PRP that contained 5-fold increase in platelets (median 
platelet count = 1297 x 103/ μL, IQR = 51.32 x 103/ μL) combined with a 
standard rehabilitation program was safe and effective treatment for grade-2 
hamstring muscle injury. Participants treated with PRP achieved full recovery 
(DRP) at a significantly earlier duration than controls. 
 
 3. Platelet-rich plasma therapy (PRP) is significant predictor of the DRP of 
hamstring injuries. 
 
 4. Platelet-rich plasma therapy (PRP) significantly lowers participant’s pain 
severity score following hamstring injury. 
 
 5. Both PRP therapy and PATS rehabilitation program were equally effective in 
lowering the pain interference score after hamstring injury. 
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6.10 Summary  
 
  Although muscle injury occurs frequently in sports, the best treatment is not yet 
known. Muscle injury frequently affected muscle of the lower limb. Hamstring muscle 
injury was the most frequent type of injury diagnosed among Malaysian athletes. 
Majority of this injury responded well with conservative treatment, however the DRP 
among Malaysian athletes was relatively longer compared to other studies.  
 
  Sports physician and researchers used several approaches to try and hasten 
muscle recovery following injury. Unfortunately evidence to support the various 
treatment approaches is lacking. Over the past few years’ researches are turning towards 
autologous biological substances including platelet-rich plasma (PRP). It is believed 
that the myriad growth factors and cytokines released from platelets could positively 
influence muscle cells differentiation and regeneration and enhances recovery. Our 
systematic review however found limited clinical evidence to support PRP use for 
muscle injury. Lack of standardisation in PRP extraction techniques and variation in 
definition of recovery complicate comparisons between studies.  
 
  A new set of criteria to determine athlete’s readiness to return-to-play based on 
current guideline was proposed. Athletes required demonstrating improvement in 
clinical and questionnaire-based assessments before been allowed to resume to pre-
injury activities level. Clinical assessments of recovery proposed include return of 
hamstring flexibility and strength (isokinetic strength test). Hamstring flexibility was 
assessed using the active knee extension (AKE) test. This test showed excellent interater 
and intrarater reliability in healthy adults.  
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    The effect of PRP on duration to return-to-play after hamstring injury was 
studied using a RCT design. Participants randomised in the PRP group attained full 
recovery at significantly shorter period compared with controls. Further the PRP groups 
also demonstrated significantly lower pain scores compared with controls at all time 
points. The PRP therapy significantly predicts DRP even after considering ten other 
potential predictors.   
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Pattern of muscle injuries and predictors of return-to- 
play duration among Malaysian athletes 
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I N T R O D U C T IO N 
Muscle injury is one of the most common injuries affecting 
athletes.(1) It accounts for up to 28% of injuries in sports 
events.(2) Contusion and strain are two common causes of muscle 
injuries. Muscle strain often occurs during sprinting or jumping, 
when the muscle is under tension while lengthening (eccentric 
contraction).(3)  Earlier studies have identified several factors that 
predispose one to muscle injury, including a history of muscle 
strain, increasing age and leg dominance.(4-6)  Muscle injuries often 
occur at the muscle-tendon (myotendinous) junction of muscles 
that span across two joints, such as the rectus femoris, 
semitendinosus and gastrocnemius. Diagnosis and grading of 
muscle injuries are usually done through clinical assessments.(2)  
Ultrasonography (US) is recommended for localising injury and 
characterising severity of injury.(7) 
In professional sports, muscle injuries can lead to significant 
pain and disability, resulting in time away from participation 
(training and competition) and high medical costs.(8)  Athletes 
and coaches are of ten concerned about the time to full 
recover y  and  return-to -play  (RTP).  Unfor tunately,  issues 
on duration to return-to-play (DRP) are often not directly 
discussed during consultation with the medical team.(9) 
Predicting  DRP  is  not  only  impor tant  for  planning  the 
rehabilitation programme, but also for enabling the coaching staff 
to restructure the team for competitions. 
Recent studies have identified several factors that may help 
in estimating DRP.(6,10,11)  An observational study of 59 players 
from ten Victoria-based Australian Football League clubs 
showed that the time taken for an athlete to walk pain-free after a 
hamstring injury was a significant predictor of time to RTP.(12)  
That study, however, did not discuss the severity of the muscle 
injury sustained and give details of the rehabilitation programme. 
In addition, a prospective study among athletes with  grade  1– 4  
hamstring  injuries  suggested  that  active knee range of 
motion deficit was an objective and accurate measurement in 
predicting DRP.(11) 
Information on the pat tern  of  muscle  injuries  among 
Malaysian athletes is limited.(13)  Differences in physical build, 
climate, dietary intake and training regimen between Malaysian and 
foreign athletes may affect muscle injury pattern. Identifying the 
pattern of muscle injuries, including the magnitude of the 
problem, is an important initial step in injury prevention 
programmes.(14)  However, there is no information on the current 
management  of  muscle  injuries  and  the  ef fectiveness  of 
treatment (e.g. DRP) among Malaysian athletes. Hence, the aim of 
this study was to examine the pattern of muscle injuries and 
explore the predictors of DRP among Malaysian athletes. 
M E T H O DS  
A retrospective study using data extracted from athletes’ 
medical records was conducted at the National Sports Institute 
Clinic, Kuala Lumpur, Malaysia. A structured form was prepared to 
record the sociodemographic background of the athletes and 
clinical information of their injury. All of the athletes were 
1Unit of Spor ts Medicine, 2Spor ts Centre, 3 Depar tment of Or thopaedic Surger y, University of Malaya, Kuala Lumpur, Malaysia 
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INTRODUCTION The purpose of  this  study  was to investigate  the pattern of  muscle injuries and the factors that 
predict the return-to-play duration among Malaysian athletes. 
METHODS This is a retrospective  review of the case notes of athletes  who attended the National Sports Institute 
Clinic  in  Malaysia. The medical records  of  athletes  with muscle injur y,  diagnosed on  clinical assessment  and 
confirmed by diagnostic ultrasonography, were included for final  analysis. 
RESUlTS  From June 2006 to December 2009, 397  cases of  muscle injur y were diagnosed among 360  athletes. 
The median age of the athletes  with muscle injuries was 20.0 years. Muscle injuries were mostly diagnosed among 
national-level athletes and frequently involved the lower limb, specifically the hamstring muscle group. Nearly all of 
the athletes  (99.2%) were treated conservatively. The median return-to-play  duration was 7.4  weeks. Athletes  who 
waited more than one week before seeking medical attention,  those with recurrent muscle injuries and female 
athletes were significantly more likely (p < 0.05) to take more than six weeks before returning to the sport. 
CONClUSION  Grade 2  lower limb muscle injur y was commonly diagnosed among national-level  athletes  in  this 
study.  The frequency of  weekly physiotherapy  sessions  did not affect the return-to-play  duration. Factors such as 
initial consultation at  more than one week post  injur y,  recurrent  muscle injuries and  female gender  were 
significant predictors  of return-to-play  duration among Malaysian athletes.  These  predictive  factors should be kept 
in mind during clinical assessment so as to aid in prognosticating recovery after muscle injury. 
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under the care of spor ts medicine specialists. A visiting 
musculoskeletal radiologist with 14 years of experience 
performed all of the US assessments. US was conducted using an 
ACUSON Antares™ Ultrasound System (Siemens AG, Erlangen, 
Germany) with a 4-cm linear transducer set at 10 MHz. Severity of 
muscle injury was graded based on the US classification 
described by Peetrons.(15)  The University of Malaya Medical 
Centre Ethics Committee approved the study. 
The US registration records from June 2006 to December 
2009 were reviewed. The medical records of athletes diagnosed 
with muscle injuries on US were evaluated. Information on the 
athlete’s age, gender, playing level (school, club, state or 
national) and type of sport was collected. Information on 
injuries, including date of injury, date of first consultation, event 
leading to injury (training session or competition), injury severity 
and date of RTP, was also recorded. Pattern of muscle injuries, 
including injury severity, region of injury and event leading to 
injury, was reviewed. DRP following muscle injury was 
recorded. DRP was defined as the dif ference (in weeks) 
between the date on which the attending doctor allowed full 
participation in sports and the date of onset of injury. 
Data was analysed using the Statistical Package for the 
Social Sciences version 19.0 (SPSS Inc, Chicago, IL, USA). Data 
was described descriptively and a normality test was performed 
using the Shapiro-Wilk test. DRP < 6 weeks was used as the 
cutoff value for adequacy of DRP – this definition was based on a 
recent systematic review of muscle injury by Prior et al,(16)  and 
supported by the results of another study, where athletes whose 
DRP was > 6 weeks after muscle injury were found to have a 
significantly lower chance (3.1%) of sustaining repeat injury 
compared to those who resumed sports at 2 weeks (8.1%) or 3 
weeks (6.8%) post injury.(17) 
The associations between DRP and gender; age group (≥ 
18 vs. < 18 years); and duration before first consultation (≤ 1 
vs. > 1 week) were assessed using Mann-Whitney U test. Kruskal-
Wallis test was used to determine the association bet ween  
DRP  and  t ype  of  spor t;  frequency  of  weekly 
physiotherapy sessions; playing level (school, state, national or 
others); new vs. recurrent injury; region of injury (upper limb, 
lower limb or truncal muscles); and US grading of injury (grade 0–
3). Stepwise logistic regression analysis was conducted to identify 
the predictors of DRP. Variables < 0.25 on univariate testing were 
included in the multivariate logistic regression model, as 
recommended by previous researchers.(18,19)  Adjusted odds ratios 
(ORs) and 95% confidence intervals (CIs) of ORs 
were calculated, with the significance level set at p < 0.05. 
(i.e. ligaments and tendons) (n = 102). Only 360 medical records 
(237 men and 123 women) were eventually analysed. Among these 
360 athletes, 397 muscle injuries were diagnosed. The majority 
(60.6%) of muscle injuries were classified as a new injury. The 
median age of the athletes at the time of injury was 
20.0 (interquartile range [IQR] 6.0) years. 
Most injuries (90.0%) occurred among national-level 
athletes participating in various sports – track and field (30.3%), 
field hockey (17.8%), racket sports (11.4%), martial arts (6.7%), 
soccer  (5.3%),  weightlif ting  (5.0%),  g ymnastics  (4.7%), 
swimming (4.2%) and others (14.4%). Injuries were frequently 
diagnosed in muscles of the lower limb, especially the 
hamstring and adductors muscle groups (Table I). Athletes with 
a primary complaint of lower back pain (n = 29) were clinically 
assessed, and plain radiography of the lumbosacral region was 
performed to rule out any bony pathology. Magnetic resonance 
(MR) imaging was performed in three cases, as the clinical 
assessments led to suspicions of neurological involvement; this 
was in accordance with the clinical practice guidelines by the 
American College of Physicians and American Pain Society.(20)  
MR imaging was unremarkable in two athletes, while a 
sacrospinalis tear was demonstrated in the third. All athletes 
subsequently underwent US assessment of the lumbosacral 
region using a simple grading system for severity.(15,21) 
The median time to first consultation was 7.0 (IQR 12.0) days 
after injury, and the median time before US evaluation was 17.0 
(IQR 29.0) days. Out of a total of 397 muscle injuries, grade  2  
muscle  injur y  was  diagnosed  in  368  (92.7%) athletes, 
grade 1 in 26 (6.5%) and grade 3 in 3 (0.8%). Most (93.9%) injuries 
occurred while the athletes were performing sports-related 
activities, with the majority (82.5%) occuring during training or 
practice sessions. A large number of track and field athletes 
(69.7%) sustained muscle injuries during sprinting; the injuries 
occurred less frequently during jumping (13.8%) and weight 
training (5.5%). Similar results were observed among the field 
hockey athletes, whose muscle injuries occurred primarily during 
sprinting (75.0%). In contrast, approximately 40% of the racket 
sport athletes sustained injury during jumping activities (e.g. 
jumping smash). 
Nearly all athletes (99.2%) were treated conservatively (i.e. 
nonsurgical intervention). Most (66.4%) received a short course (< 
1 week) of analgesia (e.g. nonsteroidal anti-inflammatory drugs) 
combined with at least one form of electrotherapeutic modality. 
Only three athletes with complete muscle rupture underwent 
surgical intervention. Documented dates of RTP were available 
for only 168 athletes, while that for the remaining 
192 athletes were unavailable as they were lost to follow-up. 
Approximately 40% (n = 67) of athletes were allowed full 
RTP within six weeks after injury. DRP ranged from 1 to 72 
weeks, with a median of 7.4 (IQR 8.5) weeks. No significant 
differences in DRP across the type of sport (H(26) = 25.32, 
p = 0.50) and frequency of weekly physiotherapy session R E S U lTS  
A total of 562 medical records of athletes with suspected muscle 
injuries were screened. Of these, 202 medical records were 
excluded from analysis for the following reasons: incomplete 
medical information (n = 25); missing US report (n = 75); and 
injuries involving structures other than muscles 
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Table I. Muscle injuries (n = 397) according to body region. Ta b le I I . Fa c to r s a s s o c iate d  wit h  d u r atio n  to  re tu r n - to - p l ay 
a m o n g  p a t i e n t s w i t h  d o c u m e n t e d  d a t e o f  r e t u r n - t o - p l a y 
(n = 16 8). 
Body  region/muscle group No. (%) 
Factor No. (%) U*/χ2 † p-value 
Male 107  (63.7) 
< 18 52  (31.0) 2,730 0.32 
*Anterior tibialis, posterior tibialis, peroneal muscles; †Pectoralis, rhomboids, 
small muscles of  the hand; ‡E x ter nal  obliques, tr ansversus abdominis; 
§Erector spinae, quadratus lumborum 
(H(3) = 0.44, p = 0.93) were found. In most cases, a physiotherapy 
session  t ypically  star ted  with  range  of  motion  exercises 
(stretching), followed by progressive muscle strengthening 
activities and cryotherapy at the end of the session. In addition, the  
treating  physiotherapist s  of ten  incorporated  various 
electrotherapeutic modalities during these sessions. Further 
analysis revealed that athletes who were lost to follow-up were 
significantly older (U = 13197, z = −3, p = 0.03). 
A moderate, significantly positive relationship was found bet 
ween  time  to  first  consultation  and  DRP  (U  =  2023, p < 
0.001). A significant relationship between DRP and muscle region 
(limb versus trunkal) was also demonstrated (χ2  = 6.8, p = 0.04) 
(Table II). 
Gender, time to first consultation, injury type (new vs. 
recurrent), injury severity, number of injured muscles and side 
of injury were factors that met the criteria for inclusion in  the  
multivariate  model.  Delay  in  first  consultation  of more than 
one week, recurrent muscle injuries and female gender were 
identified as predictors of DRP of > six weeks (Table III). No 
interactions were noted between the predictors. 
All other variables were eliminated by the stepwise procedure. 
*Mann-Whitney U test †Kruskal-Wallis test 
US: ultrasonography 
D I S C US S I ON  
In this study, grade 2 muscle injury was the most common form 
of injury diagnosed among national-level athletes. We also found 
that the muscle injuries often affected the lower limb, especially 
the hamstring muscle groups. Similar findings were also noted in a 
study conducted among intercollegiate hockey  players.(22)   Fur 
thermore,  lower  extremit y  muscle strain was the most 
frequent injury diagnosed at the 2007 
International Association of Athletics Federations World 
Athletics Championships.(23)  Excessive tensile force on muscle 
fibres during fast bursts of speed has been suggested to be 
the main cause of muscle injury. Such an injury predominantly 
af fects muscles that span two joints, such as the biceps 
femoris, semimembranosus, semitendinosus, gastrocnemius 
and rectus femoris.(24) 
The pattern of muscle injuries among Malaysian athletes is 
comparable to that reported in other studies.(22,23)  However, the 
median DRP of 7.4 (IQR 8.5) weeks among the athletes in this 
study is longer than that in earlier studies.(6,25) A study conducted by 
Malliaropoulos et al in Greece reported a mean time loss from 
training and competition of 14.7 days among elite-level track-and-
field athletes.(25)  This shorter DRP could be explained by the higher 
proportion (64.5%) of low-grade muscle injury (grade 1) in 
Malliaropoulos et al’s study.(25)   Another study on hamstring 
injury among Australian footballers reported a 
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Gender* 2,898 0.23 
 
Female                                        61  (36.3) 
 
Age  group (yrs)* 
 
≥ 18                                                   116  (69.0) 
 
Time to first 
consultation (wk)* 
≤ 1                                                       91  (54.2)       2,023       < 0.001 
> 1                                                       77  (45.8) 
 
Injury type* 
New                                                   104  (61.9)        2,908          0.17 
Recurrent                                   64  (38.1) 
 
Injurious event* 
Traumatic                                          10  (6.0)          646                0.34 
Nontraumatic                            158  (94.0) 
 
Injury grade (via  US)* 
Grade 1                                              12  (7.1)          681                0.12 
Grade 2                                           156  (92.9) 
 
No. of muscles injured* 
1                                                        147  (87.5)        1,144          0.07 
2                                                           21  (12.5) 
 
Activity leading to injury† 
Training                                       140  (83.3)        0.69            0.71 
Competition 26  (15.5) 
Others   2 (1.2) 
Affected side† 
Right                                                    73  (43.5)        3.50            0.18 
Left 84  (50.0) 
Bilateral 11  (6.5) 
Affected region† 
Upper limb                                        31  (18.5)       6.8                  0.04 
Lower limb  121  (72.0) 
Truncal  16  (9.5) 
level of play† 0.24 
National                                     155  (92.3)                           0.97 
State                                          3 (1.8) 
School                                          7 (4.2) 
Others                                         3 (1.8) 
Physiotherapy session† 
Daily                                                 119  (70.8)        0.60            0.90 
Weekly                                                22  (13.1) 
Twice  a week                              21  (12.5) 
Thrice a week                               6 (3.6) 
lower limb 
Hamstring 145  (36.5) 
Adductor    43  (10.8) 
Calf     49  (12.3) 
Quadriceps    31  (7.8) 
Others*    11  (2.8) 
Upper  limb 
Deltoid                                                                      15  (3.8) 
Biceps 6 (1.5) 
Triceps                                                                                    4 (1.0) 
Rotator cuff                                                                         15  (3.8) 
Others† 
 
Abdomen 
Rectus abdominis 
Others‡ 
 
Back 
Muscles of the back§ 
35  (8.8) 
 
12  (3.0) 
2 (0.5) 
 
29  (7.3) 
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Table III. Predictors of duration to full return-to -play of more than  six weeks after muscle injur y. 
Determinant B (SE) p-value Adjusted OR 95%  CI 
SE: standard error; OR: odds ratio; CI: confidence interval 
median time of 26 days before the injured athletes returned to 
competition.(6)   However, the authors of that study did not 
describe the severity of muscle injury suffered by the athletes. 
The present study found that athletes who delayed medical 
consultation by more than one week (after the onset of injury) had 
a significantly higher likelihood of taking more than six weeks to 
recover compared to those who sought treatment earlier. In a 
study by Askling et al, a median DRP of 31 weeks was reported 
among 30 elite-level Swedish athletes who presented  12  
weeks  af ter  sustaining  hamstring  injuries, with 47% of the 
athletes making the decision to retire after a follow-up period 
of 63 weeks.(26) Early management of muscle injuries was shown 
to affect the extent of injury and the amount of scar tissue 
formed, which influences the duration of muscle healing.(1,27,28)  
Early immobilisation (less than one week) has been shown to limit 
the size of connective tissue (scar) formed within the site of injury 
in rat gastro- cnemius muscle.(27) In addition, early use of 
cryotherapy hastens regeneration and has been associated with 
significantly smaller haematomas, less inflammation and less 
tissue necrosis.(1,29) Educating  athletes  on  the  impor tance  of  
early  medical consult ation  following  injur y  and  
improving  me dic al accessibility (e.g. having readily available 
onsite medical team support) may help to shorten the duration 
between the time of injury and the first consultation, which may 
in turn positively affect DRP. 
History of previous muscle injury is one of the most 
important risk factors for subsequent muscle injury. Athletes 
with a history of muscle strain are two to six times more likely to 
experience recurrent strains.(5,12)  Some possible explanations for this 
observation include reduced tensile strength of scar tissue, 
decreased muscle strength, diminished muscle flexibility, as well as 
possible adaptive changes in the biomechanics and motor patterns 
of movements after injury.(22)  Moreover, the current study found 
that athletes with a history of muscle injury were more likely to 
take more than six weeks to return to play than those with a new 
injury. A significantly longer recovery time was observed among 
National Football League athletes with hamstring re-injuries (56 
days) compared to those with first- time hamstring injury (16.5 
days).(30)  In a laboratory study, the lack of activated myogenic 
satellite cells within the fibrotic discontinuit y  area  (scar  
tissue)  was  suggested  to  be  the phenomenon responsible for 
the delay in healing of recurrent muscle injuries.(31) 
Female athletes with muscle injuries in the present study 
took a longer time (more than six weeks) to recover compared 
to male athletes. While the reason for this is unclear, it could 
be due to the difference in the circulating sex hormones 
between males and females. It has been found that there are 
significantly fewer inflammatory cells (neutrophils and 
granulocytes) infiltrating the vastus lateralis muscle of female 
university students after a standardised pain-inducing eccentric 
exercise compared to males.(32)  Infiltration of the muscle with 
leucocytes and macrophages is important for satellite cell 
activation and initiation of muscle regeneration. Therefore, the 
oestrogen-attenuating effects on leucocyte infiltration may delay 
important stages in muscle recovery.(33-35)  Bell et al 
demonstrated the presence of significant hamstring muscle 
extensibility changes throughout the different phases of the 
menstrual cycle,(36)  which may increase the likelihood of 
sustaining acute hamstring injury, as was demonstrated in 
Watsford et al’s study.(37) 
Interestingly, the frequency of physiotherapy sessions did not 
affect the DRP in our study. Contrary to our findings, 
Malliaropoulos et al demonstrated that athletes diagnosed with  
hamstring  injur y  who  under went  a  more  intensive 
stretching programme had a statistically significant shorter time 
of recovery.(38)  It should be noted that an optimal method for the 
treatment of muscle injury has yet to be identified.(39) 
Consequently, the treating physiotherapists in our study used 
different treatment protocols based on anecdotal reports and 
personal experience. The treatment protocols differed with 
respect to the type and sequence of activities prescribed, 
duration of the treatment session and the use of electro- 
therapeutic modalities, further complicating comparisons 
among the different regimens. 
The high loss to follow-up rate of about 53% is of major 
concern, especially when it involves national-level athletes. It 
is, however, possible that the athletes who defaulted had 
recovered from their injuries, retired or sought treatment 
elsewhere. A prospective study to explore the factors associated 
with loss to follow-up is currently underway. It should also be 
noted that the reliability and accuracy of US in diagnosing acute 
back muscle strain is still not documented.(40)  Hence, it is 
possible that other conditions such as abnormalities of the 
intervertebral discs and facet joints were missed or overlooked 
in these athletes. This study has demonstrated that the timing of 
first consultation, past history or recurrence of muscle injury, 
and female gender were useful factors in predicting the DRP 
among Malaysian athletes. 
In conclusion, grade 2 lower limb muscle injury was the 
most common type of injury diagnosed among the national- 
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Time  to consultation > 1 wk  1.29 (0.32) < 0. 
Recurrent injuries 0.76 (0.37)    0. 
Female gender 0.74 (0.37) 0. 
001  3.63 1.80–7.30 
 
038  2.14 1.04–4.38 
 
048  2.09 1.01–4.34 
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level athletes in our study. The athletes with muscle injuries 
were conservatively treated, with a median DRP of 7.4 weeks. This 
study has identified several predictors of DRP of more than six 
weeks post muscle injury – time to first consultation of more 
than one week, recurrent muscle injury and female gender. 
These factors are important and should therefore be 
considered during early assessments of muscle injuries. Strategic 
steps need to be taken to ensure early consultation and treatment as 
soon as an injury occurs. It is important to increase awareness of 
the factors associated with extended DRP among athletes, coaches 
and practitioners involved in the care of athletes. A prospective 
study with a larger sample size could better show the associations 
between clinical assessments and outcomes, including potential 
variables with small to moderate effects. Such a study is being 
planned for the near future. 
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Interrater and Intrarater Reliability of the Active 
Knee Extension (AKE) Test among Healthy Adults 
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Abstract.    [Purpose] The purpose of this study was to determine the reliability of the active knee extension (AKE) 
test among healthy adults. [Subjects] Fourteen healthy participants (10 men and 4 women) volunteered and gave 
informed consent. [Methods] Two raters conducted AKE tests independently with the aid of a simple and inexpen- 
sive stabilizing apparatus. Each knee was measured twice, and the AKE test was repeated one week later. [Results] 
The interrater reliability intraclass correlation coefficients (ICC2,1) were 0.87 for the dominant knee and 0.81 for 
the nondominant knee. In addition, the intrarater (test-retest) reliability ICC3,1 values range between 0.78–0.97 and 
0.75–0.84 for raters 1 and 2 respectively. The percentages of agreement within 10° for AKE measurements were 
93% for the dominant knee and 79% for the nondominant knee. [Conclusion] The finding suggests the current AKE 
test showed excellent interrater and intrarater reliability for assessing hamstring flexibility in healthy adults. 
Key words: Hamstring, Flexibility, Range of movement 
(This article was submitted Feb. 13, 2013, and was accepted Mar. 29, 2013) 
conducted within 30 minutes16, 20). Others though, question 
the practicality of such method, as the apparatus used by 
researchers are complicated, rarely available in a clinical 
setting, and require more than one assessor to conduct the 
test21, 22). Therefore, a simple and reliable method of ham- 
string flexibility assessment that ensures pelvic and leg sta- 
bility during measurement is needed. 
We designed and made a simple, portable and easy-to- 
use stabilizing apparatus for use in performance of the 
AKE test. The apparatus was made using polyvinyl chlo- 
ride (PVC) hollow tubes. PVC tubes were selected because 
they are light, easily cut, commonly available in hardware 
stores, and inexpensive. When used with a universal goni- 
ometer, this apparatus allows measurement in the AKE test 
to be conducted by a single assessor without assistance. 
The objective of this study was to determine the inter- 
rater and intrarater reliability of the AKE test using a PVC 
stabilizing apparatus for hamstring flexibility assessment in 
healthy subjects. 
INTRODUCTION 
Hamstring muscle injury is one of the commonest sports 
injuries among athletes1, 2). Based on the literature, risks of 
hamstring muscle injury include previous injury, strength 
imbalance, older age, inadequate warm-up, poor quadriceps 
flexibility and muscle fatigue1–5). Another possible cause of 
hamstring injury is muscle tightness. This factor remains 
inconclusive, as studies have shown conflicting results6 –10). 
Despite  this,  hamstring  flexibility is  recommended  dur- 
ing routine pre-participation examinations and in deciding 
athlete readiness to return-to-play following injury11–13). 
Therefore, a simple and reliable method of hamstring flex- 
ibility assessment is relevant. 
Methods to assess hamstring flexibility include the 
straight-leg-raising (SLR) test, sit and reach (SR) test, and 
active knee extension (AKE) test14–16). The SLR test speci- 
ficity has been questioned, as it is also widely used as a 
neurological test17). Further, cinematographic study showed 
that pelvic rotation may influence the validity of SLR angle 
measurements18). Even though hamstring flexibility assess- 
ment is easy using the sit and reach (SR) test, the validity 
of this test is considered poor19). The AKE test is an ac- 
tive test that involves movement at the knee joint, and most 
considers it safe, as the patient dictates the end point of 
movement. Further, the AKE test aided by a metal rig and 
straps to limit pelvic and leg motion (as a stabilizing appa- 
ratus) showed a high intrarater correlation coefficient when 
SUBJECTS AND METHODS 
The University of Malaya Medical Centre Ethics Com- 
mittee approved the study (MEC Ref no. 835.11). A con- 
venient sample of 16 healthy participants (10 men and 6 
women) with ages ranging from 28 to 39 years was used in 
this study. Participants were Sports Medicine postgraduates 
and staff at the Faculty of Medicine, University of Malaya. 
All participants were free from any orthopaedic or neuro- 
logical disorders. 
We designed a simple, portable apparatus made up of 
PVC tubes (total cost of USD 6.00) to aid in performance 
*To whom correspondence should be addressed. 
Email: ayip@um.edu.my 
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Fig. 1. Flexion of the knee until the thigh touches 
the horizontal PVC bar 
Fig. 2.  Knee position during the AKE test 
of the AKE test. The apparatus is based on those used by 
an earlier study16). It consisted of a single horizontal bar 
anchored (removable) by two vertical poles on either side 
of the plinth. Assessments were conducted at the Sports 
Medicine Clinic, University of Malaya Medical Centre. To 
ensure that all participants would be assessed in the stan- 
dard manner, both assessors attended a half-day workshop 
on the AKE test using the PVC stabilizing apparatus. The 
AKE testing procedure was described to all participants, 
and each provided informed consent. The AKE measure- 
ments were taken for both knees. The dominant knee was 
determined based on the participant’s preferred leg when 
kicking a ball or when performing a single-leg jump, while 
the other knee was considered the nondominant knee; a pre- 
vious researcher used a similar definition23). 
A sports physician (SAH) and a physiotherapist (LPC) 
performed all the AKE tests independently. All assess- 
ments were conducted at the Sports Medicine Clinic of the 
University of Malaya Medical Centre between 9.00 and 
11.00 am at room temperature. Participants were advised 
to avoid any sporting activities on the day of assessment. 
As previous study demonstrated changes in biomechanical 
characteristics of collagen and muscle viscoelastic proper- 
ties, no warming up activities were allowed24). Participants 
were assessed on a plinth in the supine position with both 
lower extremities extended. Both anterior superior iliac 
spines were positioned by aligning them with the verti- 
cal bars of the apparatus. The lower extremity not being 
measured was secured to the plinth using a strap across the 
lower third of the thigh. Each assessor marked the lateral 
knee joint line with washable ink. From there, two lines 
were drawn. The first was drawn to the greater trochanter, 
and another to other was drawn to the apex of the lateral 
malleolus. The participants were told to flex the hip until 
the thigh touched the horizontal PVC bar (Fig. 1). While 
maintaining the contact between the thigh and horizontal 
PVC bar, the participants were asked to extend the leg as 
much as possible while keeping their foot relaxed and to 
hold the position for about 5 seconds. A standard univer- 
sal goniometer was placed over the previously marked joint 
axis, and the goniometer arms were aligned along the femur 
and fibula (Fig. 2). 
The AKE measurement was defined as the degree of 
knee flexion from terminal knee extension. Each knee was 
measured twice, and the mean angle of the AKE test was 
used for analysis. All participants attended two testing ses- 
sions one week apart to allow for establishment of test-re- 
test reliability of the method. The order in which the rater 
assessed the participants was randomly assigned in the first 
session and maintained thereafter. 
All data were analyzed using the Statistical Package for 
the Social Sciences (SPSS) version 20.0 software. Data were 
described descriptively, and a normality test was performed 
using the Shapiro-Wilks test. Paired t-tests were performed 
to compare differences between tests and retest measure- 
ments within and between raters. 
Two different types of measures of reproducibility were 
assessed: measures of agreement and measures of reliabil- 
ity. The interrater agreement was quantified by calculating 
the mean difference between the two raters (rater 1 − rater 
2) and the standard deviation (SD) of this difference. Fur- 
ther, the 95% limits of agreement were calculated according 
to the method of Bland and Altman25). These limits repre- 
sent the range in which 95% of the differences between the 
two raters fall. 
Plots of differences between raters against the corre- 
sponding mean of the two raters for each participant were 
produced to examine homoscedasticity as proposed by 
Bland-Altman25). Further, the frequency of agreement of 
the raters within 5° and 10° was calculated. Differences ex- 
ceeding 10° were determined as being unacceptable, as a 
previous study suggested they are likely to affect decisions 
on patient management26). 
The reliability was evaluated by computing intraclass 
correlation coefficients (ICCs), which analyzed the consis- 
tency of quantitative measures. An ICC based on a two-way 
random model was used to establish test-retest reliability, 
while an ICC based on a two-way mixed model was chosen 
for intrarater reliability27). The ICC value of the standard 
error of measurement (SEM) was calculated to express the 
magnitude  of  disparity  between  measurements28).  SEM 
was calculated using the formula , SEM = SDavg (√1−ICC) 
where SD corresponds to the pooled standard deviation and 
ICC is the reliability coefficient29). A smaller SEM value 
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Table 1.  Descriptive data of participants’ physical characteristics 
All participants Male 
Mean (SD) 
Female 
Mean (SD) Mean (SD*) Variables Range 
Age (years) 
Body weight (kg) 
Height (cm) 
Body mass index (BMI) 
AKE† dominant knee (°) 
AKE nondominant knee (°) 
31.5 (2.8) 
71.6 (13.5) 
168.4 (6.1) 
25.1 (3.5) 
24.9 (9.3) 
23.7 (8.1) 
28–39 
54–100 
159–181 
19.1–31.8 
10.0–45.0 
12.5–39.0 
32.3 (3.0) 
77.7 (12.9) 
170.9 (5.8) 
26.5 (3.4) 
26.6 (10.8) 
26.1 (9.3) 
30.5 (2.4) 
63.4 (10.3) 
165.0 (4.9) 
23.2 (3.0) 
22.8 (7.2) 
20.6 (5.3) 
*SD, standard deviation 
†AKE, active knee extension 
Table 2.  Mean, SD, and the frequency of agreement within 5 and 10 degrees 
AKE* test Rater 1 
Mean (SD*) 
Rater 2 
Mean (SD) 
Rater 1 – 2 
Mean (SD) 
Upper and lower limit 
of agreement 
Rate of agreement 
(%) 
5° 10° 
Dominant knee (°) 
Nondominant knee (°) 
24.9 (9.3) 
23.7 (8.1) 
24.8 (10.1) 
24.9 (7.2) 
0.1 (6.9) 
−1.1 (7.2) 
−13.4 – 13.6 
−15.2 – 13.0 
43 
43 
93 
79 
*AKE, active knee extension 
†SD, standard deviation 
Fig. 3. Bland-Altman plot of the differences versus means 
of the dominant knee AKE measurements 
Fig. 4. Bland-Altman plot of the differences versus means 
of the nondominant knee AKE measurements 
suggests greater agreement between measurements30). The 
minimum detectable change (MDC) was calculated using 
the formula MDC = 1.96 × SEM × √231). 
addition, no significant difference was observed between 
test and retest sessions for both dominant (t=0.77, p=0.46) 
and nondominant (t=–1.01, p=0.33) knees. 
A summary of the interrater agreement observed in this 
study is displayed in Table 2. Both raters had similar AKE 
measurements, with the limits of agreement being 0.1 ± 
12.9 (SD) for the dominant knee and −1.1 ± 15.7 for the non- 
dominant knee. The percentages of agreement within 10° 
for these measurements were 93% and 79% for the domi- 
nant and nondominant knees respectively. 
The AKE measurement differences between raters were 
plotted against the mean value of both raters for both the 
dominant and nondominant knees (Fig. 3 and 4). Errors of 
measurement for both knees were independent of the mag- 
nitude of the range of measurements (homoscedasticity) 
RESULTS 
Fourteen  (8  men  and  6  women)  participants com- 
pleted the test and retest sessions. Two participants were 
excluded from the final analysis, as one suffered a ham- 
string injury and the other was involved in a road traffic 
accident. A significant difference in body weight between 
male (mean=77.69, SD=12.86) and female (mean=63.42, 
SD=10.27) participants was found (t=2.23, p=0.046; Table 
1). There was no significant difference in AKE measure- 
ments between the dominant and nondominant knees. In 
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Table 3.  Interrater reliability of the AKE test 
AKE* measurements ‡ § || Rater 1, mean 
(SD†) 
Rater 2, mean 
(SD) 
p value ICC2,1 95% CI  ICC SEM 95% CI 
SEM 
Dominant knee (o) 
Nondominant knee (o) 
24.9 (9.3) 
23.7 (8.1) 
24.8 (10.1) 
24.9 (9.5) 
0.95 
0.56 
0.87 
0.81 
0.58 – 0.97 
0.41 – 0.94 
3.5 
3.8 
18.0 – 31.7 
16.9 – 31.7 
*AKE, active knee extension test 
†SD, standard deviation 
‡ICC, intraclass correlation coefficient 
§CI, confidence interval 
||SEM, standard error measurement 
Table 4.  AKE test-retest reliability of raters 1 and 2 
§ Session 1, mean 
(SD†) 
Session 2, mean 
(SD) 
95% CI 
ICC 
95% CI 
SEM 
AKE* test Rater p value ICC3,1 
‡ SEM || 
AKE dominant 
knee (o) 
AKE nondominant 
knee (o) 
1 
2 
1 
2 
24.9 (9.3) 
24.8 (10.1) 
23.7 (8.1) 
24.9 (9.5) 
24.0 (6.8) 
22.3 (6.2) 
25.2 (8.6) 
23.1 (5.9) 
0.46 
0.21 
0.33 
0.31 
0.92 
0.78 
0.88 
0.82 
0.76 – 0.97 
0.32 – 0.92 
0.45 – 0.92 
0.46 – 0.94 
2.3 
3.9 
2.9 
3.3 
19.9 – 29.0 
16.0 – 31.2 
18.8 – 30.2 
17.5 – 30.5 
*AKE, active knee extension test 
†SD, standard deviation 
‡ICC, intraclass correlation coefficient 
§CI, confidence interval 
||SEM, standard error measurement 
The AKE measurements of raters 1 and 2 from the first 
testing session were compared (Table 3). No significant dif- 
ference between raters was noted for both lower limbs. The 
AKE test interrater reliability was excellent, with ICC2,1 
values of 0.87 (0.58–0.97; 95%CI) for the dominant knee 
and 0.81 (0.41–0.94; 95%CI) for the nondominant knee and 
standard error of measurement (SEM) values of 3.5° (18.0°– 
31.7°; 95%CI) and 3.8° (16.9°–31.7°; 95%CI) respectively. 
Minimal detectable change was between 9.7° and 10.5°. 
No significant difference in mean AKE measurements was 
noted between the first and second testing sessions for both 
raters (Table 4). The ICC3,1 values ranged from 0.78 to 0.92. 
with ICC3,1 values ranging from 0.78 to 0.92 for both raters. 
Our finding is in agreement with earlier studies. Gajdosik 
reported a Pearson product-moment correlation coefficient 
for the AKE test of 0.99 for both lower extremities33). The 
higher reliability coefficient value could be explained by 
the different statistical analysis used. Further, the interval 
between the first AKE test and the retest session was very 
short. Both AKE tests were conducted on the same day 30 
minutes apart, and this may have introduced systematic 
bias and affected reliability2). We chose an interval of one 
week between the test and retest AKE assessment because 
it reflects our clinical practice, as majority of cases are re- 
viewed a week apart. 
Using the mean value of AKE measurements from both 
knees, Gabbe reported excellent test-retest reliability, with 
ICC3,1 values of 0.94–0.9629). In contrast to Gabbe et al., the 
current study evaluated each knee separately to explore any 
potential differences between the dominant and nondomi- 
nant knees, and such differences in method may explain the 
wider ICC3,1 values noted in this study. Further, the current 
study found no significant difference in AKE measurement 
between the dominant and nondominant knees of healthy 
individuals. 
Similarly, a pilot study conducted by Davis reported 
excellent intrarater reliability of the knee extension angle 
(KEA) test, with an ICC3,1 of 0.9432). The method of ham- 
string flexibility assessment employed by the previous au- 
thor differs from that in the current study. In the former 
study, measurements were taken from two gravity incli- 
nometers placed immediately superior to patella, and an- 
other was placed on the distal anterior tibia of the patient’s 
lower extremity. In addition, the examiners performed hip 
flexion and knee extension passively, whereas participants 
DISCUSSION 
Despite conflicting findings concerning the association 
of poor hamstring flexibility and the risk of hamstring mus- 
cle injury, assessment of hamstring flexibility is routinely 
conducted. Hamstring flexibility assessment is useful, es- 
pecially in deciding an athlete’s readiness to return-to-play 
following injury11–13). The AKE test is considered by some 
to be the gold standard for hamstring flexibility assess- 
ment32). 
With the aid of a simple stabilizing apparatus and a uni- 
versal goniometer, we showed that a single assessor can 
conduct the AKE test easily. Interrater reliability ICC2,1 
values of 0.87 and 0.81 were found for the dominant and 
nondominant knees respectively. Further, the device also 
produced a standard error of measurement of 3.5° for the 
dominant knee and 3.8° for the nondominant knee. In ad- 
dition, a good level of agreement between raters was es- 
tablished. 
The test-retest reliability in this study was excellent, 
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actively performed all movements in the current study. 
Our finding concerning interrater reliability was con- 
sistent with those reported by earlier studies29, 34). Gabbe 
reported an interrater reliability ICC2,1 of 0.93 and 4° SEM 
for the AKE test in 15 healthy participants of comparable 
age group (mean age: 31.6 years)29). Similarly, in a study 
to determine the effect of pelvic positioning and stretching 
method on hamstring flexibility, Sullivan reported an inter- 
rater reliability ICC1,1  and SEM of 0.93 and 4.81° respec- 
tively for the AKE test among 12 healthy subjects34). On the 
other hand, Rakos et al. performed the AKE test with aid of 
an intricate stabilizing apparatus and demonstrated a good 
interrater reliability with an ICC2,1 of 0.79 among children 
age 10 to 13 years old22). 
Despite demonstrating excellent interrater and test-retest 
reliability, a wide range of CIs was noted for some of the 
point estimates. Such findings, suggests that further re- 
search with larger samples may be necessary to determine 
the reliability estimates with greater precision35). Second, 
the reliability displayed in this study was based on assess- 
ment in healthy and uninjured volunteers. Whether the 
AKE test would be as reliable in a population of injured 
athletes remains unanswered. The AKE test might still be 
useful, especially during the preseason assessment, as most 
athletes are free from injury at the beginning of the season. 
The current study demonstrated that the AKE test can 
be performed easily by a single assessor with a simple, por- 
table, and inexpensive stabilizing apparatus and have excel- 
lent interrater and intrarater reliability. 
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Enhancing muscle healing using platelet-rich plasma (PRP) injection 
ISRCTN 
 
ClinicalTrials.gov 
identifier 
 
Public title 
 
Scientific title 
ISRCTN66528592 
Enhancing muscle healing using platelet-rich plasma (PRP) injection 
 
Platelet-rich plasma (PRP) injection for the treatment of grade-2 muscle injury: A randomised single 
blinded clinical trial 
 
PRP- RTP 
 
835.11 
 
1. There is a significant difference in the recovery time following acute muscle injury in patient 
receiving platelet-rich plasma (PRP) injection therapy compared with patient receiving rehabilitation 
therapy only. 
2. The PRP intervention group will demonstrate a faster duration to return-to-play (RTP) than the 
control group. 
 
Lay summary under review 1 
 
Medical Ethics Committee, University Malaya Medical Centre approved on 25 February 2011, MEC 
Ref. No: 835.11 
 
Randomised single blinded trial 
 
Malaysia 
Acronym 
 
Serial number  at source 
 
Study hypothesis 
Lay summary 
 
Ethics approval 
Study design 
 
Countries of 
recruitment 
Disease/condition/study Muscle injury 
domain 
Participants - inclusion 
criteria 
1. 18 years old and above 
2. Acute muscle injury (less than 1 week) 
3. Able to understand study protocol and informed consent 
 
1. Received any form of injection therapy 
2. Using non-steroidal anti-inflammatory drugs (NSAIDs) within 1 week prior to randomisation 
3. Unable to fulfill follow-up schedule 
4. Significant cardiovascular, renal, hepatic disease, malignancy, history of anemia or previous muscle 
surgery 
 
01/11/2011 
 
01/01/2013 
 
Completed 
 
Not available in web format, please use the contact details below to request a patient information 
sheet 
 
30 
Participants - exclusion 
criteria 
Anticipated start date 
 
Anticipated end date 
 
Status of trial 
 
Patient information 
material 
 
Target number  of 
participants 
 
Interventions Eligible injured athletes were randomised using computer block randomisation software into two 
groups. 
1. Control group (C) 
2. PRP group (PRP) 
Control group 
Participants in the control group will receive a standard physiotherapy treatment (attended by a 
trained sports physiotherapist). This consists of the use of cryotherapy, range of motion (ROM) and 
muscle strengthening exercises. In addition the use of non-steroidal anti-inflammatory drugs 
(NSAIDs) will not be allowed throughout the study. The use of oral paracetamol however is allowed. 
PRP group 
In addition to the standard physiotherapy treatment participants in this group will receive a single PRP 
(3 mls) injection into the site of injury. The PRP will be extracted from participant’s own blood. The use 
of non-steroidal anti-inflammatory (NSAIDs) will not be allowed throughout the study. The use of oral 
paracetamol however is allowed. 
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Primary outcome 
measure(s) 
1. Duration to full recovery (return-to-play) 
Criteria to RTP 
1.1. Muscle strength: At or near pre-injury levels or symmetrical with unaffected site 
1.2. Range of motion: At or near pre-injury levels or symmetrical with unaffected site 
1.3. Tenderness: Injury site should be non-tender 
1.4. Inflammation or swelling: No swelling or inflammation 
Outcomes are measured on a weekly basis until full recovery of the end of week 16 
 
1. Level of platelets - blood and PRP 
2. Level of growth factors in PRP 
2.1. Insulin-like growth factor (IGF-1) 
2.2. Transforming growth factor (TGF)-beta 
2.3. Basic ( fibroblast growth factor) FGF 
2.4. Platelet-derived growth factor (PDGF) 
3. Isokinetic muscle strength 
4. Brief pain inventory - Short form (BPI-SF) 
Secondary outcome 
measure(s) 
Outcomes are measured on a weekly basis until full recovery of the end of week 16 
 
University of Malaya (Malaysia) Sources  of funding 
Trial website 
Publications 
Contact  name 
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1. 2012 protocol in http://www.ncbi.nlm.nih.gov/pubmed/22866670 
 
Dr  Mohamad Shariff A Hamid 
Unit of Sports Medicine 
Faculty of Medicine 
University of Malaya 
Kuala Lumpur 
50603 
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+60 (0)3 7967 4968 
+60 (0)3 7967 7511 
ayip@um.edu.my 
University Malaya Medical Centre (Malaysia) 
Unit of Sports Medicine 
Faculty of Medicine 
University of Malaya 
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+60 (0)3 7967 4968 
+60 (0)3 7967 7511 
ayip@um.edu.my 
http://www.ummc.um.edu.my 
16/08/2011 
18/03/2013 
25/08/2011 
City/town 
Zip/Postcode 
Country 
Tel 
Fax 
Email 
Sponsor 
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Country 
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Platelet-rich plasma (PRP): an adjuvant to hasten 
hamstring muscle recovery.  A randomized 
controlled trial protocol (ISCRTN66528592) 
 
Mohamad  Shariff A Hamid1,2*, Mohamed Razif Mohamed Ali1†, Ashril Yusof3†  and John George4† 
Abstract 
 
Background:  Muscle injuries are one of the commonest injuries affecting athletes. It often leads to significant pain 
and disability causing loss of training and competition time. With current treatment, the duration to return-to-play 
ranges form six weeks to never, depending  on injury severity. Recent researches have suggested that autologous 
platelet-rich plasma (PRP) injection into the injured site may hasten soft tissues healing. To-date, there has been no 
randomised clinical trials to evaluate the effects of PRP on muscle healing. The aim of this study is to examine the 
effects of autologous PRP on duration to return-to-play after muscle injury. 
Methods  and design:  A randomised, single blind controlled trial will be conducted. Twenty-eight patients aged 
18 years and above with a recent grade-2 hamstring injury will be invited to take part. Participants  will be 
randomised to receive either autologous PRP injection with rehabilitation programme, or rehabilitation programme 
only. Participants will be followed up at day three of study and then weekly for 16 weeks. At each follow up visit, 
participants will be assessed on readiness to return-to-play using a set of criteria. The primary end-point is when 
participants have fulfilled the return-to-play criteria or end of 16 weeks. 
The main outcome measure of this study is the duration to return-to-play after injury. 
Conclusion: This study protocol proposes a rigorous and potential significant evaluation of PRP use for grade-2 
hamstring injury.  If proven effective such findings could be of great benefit for patients with similar injuries. 
Trial registration: Current Controlled Trials ISCRTN66528592 
Background 
Muscle  injuries  are one of the commonest injuries affect- 
ing athletes [1]. They account  for up to 30 – 50% of the in- 
juries  in  sports  events  [2,3]. Majority  of muscle  injuries 
are  results  of excessive  strain  on  muscle,  which  occurs 
during sprinting  or jumping. Muscle injury may be the re- 
sult of excessive eccentric contraction, when the muscle 
develops tension  while lengthening  [4]. This injury often 
affects the myotendinous junction  of superficial muscles 
spanning across two joints, such as the rectus femoris, 
semitendinosus, and gastrocnemius muscles [1]. 
The  diagnosis  and  grading  of muscle  injury  is usually 
made  through  a thorough clinical assessment.  Diagnostic 
ultrasound examination is often recommended as the 
method  of choice for confirming  and grading  the  muscle 
injury [5]. Despite the high frequency of muscle injury, the 
best  method   of  its  treatment has  not  yet  been  clearly 
defined. Currently,  many interventions are used, guided by 
limited randomised controlled  trials and quality prospect- 
ive studies  [6]. In professional  sports,  muscle  injury often 
leads to significant pain and disability causing loss of train- 
ing   and   competition   time.   Despite   many   treatment 
options, the duration of the return-to-play (RTP) period 
ranges  from  six weeks to never, based  on the  severity of 
the strains  [7]. Current treatment includes  rest, ice, com- 
pression  and elevation (RICE) with a short period of 
immobilization during  the early phase. In addition,  short- 
term   use  of  nonsteroidal  anti-inflammatory  (NSAIDs), 
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corticosteroid medications and rehabilitation programmes 
is recommended [6,8-14]. 
Basic science  of muscle  healing  has directed  attention 
towards the use of autologous  biological products as a 
treatment alternative  for muscle injury. Damaged  muscle 
goes through the  early phase  of destruction (inflamma- 
tory   phase),   where   affected   cells   including   muscles, 
blood   vessels,   connective    tissues   and   intramuscular 
nerve  undergo  necrosis  [15]. This  phase  is followed  by 
repair and remodelling phases, in which undifferentiated 
satellite cells, in response  to various growth  factors, pro- 
liferate and differentiate  into  mature  myoblasts  in an ef- 
fort to replace the injured  muscle fibers [1]. Many of the 
growth   factors   are   stored   in  the   alpha   (α)  granules 
within platelets  [16]. 
Inflammation  occurring   after   muscle   injury   usually 
leads to accumulation of inflammatory  cells, neutrophils 
and   macrophages.   Activation   of  platelets   also  occurs 
early at the injured site. Activated platelets degranulate 
releasing  various  substances,   including   growth  factors. 
In addition, platelets contain other metabolically active 
substances   such  as  adhesive  proteins   (TSP-1),  clotting 
factors  and their  inhibitors  (TFPI), proteases  (MMP-1,  2 
& 9 and TIMP1-4),  chemokines (SDF-1α), cytokines  and 
membrane glycoproteins  (CD40L), involved in tissue  re- 
pair  and  regeneration [16]. Platelet  derived  growth  fac- 
tors    (PDGF),    vascular    endothelial     growth    factors 
(VEGF), epidermal  growth factor (EGF), basic fibroblasts 
growth    factors   (bFGF),   insulin-like    growth    factor-1 
(IGF-1) and transforming growth  factor beta-1  (TGF-β1) 
are some of the growth  factors released by platelets  [17]. 
IGF-1 and bFGF have the ability to accelerate healing 
following  muscle   and  tendon   injury  [18].  A  previous 
study from an animal model  showed autologous  PRP in- 
jection significantly hastens tibialis anterior muscle re- 
covery from 21 days to 14 days [19]. Sanchez et al. at the 
2nd World Congress on Regenerative Medicine 2005 
presented a similar  finding.  They  noted  athletes  receiv- 
ing PRP injection under ultrasound guidance gain full 
recovery within half of the expected  time [20]. In a study 
involving professional athletes, Wright-Carpenter et al. 
(2004)  demonstrated autologous  conditioned serum 
(ACS) injected  into the injured  muscle shortened the 
duration  to  full RTP by 30% (six days). They  attributed 
the  observed  effects to  the  presence  of increased  levels 
of  growth  factors  (FGF-2,  HGF  and  TGF-β1)  demon- 
strable  on ELISA [7]. In 2010, the International Olympic 
Committee (IOC) concluded  that  currently  there  is very 
limited scientific evidence of clinical efficacy and safety 
profile  of  PRP  use  in  athletic   injuries  [21].  More  re- 
cently,  a  systematic   review  article,  reported   there   has 
been  no  randomised  clinical  trials  of  PRP  effects  on 
muscle  healing.  In  addition,   only  four  clinical  reports 
(level of evidence 3 or 4) were available [22]. More  work 
on  clinical science  of PRP using  robust  clinical trials  to 
demonstrate its efficacy has been recommended [21,22]. 
This paper describes  the protocol  of a randomised con- 
trolled  trial to evaluate the clinical efficacy of a single in- 
jection of PRP combined  with a rehabilitation programme 
on  the  duration to  RTP  after  grade-2  hamstring injury. 
We  hypothesized  that  distinct  differences  would  be 
observed  in  the  duration of RTP  between  those  treated 
with combined  PRP and rehabilitation programme versus 
rehabilitation programme alone. The  presence  of various 
growth factors in PRP could speed up muscle recovery. 
Methods and design 
Study design 
This study involved a randomised, assessor-blinded con- 
trolled    trial   of   16-week   duration.    Participants   were 
screened  before  enrolment. Measurements (described 
below) were taken upon study enrolment. On day three 
following the PRP injection, the participants were reviewed 
for any adverse reaction.  Subsequently,  all the participants 
were  reassessed  once  a week  until  the  end  of the  study 
period.  The protocol  conformed to the CONSORT  guide- 
lines for nonpharmacological interventions [23]. 
Participants 
Patients  with confirmed  grade-2  hamstring muscle  injury 
were invited to participate in this study. Study notice and 
invitation  to take part were distributed to all sports  physi- 
cians  practicing  within  Klang Valley, Selangor,  Malaysia. 
The eligibility criteria for inclusion  were as follows: 
(i) Aged ≥ 18 years; 
(ii) Acute hamstring  muscle injury (≤ seven days); 
(iii) Able to understand study protocol  and completing 
the written  informed consent. 
The exclusion criteria were: 
(i) Having received any form of injection therapy for 
current  injury; 
(ii) Using nonsteroidal  anti-inflammatory drugs 
(NSAIDs) within one week before randomisation; 
(iii) Unable to fulfil follow-up; 
(iv) Significant cardiovascular, renal, hepatic disease, 
malignancy, history of anaemia, and previous 
muscle surgery. 
Procedure 
The procedure is outlined  in Figure 1. An initial screening 
was conducted at the Sports  Medicine  Clinic of the Uni- 
versity of Malaya Medical  Centre  to determine injury se- 
verity. A sport  physician and a physiotherapist conducted 
physical examination and grading  of injury severity using 
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Figure  1 Summary of trial design. 
clinical  grading  as  recommended by Jarvinen  et  al. and 
DeLee et al. [24,25]. 
Later, two experienced  musculoskeletal radiologists 
conducted a diagnostic ultrasound (Philips IU 22 ultra- 
sound  with 17–5  MHz  Probe)  to confirm  the  diagnosis, 
using  the  grading  system  used  at our  hospital  (Table  1) 
and the grading suggested by Peetrons  et al. [26]. Any 
disagreement between assessors was resolved through 
discussion. Diagnostic ultrasound assessment  was con- 
ducted 24 to 48 hours after completion of physical 
examination. We also kept the  record  of those  found  to 
be ineligible. Patients  with grade-2  hamstring muscle  in- 
jury on clinical assessment and confirmed on diagnostic 
ultrasound examination were invited to participate. 
Randomisation 
Participants  were  randomly   allocated  into  one  of  two 
groups: (i) autologous  PRP group or (ii) control  group. 
Randomisation  was  performed  on  those   eligible  after 
 
Table 1 Grading  of muscle  strain injuries  on ultrasound 
Grade Ultrasound findings 
0 
1 
2a 
2b 
2c 
3 
No ultrasound features seen 
Muscle oedema only 
Partial tears of muscle fibres, disruption involving <33% 
Partial tears of muscle fibres, disruption involving ≥ 33 – 66% 
Partial tears of muscle fibres, disruption involving ≥ 66 - 99% 
Complete tear of muscle 
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they  had  signed  the  written  informed  consent.  A com- 
puter  generated  block randomisation of four was used to 
create a randomisation schedule.  Treatment assignments 
were conducted by the trial manager  MS. 
Injection  technique 
As a recent  study  showed,  a statistically  significant  de- 
crease in tenocyte  proliferation and cell viability, follow- 
ing PRP combined  with the local anaesthetic agent 
(lidocaine   and  bupivacaine)   [28],  no  local  anaesthetic 
was given prior to PRP injection  in the current study. 
To  the  best  of  our  knowledge   the  current  existing 
guideline lacks information on the optimal timing, fre- 
quency  of administration, clinical effective dose and vol- 
ume, as well as post-injection rehabilitation technique 
following PRP injection for muscle injury [21,29]. Fur- 
thermore, no long-term clinical studies exist on potential 
adverse  effects. Our  decision  to use a single injection  of 
3 ml of PRP in the intervention group  was based on the 
findings   of   existing   clinical   studies.   Sanchez   at   al. 
reported  ultrasound guided injection  of autologous  prep- 
aration  rich in growth  factors (PRGF) within  the injured 
muscle  enhances   healing  and  functional  recovery.  Fur- 
ther, small tears indicated  good progress with a single ap- 
plication of PRGF, while a medium  to large size tears 
required  two or three  applications  of PGRF [20]. Hamil- 
ton et al. reported  single injection  of PRP combined  with 
daily physiotherapy  programme was effective for grade II 
semimembranosus   strain    injury.   They   demonstrated 
17 days following injection  of 3 ml PRP, the  athlete  was 
pain free and able to achieve full range of motion. The 
athletes   were   back   to   their   preinjury   activities   after 
3 weeks [30]. 
Under  ultrasound guidance,  3 ml of PRP were injected 
directly into  the injured  area via an 18 G needle  using a 
peppering   technique.   All  injections   were  done   under 
aseptic technique.  Each participant in the PRP combined 
rehabilitation programme group  received  a single injec- 
tion of PRP throughout the study. Immediately after in- 
jection, the patient  was kept in supine  position  for 10 to 
15 minutes.  Participants were advised to rest, limit their 
activities for the next 48 hours,  and use only acetamino- 
phen for pain. The use of non-steroidal medication was 
prohibited. 
Participants were  reassessed  for  any  adverse  reaction 
three  days  after  receiving  PRP.  Later,  weekly  reassess- 
ment  was conducted until  the end of the study. All par- 
ticipants  were  asked  to  continue   with  an  unsupervised 
daily  home  exercise  programmes  as  prescribed   and  to 
keep  a record  of these  sessions.  The  use  of painkillers, 
other than nonsteroidal anti-inflammatory drugs, was 
allowed. All medication use was recorded. 
Participants in both groups were required to attend a 
weekly rehabilitation session with a physiotherapist until 
full recovery  or the  end  of 16 weeks. At each visit, out- 
come  measures   were  assessed,  and  rehabilitation pro- 
grammes were conducted under a physiotherapist’s 
supervision. Each treatment session lasted for 45 – 60 
minutes.   Three-experienced   physiotherapists  (with   at 
Blinding 
Three  physiotherapists (PC, FJ, SR) acted as the outcome 
measure   assessors.   They   were   involved   in   providing 
standard  rehabilitation  programmes  to  all  participants 
but  were blinded  about  the participant group  allocation. 
The  participants were  requested   not  to  disclose  details 
of their  treatment. On trial completion, the assessor was 
asked  to  guess  which  treatment  each  participant 
received. The success of blinding was determined by cal- 
culating the ‘blinding index’ using the method  demon- 
strated  by James et al. [27]. 
Interventions 
PRP intervention group 
Participants in the PRP group  received a single injection 
of autologous  PRP under  expert  ultrasound guidance  by 
a musculoskeletal radiologists trained  in interventional 
musculoskeletal  injections.  The  injection  was  adminis- 
tered   once,  following  randomisation 
group  (day 1 of the study). 
of  the  treatment 
PRP preparation 
Fifty-five  millilitres   (ml)   of  venous blood   were   col- 
lected  from  the  participants’  arm  into  a 60  ml  syringe 
primed   with   ACD-A.   In   addition,   2   ml   of   venous 
blood  were  collected  and  sent  to  the  hospital  labora- 
tory   for   determination   of   platelets    and    leucocytes 
count.    The   blood   collected   for   PRP   was   prepared 
according   to   the   GPSTM   III  Systems   instruction   for 
use   (Biomet   Biologics,  Inc.,  Warsaw,   Ind).   Since   an 
acidic  anticoagulant  was  added   during   the   collection 
of  whole  blood,  PRP  was  buffered  to  increase  the  pH 
to  normal   physiological  levels.  This  was  accomplished 
by adding  8.4% sodium  bicarbonate solution  in  a ratio 
0.05  ml  of  sodium   bicarbonate  to  1  ml  of  PRP.  No 
activating   agent   was   added   to   the   PRP.   The   time 
taken  to prepare  PRP was about  30 minutes.  A standard 
60 ml GPSTM  III kit could  produce  approximately  6 ml 
of PRP. 
In  our  study,  3  ml  of  extracted   PRP  were  injected 
into  the  injured  area  under   ultrasound  guidance.  One 
ml was sent to the hospital laboratory for platelets and 
leucocyte  count,  while the  remaining  2 ml  were  stored 
in −20° Celsius for analysis of growth factors (basic 
fibroblast   growth   factor   [bFGF];   insulin-like    growth 
factor-1 [IGF-1]; transforming growth factor-β1 [TGF-β1]), 
which were done later. 
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least five years of clinical experience)  practicing  at Uni- 
versity Malaya Medical  Centre  and  National  Institute of 
Sports were trained  to assess outcome  measures  and de- 
liver rehabilitation programmes. The training involved a 
half-day course  delivered by the principal  researcher and 
a treatment manual.  The  treatment manual  contained a 
brief summary  of the study, assessment  methods  and 
hamstring rehabilitation based  on  the  programme used 
by Sherry et al. [31]. In addition, the participants were 
expected  to  independently  track  their  exercise  compli- 
ance  by  recording   the  days  they  performed  the  pre- 
scribed  rehabilitation  programme  on  a logbook  and  to 
report  any difficulties at each follow-up visit. The re- 
habilitation  programme used in the study focused on 
progressive    agility   and   trunk    stabilization    exercises 
(Table  2). This  programme was based  on  a set of exer- 
cises  used  in  an  earlier  study  [31]. Further,  this 
programme was found to be more effective than a 
programme that  only emphasized  on hamstring stretch- 
ing and strengthening in promoting RTP and preventing 
injury recurrence in athletes  affected with an acute ham- 
string strain [31]. 
Table 2 Rehabilitation programme 
Phase 1 
1. 
2. 
Low to moderate-intensity sidestepping, 3 × 1 min 
 
Low to moderate-intensity grapevine stepping (lateral stepping with 
the trail leg going over the lead leg and then under the leg), both 
directions, 3 × 1 min 
Low to moderate-intensity steps forward and backward over a tape 
line while moving sideways, 2 × 1 min 
Single-leg stand progressing from eyes open to eyes closed 4 × 20 sec 
 
Prone abdominal body bridge (performed by using abdominal and 
hip muscle to hold the body face-down straight-plank position with 
the elbows and feet as the only point of contact), 4 × 20 sec 
Supine extension bridge (performed by using abdominal and hip 
muscles to hold the body in a supine hook lying position with the 
head, upper back, arms, and feet as the points of contact), 4 × 20 sec 
Side bridge, 4 × 20 sec on each side 
Ice in long-sitting position for 20 min 
3. 
4. 
5. 
6. 
7. 
8. 
Phase 2* 
1. 
2. 
3. 
Moderate to high-intensity sidestepping, 3 × 1 min 
Moderate to high-intensity grapevine stepping, 3 × 1 min 
 
Moderate to high-intensity steps forward and backward while 
moving sideways, 2 × 1 min 
 
Single-leg stand windmill touches, 4 × 20 sec of repetitive alternate 
hand touches 
Push-up stabilization with trunk rotation (performed by starting at 
the top of a full push-up, then maintain this position with 1 hand 
while rotating the chest toward the side of the hand that is being 
lifted to point toward the ceiling, pause and return to the starting 
position), 2 × 15 reps on each side 
 
Fast feet in place (performed by jogging in place with increasing 
velocity, picking the foot only a few inches off the ground), 
4 × 20 sec 
Proprioceptive neuromuscular facilitation trunk pull-downs with 
Thera-Band, 2 × 15 to the right and left 
Symptom-free practice without high-speed manoeuvres 
Ice for 20 min if any symptoms of local fatigue or discomfort present 
4. 
Primary  outcome measures 
In this study, primary  outcome  was the duration of RTP. 
Duration  of RTP is defined  as the  duration  (days) from 
the date  of injury until  the participants fulfil the  criteria 
for  RTP.  The  decision  on  determination  of  fitness  for 
RTP is based on expert  opinion  [32]. As there  were lim- 
ited  scientific  studies  done  to  examine  the  outcome  of 
various RTP strategies  [33], we decided  to come up with 
our  own criteria  of RTP (Table  3) based  on recent  clin- 
ical sports  medicine  recommendations [8,34-37]. 
Direct hamstring palpation  was conducted and pain 
elicited was recorded  in the participants’ clinical research 
form  (CRF). Pain provocation test  was evaluated  by iso- 
metric contraction of the hamstring muscles when palpa- 
tion  did  not  elicit  any  tenderness. This  test  was 
performed in prone lying with the knee flexed at approxi- 
mately  15° [38]. Hamstring range  of movement  (ROM) 
was assessed using the active knee extension  (AKE) test. 
The  AKE test  involves movement of the  knee  joint  but 
not the hip, unlike the straight-leg  raise (SLR) test which 
involves  movements of  both  hip  and  knee  joints.  AKE 
test is an active test and is considered safe as the partici- 
pants  dictate  the  end  point.  This  test  has  been  recom- 
mended  and often  used to measure  hamstring tightness. 
AKE test normal  values of knee motion  were reported  to 
be within 20° on full extension  of the knee [39]. 
Hamstring muscle  strength was assessed using an iso- 
kinetic dynamometer (System 4 Pro, Biodex Medical 
System, NY, USA). Assessment  of hamstring and quadri- 
ceps muscles of both legs was also conducted during 
participants’  weekly  visit.  Participants  were  allowed  to 
5. 
6. 
7. 
8. 
9. 
Key: Low intensity, a velocity of movement that is less than or near that of 
normal walking; moderate intensity, a velocity of movement greater  than 
normal walking but not as great as sport; high intensity, a velocity of 
movement similar to sport activity. 
* Participants allowed to progress from phase  1 to phase  2 when they could 
walk with a normal gait pattern  and perform a high knee march in place 
without pain. 
familiarise with the experimental protocol  before testing. 
During  the  familiarization  period,  participants practiced 
with  sub-maximal  effort.  The  participants’  knee  joint 
centre  was kept  aligned  with the  axis of the  dynamom- 
eter crank arm. The testing protocol included maximum 
voluntary  strength  of both  legs, with  the  uninjured leg 
tested  first.  Muscle  strength test  was performed under 
concentric  exertion   at  three   angular  speeds  (60°, 180° 
and  240°/second).  Each participant performed five max- 
imum contractions at angular speeds of 60°/s, ten max- 
imum   contractions  at  angular   speeds   of  180°/s,  and 
fifteen maximal  contractions at angular  speeds of 240°/s, 
with  a rest  interval  of about  60 seconds  between  each 
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zð1-βÞ of 80%= .84 (percentage  of the normal Table 3 Criteria  for return-to-play (RTP) 
distribution  for statistical power of 80%) 
μ1 = population  mean in treatment Group  1 
Sign General Recommendation 
Pain Pain-free (on direct palpation) 
 
Pain free on hamstring contraction (resisted isometric 
hamstring muscle contraction) 
Symmetrical with unaffected site 
Isokinetic strength within 5% [29,30] 
to 10% [8] of contralateral side 
μ2 = population  mean in treatment Group  2 
μ1  – μ2 = the mean difference 
σ2 = population  [standard  deviation (SD)] 
Total sample size after estimation  of 30% attrition  rate 
= 11 + 3 = 14 participants  in each intervention group 
giving a total of 28 participants  altogether  [7]. 
Range of motion 
Strength 
speed.  At  each  speed,  quadriceps   muscles were  tested 
first  followed  by  the  hamstrings.   The  participants  did 
not  receive any visual feedback during  the test; however, 
verbal encouragements were given. 
The participants that  failed to meet the RTP criteria  at 
the end of week 16 were allowed to continue their  treat- 
ment  in the UMMC  until full recovery. 
Data and  statistical analysis 
The primary analysis was done using the principle of 
intention-to-treat  (ITT).  ITT  analysis  includes   partici- 
pants  with  incomplete   data,  those  who  deviated  from 
the  study  protocol   and  those  who  withdrew  from  the 
study. Missing data were handled through multiple im- 
putation methods [43]. 
Socio-demographic,  clinical  characteristics  and  base- 
line information were presented to assess comparability 
between  groups.  Similar  variables  were  also  examined 
among the participants who withdrew  from the study. 
The  primary  endpoint of the study  was the date  when 
RTP was achieved or the end of week 16. Differences for 
categorical variables are tested with a chi-square  test or 
Fischer’s exact test. As clinical outcome  variables were 
repeatedly  measured  over time, a multivariate  analysis of 
variance  (MANOVA)   for  repeated   measures   was  per- 
formed  to  explore  an  overall  time,  general  group,  and 
the time by group interaction effect. 
Signs and  symptoms  changes  were explored  using lin- 
ear  regression  analysis to  determine the  rate  of change. 
In addition,  levels of the  various  growth  factors  (IGF-1, 
bFGF  and  TGF)  were  determined.  Statistical   analyses 
were  carried  out  using  SPSS (Version  19). For  all ana- 
lyses, a value of P <.05 was considered  significant. 
Secondary outcome measures 
The Brief Pain Inventory  - Short Form (BPI-SF) ques- 
tionnaire  were used  to assess the  severity and  impact  of 
pain on the participants’ daily functions.  The BPI-SF is a 
self-reported questionnaire. It consists of four questions 
related  to  pain  severity  and  seven  questions   related  to 
pain  interference on  daily functions.  The  pain  intensity 
items   are  presented  as  numeric   rating   scales,  with  a 
minimum score  of  0  (indicating   no  pain)  and  a  max- 
imum  score of 10 (when pain is as bad as one could im- 
agine). Similar scales are used for the seven items on 
interference of participants’  daily functions.  The  BPI-SF 
has been validated in several languages, including  Malay 
[40] and demonstrated a Cronbach alpha reliability that 
ranges from 0.77 to 0.91 [41]. 
Platelet  levels in  participants’  venous  blood  and  PRP 
were   determined.   In   addition,    levels   of   insulin-like 
growth factor-1 (IGF-1), basic fibroblasts growth factor 
(bFGF) and transforming growth  factor-beta  1 (TGF-β1) 
were determined using ELISA kits (Cusabio, USA). 
The participants’ attendances to the physiotherapy session 
were  recorded  to  determine adherence.  In  addition,  their 
daily logbook of self-home exercise was also evaluated. 
Any  adverse  events  occurring   during  the  study  were 
documented and proper  measures  were taken. 
Timelines 
The study was approved  by the University Malaya Medical 
Centre  (UMMC),  Medical  Ethics  Committee in February 
2011 (MEC Ref. No: 835.11). Recruitment and training  of 
physiotherapists were  conducted in September  2011. Pa- 
tient recruitment started from February 2012. Expected 
completion date of the study is in December  2012. 
Sample  size 
Sample  size was determined using  the  following  formula 
[42]: 
Discussion 
This  is the  first  randomised controls  study  to  examine 
the effect of PRP on duration of RTP after a grade-2 
hamstrings injury.  There  are  several  major  strengths of 
the  intervention design  in this  study.  The  primary  out- 
come  of this study  includes  a combination of subjective 
and  objective  assessments   of RTP  criteria.  The  criteria 
used   are   based   on   several  current  recommendations 
from leading experts and reflect present clinical practice 
[8,34-37]. 
2 2 2 x ½zð1-α=2Þ  þ zð1-βÞ ]  σ 
N ¼ 2 ½μ1  - μ2 ] 
Where: 
N = the sample size in each of the groups 
zð1-α=2Þ of :05= 1.96 (percentage  of the normal 
distribution  for statistical significance level of .05) 
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The  rehabilitation programme for this  study  has been 
based  on  a contemporary programme that  was effective 
for  acute   hamstring   strain.   The   average   (±SD)  time 
needed to RTP in athletes under such a rehabilitation 
programme was 37.4 ± 27.6 days [31]. 
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Grade-2   muscle   injury   is  confirmed on   ultrasound 6. 
(US) assessment.  US is a cheap,  reproducible and  well- 
tolerated   imaging  examination,   which  also  provides  a 
real-time   functional   assessment   in  multiplanar  views 
[44]. US is suggested  to have equal sensitivity to MRI for 
acute  hamstring muscle  complex  injury, especially when 
performed within 2 weeks following injury [45]. US as- 
sessment  of hamstring injury in our  study  would ensure 
uniformity  of injury grading and allow comparison of 
treatment interventions between  groups. 
Infiltration  of autologous  PRP under  ultrasound guid- 
ance allows accurate  delivery of PRP contents to the site 
where  it is to have the  greatest  effect [46].Finally, levels 
of growth  factors  including  IGF-1, bFGF and TGF-β1  in 
the  PRP are  determined using  ELISA kits.  This  would 
allow us to explore the potential  individual  effect of PRP 
constituents on muscle healing. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
Conclusion 
This is a randomised controlled trial exploring the ef- 
fectiveness of a single injection  of autologous  PRP com- 
bined with hamstring rehabilitation programme on the 
duration   of RTP  after  a grade-2  hamstring injury.  The 
major  strengths of this study include  reproducibility and 
reflection of current clinical management of grade-2 
hamstring injury. The  findings  enable  recommendations 
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16. 
17. 
18. 
of   this 
injury. 
treatment alternative for grade-2 hamstring 
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